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ABSTRACT 
The infections from bacterial pathogen Pseudomonas aerugionsa are very 
difficult to cure and cause premature death of many patients with AIDs, cystic 
fibrosis and cancer.  Bacteria need iron to infect an organism, but the 
concentration of free iron in mammals is very low (~10-9 M).  Therefore, bacteria 
have developed sophisticated iron acquisition mechanisms, including the 
utilization of heme iron.  Heme oxygenase is the only known protein used for 
heme degradation and iron release inside a cell.  In Pseudomonas aerugionsa, 
once heme is internalized to the cytoplasm, heme oxygenase (pa-HO) uses heme 
as a cofactor and substrate and degrades it into biliverdin and releases iron and CO.  
This heme degration process uses three oxygen molecules and seven electrons 
obtained from a novel redox partner protein: ferredoxin NADPH reductase (pa-
FPR).   
The unique heme degradation catalysis in pa-HO was studied from a 
global view by probing a series of hydrophobic phenylalanine (Phe) rings inside 
heme oxygenase.  We probed the Phe rings via mutagenesis, fluorine labeling 
using reactivity assays and spectroscopic methods to understand the relationship 
of protein structure, dynamics and catalysis.  The results show that the 
hydrophobic cluster not only maintains protein structure, but also fine-tunes 
protein dynamics to facilitate the channeled H-bonding network from the heme 
binding site to the protein periphery to sustain catalysis. 
 iv 
In bacteria, it is proposed that electrons from NADPH are transferred to 
ferredoxin reductase, then to ferredoxin, at last to heme oxygenase.  In the study 
of pa-HO redox partner, we found a surprising result that pa-FPR by itself can 
donate all seven electrons to pa-HO for heme degradation and iron release.  We 
studied pa-FPR by X-ray crystallography and spectroscopic methods in order to 
understand how pa-FPR interacts with pa-HO.  Pa-FPR is a bacterial subclass I 
ferredoxin NADPH reductase (FNR) protein.  In a study of NADP+ coenzyme 
binding to pa-FPR, we obtained the NMR backbone resonance assignments for 
pa-FPR in solution, co-crystallized the pa-FPR-NADP+ complex and obtained its 
crystal structure, which is the first example of a bacterial subclass FNR and 
second example in the whole FNR family.  From this study, we proposed a novel 
stepwise e-/H+/e- hydride transfer mechanism for bacterial FNR rather than 
adopting the conventional direct hydride transfer mechanism for plastidic FNR.  
Furthermore, we studied the protein-protein interaction (PPI) between pa-FPR and 
pa-HO.  The preliminary data suggests that this PPI is transient, ultra-weak and 
electrostatic and the interaction interface on pa-HO is around the heme binding 
site.  
 v 
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CHAPTER I: INTRODUCTION 
Pseudomonas aeruginosa, as an opportunistic pathogen, is well-known 
because it uses sophisticated virulence factors to infect many patients suffering 
from cystic fibrosis, AIDs and other diseases.  It colonizes and damages the 
defense mechanism of its host and the infection is very difficult to cure and often 
leads to the death of the host [1].  With the available Pseudomonas aeruginosa 
genome: www.pseudomonas.com, many studies of this pathogen have become 
possible.  One of the most interesting topics is how the bacterium acquires its 
nutrient, specifically iron from its host.  Based on our previous study of heme 
containing proteins like cytochrome b5 and heme oxygenase, we are especially 
interested in identifying and studying the proteins involved in the heme-iron 
acquisition pathway in Pseudomonas aeruginosa.  Through this pathway, well-
designed by nature, the bacterium can successfully acquire heme-iron from the 
host for its own survival [2].  Understanding of this pathway can be used to 
discover novel treatments for infections with drug resistant P. aeruginosa strains.  
The importance of the iron acquisition has been recognized and acknowledged by 
more and more studies in recent years with the aid of fast developing 
biotechnologies, such as sequencing and high throughout screening etc.  
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Figure 1-1.  Result of searching “Iron Acquisition” in SciFinder 2007(done at 1/10/2008). 
 
1. Background of Heme-Iron Acquisition in Pseudomonas aeruginosa 
It is known that pathogenic bacteria need iron to colonize (infect) an 
organism.  However, the concentration of free iron in mammals is typically very 
low (~10-9 M) because it is sequestered by iron-binding and iron-containing 
compounds such as transferrin, lactoferrin, heme, hemoglobin and ferritin [3].  In 
addition, mammals have evolved means to fight invading pathogens by making 
iron even less accessible by reducing levels of transferrin and by down-regulating 
the recycling of iron from macrophages [4].  It has also been shown that lipocalin 
2, an iron-binding protein innate to the immune response sequesters iron from 
bacterial siderophores in the early stages of bacterial infection [5].  It is therefore 
not surprising that pathogens such as Neisseriae meningitidis, Haemophilus 
influenzae, Shigella dysenteriae, Vibrio cholerae and the opportunistic 
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Pseudomonas aeruginosa have evolved sophisticated mechanisms for iron 
acquisition, including the utilization of heme iron [6, 7].  Heme containing 
proteins and in particular hemoglobin constitute an important reservoir of iron 
given that more than two thirds of the total iron is chelated by heme and that ~ 
95% of iron-bound heme is in the form of hemoglobin [8].  Consequently, many 
pathogenic bacteria have evolved specific heme uptake systems to acquire heme-
iron from mammalian hosts.  Although these systems are best understood in gram 
negative bacteria [6, 7], it has been recently shown that Staphylococcus aureus not 
only uses heme as an iron source but it prefers heme-iron in the initial stages of 
infection [2].  Heme uptake and utilization are also mechanisms used by the 
opportunistic pathogen Pseudomonas aeruginosa, which can deploy two operons 
regulated by Fur, the master Fe uptake regulator [9].  The global iron response 
associated with Fur-regulated genes includes the heme uptake systems phu 
(Pseudomonas heme uptake) and has (heme acquisition system).  The phu locus 
consists of a receptor gene (phuR) and the phuSTUVW operon encoding a typical 
ABC transporter.  The second uptake system, has, consists of a heme receptor 
(hasR) and a protein that binds heme with high affinity, also known as a 
hemophore [6].  Once internalized to the cytoplasm heme is delivered to heme 
oxygenase (pa-HO) for its degradation to biliverdin, thus facilitating release of the 
heme-iron for subsequent metabolic use [10]. 
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Figure 1-2.  Proposed Heme-Iron Acquisition Pathway In Pseudomonas aeruginosa 
under iron-starvation [11] condition.  (Courtesy of Saroja Weeratunga).  
 
Release of heme-iron is accomplished by the breakdown of heme to 
biliverdin.  This is a complex reaction requiring the input of 7 electrons and 3 
molecules of O2, which must be delivered to HO rapidly and efficiently in order to 
sustain catalytic activity (Figure 1-2).  Heme breakdown starts with the one 
electron reduction of ferric HO (resting state) to the deoxyferrous state, followed 
by the rapid binding of dioxygen to form an oxyferrous complex (FeII-O2) [12].  
Injection of a second electron into the FeII-O2 complex triggers electron 
rearrangement that leads to the formation of a ferric peroxide (FeIII-OO–) complex, 
which accepts a proton to form a ferric hydroperoxide (FeIII-OOH) oxidizing 
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species [13].  Ring oxidation involves attack of the FeIII-OOH intermediate on the 
aromatic macrocycle [14] to form a meso-hydroxyheme intermediate, which 
undergoes a subsequent O2- and electron-dependent elimination of the 
hydroxylated meso carbon as CO, thus forming verdoheme.  Verdoheme is then 
oxidized to FeIII-biliverdin in a reaction that requires both O2 and additional 
electrons [15, 16].  FeIII-biliverdin must be reduced to FeII-biliverdin prior to the 
sequential release of FeII and biliverdin [17].   
 
Scheme 1-1.  Heme metabolism pathway in heme oxygenase. 
 
 Heme oxygenase is the only known enzyme to degrade heme and release 
iron inside a cell.  The unique catalysis of its hydroxylation step (Scheme 1-1) that 
converts the ferric hydroperoxyl heme to α-meso-hydroxyheme is the most 
distinguishable step from all other heme-containing proteins.  A unique 
phenylalanine ring cluster has been observed in several heme oxygenases.  
Intensive studies to this aromatic ring cluster in Pseduomonas aeruginosa heme 
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oxygenase (pa-HO) have been employed for understanding how protein structure 
and dynamics regulate this unique heme degradation catalysis in heme oxygenase.  
With the understanding of how heme oxygenase works, we further studied its 
potential redox partner proteins to reveal where and how pa-HO gets the seven 
electrons for heme degradation and iron releasing. 
2. Dynamic structural regulation to functional catalysis --- Study of 
Heme Oxygenase Phenylalanine Ring Cluster  
Heme oxygenase is well known for its distinctive catalytic cycle.  Unlike 
other heme-containing proteins, heme is used as the substrate for not only electron 
transfer but also its own degradation.  Previous intensive studies have revealed 
that there is a peculiar heme hydroxylation process which is extraordinary from all 
other heme-proteins [10, 12, 14].  The focus has been placed on the input of the 
first 2 electrons that are utilized by the enzyme to reduce coordinated O2 at the 
active site.  The resultant ferric hydroperoxide intermediate (FeIII-OOH) reacts 
with the macrocycle to form meso-hydroxy heme, which in the presence of O2 and 
five additional reducing equivalents is converted to biliverdin and free iron.  
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Figure 1-3. Obligated two heme hydroxylation paths.  
 
The key in the heme degradation process is how nature tunes this enzyme 
to carry out the dioxygen activation toward heme oxygenation efficiently rather 
than taking the common alternative pathway for the formation of ferryl heme [18].  
Observations made in our lab suggested that this heme hydroxylation is facilitated 
by the deformation of the heme that is regulated by the dynamic motion of protein 
structure [19-21].  From those studies, we can understand locally how heme 
interacts with the residues and the structural water inside the heme binding pocket.  
But how does the protein fulfill its specific catalysis function in a global fashion 
instead of the local view from the heme binding site?  Also how do the 
hydrophobic cluster, H-bonding network and protein dynamics contribute to this 
unique catalysis?  The answer is very limited and unexplored.   Based on earlier 
findings, our target is to understand the protein structure-function from a global 
view.  
Ferryl 
Ferric hydroxy 
heme 
Verdoheme 
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Our entry point is originated from an intriguing observation that there is a 
cluster of conserved hydrophobic phenylalanine rings present in heme oxygenase, 
revealed by studies of protein crystal structures and structural alignment as shown 
below. 
 
Rat-HO1-1DVE    -MERPQLDSMSQDLSEALKEATKEVHIRAENSEFMRNFQKGQVSREGFKLVMASLYHIYT 59 
h-HO1-1N45      -MERPQPDSMPQDLSEALKEATKEVHTQAENAEFMRNFQKGQVTRDGFKLVMASLYHIYV 59 
cd-HO-1IW0      ------MTTATAGLAVELKQSTAQAHEKAEHSTFMSDLLKGRLGVAEFTRLQEQAWLFYT 54 
pa-HO-1SK7      MDTLAPESTRQNLRSQRLNLLTNEPHQRLES---LVKSKEPFASRDNFARFVAAQYLFQH 57 
nm-HO-1J77      ---MSETENQALTFAKRLKADTTAVHDSVDN---LVMSVQPFVSKENYIKFLKLQSVFHK 54 
 
Rat-HO1-1DVE   ALEEEIERNKQNPVYAPLYFPEELHRRAALEQDMAFWYG-PHWQEAIPYTPATQHYVKRL 118 
h-HO1-1N45     ALEEEIERNKESPVFAPVYFPEELHRKAALEQDLAFWYG-PRWQEVIPYTPAMQRYVKRL 118 
cd-HO-1IW0     ALEQAVDAVRAS-GFAESLLDPALNRAEVLARDLDKLNGSSEWRSRITASPAVIDYVNRL 113 
pa-HO-1SK7     DLEPLYRNEALARLFPGLASRARDDAARADLADLGH--------PVPEGDQSVREADLSL 109 
nm-HO-1J77     AVDHIYKDAELNKAIPELEYMARYDAVTQDLKDLGE--------EPYKFDKELPYEAG-- 104 
 
Rat-HO1-1DVE   HEVGG-THPELLVAHAYTRYLGDLSGGQVLKKIAQKAMALPSSGEGLAFFTFPSIDNPTK 177 
h-HO1-1N45     HEVGR-TEPELLVAHAYTRYLGDLSGGQVLKKIAQKALDLPSSGEGLAFFTFPNIASATK 177 
cd-HO-1IW0     EEIRDNVDGPALVAHHYVRYLGDLSGGQVIARMMQRHYGVDP--EALGFYHFEGIAKLKV 171 
pa-HO-1SK7     AEALG---------WLFVSEGSKLGAAFLFKKAAALELDENFG----ARHLAEPEGGRAQ 156 
nm-HO-1J77     NKAIG---------WLYCAEGSNLGAAFLFKHAQKLDYNGEHG----ARHLAPHPDGRGK 151 
 
Rat-HO1-1DVE   FKQLYRARMNTLEMTPEVKHRVTEEAKTAFLLNIELFEELQALLTEEHKDQSPSQTEFLR 237 
h-HO1-1N45     FKQLYRSRMNSLEMTPAVRQRVIEEAKTAFLLNIQLFEELQELLTHDTKDQSPSRA---- 233 
cd-HO-1IW0     YKDEYREKLNNLELSDEQREHLLKEATDAFVFNHQVFADLGKGL---------------- 215 
pa-HO-1SK7     GWKSFVAILDGIELNEEEERLAAKGASDAFNRFGDLLERTFA------------------ 198 
nm-HO-1J77     HWRAFVEHLNALNLTPEAEAEAIQGAREAFAFYKVVLRETFGLAADAEAPEGMMPHRH-- 209 
 
Rat-HO1-1DVE   QRPASLVQDTTSAETPRGKSQISTSSSQTP 267 
h-HO1-1N45     ------------------------------ 
cd-HO-1IW0     ------------------------------ 
pa-HO-1SK7     ------------------------------ 
nm-HO-1J77     ------------------------------ 
Figure 1-4. Phe rings in five heme oxygenases aligned by ClustalW. Pa-HO sequence is 
in bold.  The possible conserved Phe rings are colored blue in pa-HO, the corresponding 
Phe residues are bold and colored red, and the corresponding Tyr residues are bold.  Rat 
heme oxygenase 1 (Rat-HO1): 1DVE (pdb ID) [22], Human heme oxygenase 1 (h-HO1): 
1N45 (pdb ID) [23], Corynebacterium diphtheriae heme oxygenase (cd-HO): 1IW0 (pdb 
ID) [24], Pseudomonas aeruginosa heme oxygenase (pa-HO): 1SK7 (pdb ID) [25], 
Neisseria meningitidis heme oxygenase (nm-HO): 1J77 (pdb ID) [26]. 
 
In the heme oxygenase protein sequence alignment shown in Figure 1-4 
above, there is a series of Phe rings in all the heme oxygenases.  In pa-HO, there 
are 13 of them.  In other HOs, there is either Phe or Tyr in the corresponding or 
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similar locations in the protein sequence.  For example, F45 and F186 in pa-HO 
are conserved, and F72, F117 and F161 in pa-HO are conserved as Phe or Tyr in 
the other four HOs.  In human HO-1, the F166, F167 and F169 are not conserved 
in pa-HO but are conserved in rat and Corynebacterium diphtheriae heme 
oxygenases.  By comparing the sequence of pa-HO with its equivalent HOs from 
other Pseudomonas strains, like P. fluorescens (PF), P. syringae (PS) and P. 
putida (PP), we found that most of the 13 Phe rings are reserved except F197, F72 
and F130 and F197 is replaced with Tyr.  Therefore, it is highly likely that these 
Phe rings are conserved.  Next, we observed the Phe rings closely in the crystal 
structure of pa-HO. 
 
Figure 1-5. Target Phenyalanines of total 13 Phenyalanines in pa-HO (PDB: 1SK7). 
 
As shown in Figure 1-5, most of the 13 Phe rings are located around the 
heme distal pocket.  F55, F189, F197, F48, F45, F39, F130 and F128 can possibly 
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form a hydrophobic channel located around the heme pocket, especially F39, F45 
and F48 are positioned so closely to each other.  As shown in the “zoom-in” view 
of the three phenylalanine rings, one can predict that the rotation of F45 can 
possibly have a cooperative motion with F39 and F48.  
In human HO-1, the rings of F47, 95, 166, and 167, Y58, and W96 are also 
close to one another spatially.  Especially between F166 and Y58 and between 
F167 and F47, there are close interactions [27].  From the human HO-1 CN 
complex NMR studies done by La Mar and coworkers, they predicted two new 
water molecules in the empty space of the 1.5 Å h-HO-1 crystal structure, one is 
between the F167 ring and V42 based on the identified H-bond from F167 CξH to 
the hypothesized water molecule, and the other is between W96 and G163 based 
on the identified H-bond from W96 NεH to the hypothesized water molecule [27].  
Therefore, they suggested that the two proposed water molecules near the 
aromatic rings, together with other water molecules observed in the crystal 
structure, form a channel of water molecules that extends from the distal ligand to 
the surface of the protein on the opposite side of the heme binding pocket [27]. 
Phe is a hydrophobic residue; its ring rotation displaces about 80 cubic 
angstroms of volume.  The cluster of Phe rings can possibly form a hydrophobic 
cluster and exclude water.  The hydrophobic cluster is likely particularly 
important to protein folding, conformational changes and possibly protein 
dynamics [28].  
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By using mutagenesis and fluorine labeling of the Phe residues, we 
investigate the protein structure-function relationship via NMR and a reactivity 
assay simulating the heme oxygenase catalytic cycle (Scheme 1-1) in next chapter. 
  With the understanding of how pa-HO works in a global view, to probe 
this iron acquisition pathway in context with other partner proteins becomes 
important and urgent.  In mammals, NADPH transfers electrons to cytochrome 
P450 reductase then to heme oxygenase [29], while heme oxygenase in plant or 
bacteria can obtain electrons from various redox partners to complete the heme 
degradation process [30].  
 
3. Characterization of FPR as a novel redox partner of Heme Oxygenase 
The identification and characterization of redox partners that deliver 
electrons to HO, as well as the characterization of protein-protein interactions that 
facilitate the vectorial electron flow from NAD(P)H to HO are important steps 
toward a molecular-level understanding of heme metabolism.  Cytochrome P450 
reductase supports the catalytic activity of mammalian HO-1 and HO-2 by 
donating all 7 electrons [17].  In comparison, current understanding regarding the 
nature of the redox partner(s) that support the catalytic activity of bacterial HO 
enzymes is significantly less developed.  It is thought that cyanobacterial and 
eubacterial HOs are ferredoxin-dependent.  However, it is noteworthy that the 
reports proposing this idea also state that HO activity in cell extracts containing 
reduced ferredoxin also requires the presence of a second (auxiliary) reductant, 
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such as trolox or ascorbate [31-34].  In fact, in the absence of such auxiliary 
reducing agents HO activity is very slow [31, 33] or is arrested at the oxyferrous 
heme stage [32].  It is also important to note that despite the widespread belief that 
bacterial HOs are ferredoxin-dependent the specific ferredoxins that support the 
activity of these HO enzymes are not yet known.  We have recently observed a 
potentially important clue regarding the nature of the enzymes that transfer 
electrons to P. aeruginosa HO (pa-HO) under conditions of iron starvation.  This 
indication comes from the analysis of relatively recent data on genes affected by 
the iron starvation response in P. aeruginosa [35], which revealed that the 
expression of 118 genes was increased at least 3-fold under iron-starvation 
conditions relative to iron-replete conditions.  We noticed that among the 118 
upregulated genes, the expression of a gene coding for a ferredoxin (bfd) is 
increased 203-fold and a gene coding for a ferredoxin reductase (fpr) is increased 
3-fold.  These observations suggested that the ferredoxin coded by the bfd gene 
may be the physiological reductant of pa-HO, a hypothesis that is in agreement 
with the fact that among the 118 genes upregulated by iron limitation, expression 
of the gene coding for pa-HO (pigA, or PA0672) is also increased 138-fold, and 
that there is no other upregulated gene coding for a ferredoxin or other classical 
electron transfer proteins.  Moreover, the product of the fpr gene, a ferredoxin 
reductase (pa-FPR) is likely the enzyme that transfers electrons to pa-Bfd from 
NAD(P)H.  Hence, the motivation of these studies was to probe a hypothesis that 
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the seven electrons needed by pa-HO to degrade heme and release iron in the 
cytosol of P. aeruginosa are shuttled from NAD(P)H to pa-FPR and subsequently 
to pa-Bfd, which in turn delivers them to pa-HO.   
 
 
 
Figure 1-6.  Structures of the pa-FPR cofactors: NADP+ and FAD. 
(A) Nicotinamide (Niacin) adenine dinucleotide phosphate (NADP+), the nitrogen 
nomenclature adopts the same numbering system for NADP in protein crystal structure 
from Protein Data Bank (PDB), e.g.   N9 is named as N9A (A stands for the adenine ring), 
the reactive site C4 is named as C4N (2nd N stands for the nicotinamide ring).  P3 
phosphate group is the feature phosphate group different from NAD+.  The above figure is 
created and modified based on an original NADPH figure from http://www.uky.edu/ 
Pharmacy/ps/porter/ CPR_NADPH.gif, obtained at 2008/1/18. 
(B) Flavin (Riboflavin) adenine dinucleotide (FAD) [36].  The numbering method is the 
same as above.  FAD nomenclature breaks down into small groups; the same applies to 
NADP+.  N(5) and N(1) are the sequential active sites for accepting hydrides. 
 
Biochemical and spectroscopic investigations demonstrated that the bfd 
gene encodes a 73-amino acid protein (pa-Bfd) that incorporates a [2Fe-2S]2+/+ 
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center, whereas the fpr gene encodes a 258-residue NADPH-dependent ferredoxin 
reductase (pa-FPR) that utilizes FAD as a cofactor.  The structures of NADP(H) 
and FAD are illustrated in Figure 1-6.  In vitro reconstitution of pa-HO catalytic 
activity with the newly characterized proteins (pa-FPR and pa-Bfd) led to the 
surprising observation that pa-FPR efficiently supports the catalytic cycle of pa-
HO, without the need of a ferredoxin.  In comparison, electron transfer from pa-
Bfd to pa-HO is sluggish, which strongly argues against the possibility that the 
seven electrons needed by pa-HO to degrade biliverdin are transferred from 
NADPH to pa-HO in a ferredoxin (Bfd)-dependent manner.  Given that pa-HO 
functions release iron from exogenous heme acquired under iron-starvation 
conditions, the use of a flavoenzyme rather than an iron-sulfur center containing 
protein to support heme degradation is an efficient use of resources in the cell.  
The crystal structure of pa-FPR (1.6 Å resolution) showed that its fold is 
comparable to that of the superfamily of ferredoxin reductases and most similar to 
the structure of Azotobacter vinelandii FPR and E. coli flavodoxin reductase.  The 
latter two enzymes interact with distinct redox partners, a ferredoxin and a 
flavodoxin, respectively.  Hence findings reported herein extend the range of 
redox partners recognized by the fold of pa-FPR to include a heme oxygenase 
(pa-HO).   
 Therefore, we propose the following electron transfer path.  
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Scheme 1-2. Proposed electron transfer path from NADPH to pa-HO.  
 
4. Characterization of FPR-NADP+ complex and protein interaction with 
pa-HO 
As shown in Scheme 1-2, NADPH first reduces the FAD in pa-FPR into 
its reduced form FADH2 in pa-FPR.  Then, the reduced pa-FPR can donate 
electron(s) to and reduce other proteins.  The chemistry of the FAD reduction by 
NADPH inside ferredoxin NAD(P)H reductase protein(FNR) and subsequent 
electron transfer from FNR to other proteins is shown below: 
NADPH + H+ + FNRox (or FAD)  NADP+ + FNRH2 (or FADH2)                 (1-1) 
FNRH2 (FADH2) + n Proteinox → FNRox (or FAD)+ n Proteinred n=1or 2     (1-2) 
The reaction in equation 1-1 is reversible for Plastidic FNRs, i.e., enzymes 
from chloroplasts and cyanobacteria, and the backward reaction is dominant for 
producing NADPH for photosynthetic use [37, 38].  While for bacterial FNR, 
equation 1-1 is not reversible, the electron from NADPH is used in many 
oxidoreductive processes, according to equation 1-2 [39-41].  The electron 
transfer between NADPH and FAD is illustrated in Figure 1-7. 
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Figure 1-7. NADPH/FAD reaction in ferredoxin reductase protein.  (NADP figures are 
created and modified based on an original NADPH figure from: 
http://www.uky.edu/Pharmacy/ps/porter/CPR_NADPH.gif at 2008/1/18, FAD figures are 
created and modified based on an original FAD figure from: 
http://www.gravitywaves.com/chemistry/CHE450/Images9-13/FAD.gif at 2008/1/18) 
 
The study of electron transfer process between NAD(P)H and protein or 
NAD(P)+ and protein is important and the first step that should be studied before 
further protein-protein interaction study.  Therefore, the binding of NADP+ to 
FNR has been studied intensively.  Because FNR protein has large protein size 
(≥30kDa), it is difficult to obtain the 3D protein structure in solution phase using 
NMR.  X-ray crystallography is the common method for obtaining protein 3D 
structure, however, it has been reported that the crystal of ferredoxin reductase in 
complex with its coenzyme NADP+ can be very difficult to obtain in many cases, 
such as spinach-FNR [42] and Anabaena-FNR[43-45].  Also, as for the pa-FPR’s 
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most similar homolog and the same bacterial subclass FNR proteins: Azotobacter 
vinelandii ferredoxin reductase (Av-FPR, 85% sequence identity to pa-FPR) and 
E. coli flavodoxin reductase (Ecl-FldR, 35% sequence identity to pa-FPR), there 
is no reported FNR crystal structure in complex with NADP+.  
 
Table 1-1. Homolog FNR protein comparison with pa-FPR.  The FNR classification is 
based on protein sequence, phylogenic relationship as well as FAD conformation [37]. 
 
plastidic17%TY 3031QUEAnabaena FNR
15%
11%
85%
Sequence identity 
to pa-FPR
plastidicVY 3081QG0Pea FNR 
plastidicVY 3141FNBSpinach FNR 
Bacteria subclass IRAFVEK 2581A8PA. vinelandii FPR
Bacteria subclass IRAFVEK 2582QDXpa-FPR
FNR ClassificationC’ Sequencepdb IDFNR Protein
 
 
NADP+ binding is believed to be a two-step process: the first step has the 
strong interactions between the 2’ adenosyl phosphate moiety and the FNR protein 
but the nicotinamide portion does not involve specific interactions with the 
enzyme, while in the second step the conserved C-terminal Tyr (shown in Table 1-
1) moves away and allows the nicotinamide ring to stack parallel to the 
isoalloxazine ring, thus forming a transient but “productive” complex conducive 
to direct hydride transfer [46].  The reason for the difficulty in obtaining the FNR-
NADP+ complex protein crystal structure is likely due to the unfinished binding in 
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the nicotinamide ring portion of NADP+ coenzyme.  In the plastidic Pea, Spinach 
and Anabaena leaves FNRs, the conserved C-terminal Tyr is located between 
NADP+ and FAD.  The Tyr-Ser mutant of pea FNR in X-ray crystal structure 
complex with NADP+ revealed that the mutation stabilizes the interaction between 
FAD and the nicotinamide ring of NADP+, which leads to the proposal that the 
displacement of Tyr upon NADP+ binding facilitates the direct hydride-transfer to 
FAD [47].  By soaking the FNR crystal in NADP+ solution, crystals of Anabaena 
FNR and its NADP+ complex were grown by Frey and coworkers in 1996 [45].  
NADP+ has only 80% occupancy in these crystals and only the ADP part of 
NADP+ is bound; the nicotinamide tail points outwards.  Next Medina and Carlos 
Gomez-Moreno et al. crystallized the Tyr303Ser mutant bound with NADP+ and 
solved the structure at 3.0 Å resolution [48].  In those studies the crystal of mutant 
Tyr303Trp-NADP+ was obtained by soaking crystal of the Tyr303Trp mutant in a 
solution of NADP+ instead of co-crystallization method [45].  In 2002, the crystal 
structure of the Anabaena FNR-NADP+ complex was solved by Medina and 
Carlos Gomez-Moreno et al. as the first co-crystallized native form FNR-NADP+ 
complex [49].  Interestingly, Tyr303 is still stacked between FAD and NADP+ 
instead of moving away to allow for a better NADP+ FAD interaction.  Also 
NADP+ is in a long distant far from FAD for direct hydride transfer.  Therefore, 
the authors concluded that a step-by-step reorganization of NADP+ will eventually 
require the terminal Tyr to be pushed away, allowing closer contact between FAD 
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and NADP+ [50].  How this putative displacement occurs is still unknown.  
(A) (B)
 
Figure 1-8. (A) Pea FNR Y308S-NADP+ (1QFY), (B) Anabaena-FNR-NADP+ (1GJR). 
 
In the context of this general accepted direct hydride transfer mechanism 
for plastidic FNR proteins, we studied the X-ray crystal structure of the pa-FPR-
NADP+ complex.  The complex crystal structure gives a first view of an extended 
network of interactions among FAD, NADP+ and the C-terminal extension typical 
of bacterial subclass I enzymes (FPRs: the group of ferredoxin reductase protein 
with coding gene: fpr) [37].  Together with other in-depth comparative 
crystallography studies, the results suggest that the C-terminal extension will 
likely not be readily displaced to allow “productive” packing of the isoalloxazine 
and nicotinamide rings for direct hydride transfer.  NMR has the obvious 
advantage in characterizing the protein-ligand or protein-protein interaction in 
solution phase.  Thus, the NMR backbone assignment of pa-FPR was carried out 
by using protein labeling, TROSY-based NMR experiments as well as selective 
amino acid labeling.  We obtained >95% of the possible assignments.  Because 
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ferredoxin reductase protein has large protein size (≥30kD), until now there is 
only one NMR backbone assignment completed for Maize leaves FNR [51].  Here 
the NMR backbone assignment work for pa-FPR protein is the second example 
for ferredoxin reductase protein, and the first one for  a bacterial FNR protein.  
The studies done with the aid of pa-FPR NMR backbone assignment in solution 
corroborate the crystal structure observation that the C-terminal tail is not 
dynamically active.  These findings suggest that the direct hydride transfer 
mechanism as explained above is not applicable to pa-FPR and instead a 
concerted two electrons and one proton transfer, a multi-step hydride transfer is 
proposed. 
 
5. Rationale of this research  
 
Pseudomonas aeruginosa colonizes and damages the defense mechanism 
of its host; the infections of this microorganism can be very difficult to cure.  This 
opportunistic pathogen infection in humans often leads to death of patients with 
diseases like cystic fibrosis or cancer, etc. [52].  It is found that these pathogenic 
bacteria need iron to colonize (infect) an organism.  However, the concentration of 
free iron in mammals is typically very low (~10-9 M).  Therefore, bacteria have 
developed sophisticated mechanisms for iron acquisition, including the utilization 
of heme iron [53-55].  In heme, iron is bound inside the porphyrin ring; it can be 
released after heme is broken.  Heme oxygenase is the only known protein used 
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for heme degradation and iron release inside a cell.  Therefore, in the quest to 
understand the iron acquisition pathway in Pseudomonas aeruginosa under iron-
starvation conditions, this Pseudomonas aeruginosa heme oxgyenase is the key 
enzyme to study (Figure 1-2).  We have carried out intensive protein structure, 
dynamics and catalysis studies for this pa-HO protein [18-21].  
The in-depth understanding of structure-function relationships in HO is 
expected to benefit the future pharmaceutical study for selectively inhibiting the 
unique heme degradation process and stopping the heme-iron release by pa-HO.  
A cluster of Phe rings exists in HO, several of them are close to the heme distal 
pocket and are poised to interact with one another.  Cooperative ring flipping may 
exist in this network of Phe.  We studied this aromatic cluster in HO using 
Pseudomonas aeruginosa heme oxygenase as a model to understand its role in 
protein structure and function.  This Phe ring cluster study is explained in chapter 
2 with a large amount of experimental results discussed in detail. 
As we know, heme oxygenase uses 3 O2 and 7 electrons to degrade heme 
into biliverdin, releasing iron and CO.  Therefore, in the context of the quest to 
understand the iron acquisition pathway in Pseudomonas aeruginosa under iron-
starvation condition, the search for pa-HO redox partner proteins was carried out 
by studying two proteins: ferredoxin reductase (pa-FPR) and ferredoxin (pa-Bfd).  
The later was studied by Yuhong Zeng and Saroja Weeratunga; some of their 
findings are discussed in this dissertation for pedagogical reasons.  The general 
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belief of ferredoxin being the redox partner of heme oxgyenase is challenged by 
our findings in the novel redox partnership between pa-FPR (ferredoxin reductase) 
and pa-HO.  The crystal structure and biochemical characterization of pa-FPR as 
well as the surprising findings regarding the redox partnership study are discussed 
in detail in chapter 3.  With this study, pa-FPR became the focus of our 
subsequent study in order to understand how and where these two novel redox 
partner proteins interact with each other.  
Pa-FPR obtains electron from NADPH, its FAD cofactor is directly 
reduced into FADH2 after coenzyme NADPH binding and the subsequent redox 
reaction inside the protein.  The study of ligand binding and electron transfer 
inside the protein is a key in understanding how ferredoxin reductase carries out 
its redox reaction and interacts with other proteins.  In general, a two-step NADP+ 
binding and direct hydride transfer are accepted for the ferredoxin reductase 
protein family.  As revealed in chapter 4, we examined the pa-FPR-NADP+ 
complex by NMR and X-ray crystallography methods as the first study of a 
bacterial subclass I FNR complex.  A novel FNR-NADP+ binding as well as the 
multi-step two electrons and one proton hydride transfer mechanism was proposed 
based on careful data analysis.  
With both a crystal structure and NMR protein backbone assignment in 
solution phase available for pa-FPR and pa-HO, investigation of their protein-
protein interactions (PPI) was carried out in order to find whether the interaction 
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interface is located on each protein.  The analysis of the two protein crystal 
structures suggests the potential interaction interface is located on the surface area 
of pa-HO, near the heme binding site, and at the concave bowl shape surface on 
top of isollaxazine ring’s methyl group for pa-FPR.  Preliminary NMR data 
suggests that PPI is an ultra-weak transient electrostatic interaction [56, 57] that 
can be detected only at the border of NMR detection limit.  Also the NMR result 
corroborates the crystallography study.  The proposed protein-protein interaction 
is discussed at the end of the chapter IV.  
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 CHAPTER II: NMR STUDY OF PSEUDOMONAS AERUGINOSA HEME 
OXYGENASE VIA MUTATION AND 19F-PHE LABELING 
 
INTRODUCTION 
Heme oxygenase (HO) is a distinctive heme containing protein.  Heme in HO 
is used not only as a prosthetic group but also as a substrate.  HO takes 7 electrons 
and 3 molecules of O2 to catalytically degrade heme into biliverdin and release FeII 
and CO.  It is the only known enzyme to degrade heme and release iron inside a cell.  
This enzyme exists in many organisms and plays a significant and diverse 
physiological role in nature.  In mammals, recycled iron from heme is the major 
resource for daily iron needs in such a way that the produced CO is an important 
neural signal transmitter and the resulting biliverdin is further reduced to bilirubin, a 
powerful antioxidant [1, 2].  Human heme oxygenase-1 as an example has been 
intensively studied by Paul Oritz de Montelleano and co-workers [3-6].  In plants, HO 
is used to degrade heme to biliverdin, biliverdin is further used for synthesizing 
photosynthetic organisms as shown in an example of Arabidopsis thaliana Heme 
Oxygenase [7].  In bacteria and fungi, heme from a host is a major iron resource [8].  
As mentioned before, heme oxygenase is different from all other heme-
containing catalytic proteins, such as cytochrome P450, nitric oxide synthases, 
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peroxidases, and chloroperoxidase in its distinguishable catalytic pathway.  As shown 
in Scheme 2-1, the release of heme-iron is accomplished by the breakdown of heme 
to biliverdin.  This is a complex reaction requiring the input of 7 electrons and 3 
molecules of O2, which must be delivered to HO rapidly and efficiently in order to 
sustain catalytic activity.  Heme breakdown starts with a single electron reduction of 
ferric HO (resting state) to the deoxyferrous state, followed by the rapid binding of 
dioxygen to form an oxyferrous complex (FeII-O2) [9].  Injection of a second electron 
into the FeII-O2 complex triggers the electron rearrangement that leads to the 
formation of a ferric peroxide (FeIII-OO–) complex, which accepts a proton to form a 
ferric hydroperoxide (FeIII-OOH) oxidizing species [10].  The ring oxidation involves 
attack of the FeIII-OOH intermediate on the aromatic macrocycle [11] to form a meso-
hydroxyheme intermediate, which undergoes a subsequent O2- and electron-
dependent elimination of the hydroxylated meso carbon as CO, thus forming 
verdoheme.  Verdoheme is then oxidized to FeIII-biliverdin in a reaction that requires 
both O2 and additional electrons [12, 13].  FeIII-biliverdin must be reduced to FeII-
biliverdin prior to the sequential release of FeII and biliverdin [14].  The peroxide 
shunt reaction (adding H2O2 in the presence of O2 to initiate the reaction forms 
verdoheme) is a commonly used method for simulating the heme oxygenase 
metabolism pathway in vitro [15-17].  The highlighted hydroxylation step (blue box 
in Scheme 2-1) that converts the ferric hydroperoxyl heme to α-meso-hydroxyheme is 
the step that distinguishes it from all other heme-containing proteins.  
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Scheme 2-1. Heme metabolism pathway of heme oxygenase. 
 
 As shown in the peroxide shunt reaction (Figure 2-1), H2O2 binds to the ferric 
heme to form an obligatory ferric hydroperoxyl heme intermediate.  From there, there 
are two possible pathways.  One pathway leads to the exclusive heme oxygenase 
metabolism.  As mentioned above, the HOO- group reacts with the heme meso-carbon 
to produce a meso-hydroxyheme intermediate, and then the subsequent reaction with 
O2 leads to the release of CO and the formation of verdoheme.  While the other 
pathway exists commonly in other heme-containing proteins like cytochrome P450 
and peroxidase, the FeIII-OOH intermediate undergoes auto-oxidation and forms 
ferryl heme.  By monitoring the products of the peroxide shunt reaction, one can 
differentiate the heme oxygenase reactivity from the peroxidase reactivity.  
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Figure 2-1. Obligatory heme hydroxylation in heme containing protein. 
 
In order to answer the essential question of how nature tunes the catalytic 
mechanism of heme oxygenase, we have performed intensive studies aimed at 
understanding the structure-function relationships of this protein.  From the past 
studies done in our lab, we observed that the deformation of heme from planarity 
facilitates heme hydroxylation by electronically activating the heme at the meso-
carbon (Figure 2-2) [18, 19].  This activated electronic structure, likely linked to 
heme hydroxylation reactivity, is stabilized by the heme environment of the H-
bonding network and the polypeptide dynamics [19].  Our previous protein dynamic 
studies [20] further confirmed that the unique heme oxygenase property is indeed 
linked with its protein structure and dynamics, involving H-bonding networks and 
polypeptide dynamics.  
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Figure 2-2. Proposed heme deformation in hydroxylation step, adapted from [18, 19]. 
 
During this study, we found a very interesting phenomenon when observing 
the protein 3D crystal structure.  A cluster of Phe rings exists in HO, and several of 
them are close to the heme distal pocket and are poised to interact with one another 
(Figure 2-3).  How does nature use this network of hydrophobic phenylalanines to 
fulfill heme oxygenase’s versatile functions?  We studied this cluster in HO from 
Pseudomonas aeruginosa heme oxygenase (pa-HO) using NMR by making 
comparisons among wild type (WT), mutants and 19F-phenylalanine labeled WT  
proteins to understand its role in protein structure and function. 
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Figure 2-3.  Structure of Pseudomonas aeruginosa heme oxygenase (PDB:1SK7).  Heme is 
in red and the conserved aromatic rings are in yellow. 
 
EXPERIMENTAL SECTION 
i. Mutagenesis of Pseudomonas aeruginosa heme oxygenase  
The wild-type Pseudomonas aeruginosa Heme Oxygenase gene on pET 21a 
plasmid was a generous gift from Dr. Angela Wilks at the University of Maryland.  
All F39L, F45L, F128L, F48L, F189L, F189V, F39/45L, F39/48L, F39/F128L, 
F45/128L, F39/189L and F45/189L pa-HO mutants were prepared using the 
Quickchange Mutagenesis Kit from Stratagene (La Jolla, CA) with oligonucleotides 
synthesized by the Biotechnology Support Facility, the University of Kansas Medical 
Center.  After DNA sequencing and DNA plasmid were transformed into E. coli 
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BL21 (DE3) GOLD supercompetent cells, protein expression and purification were 
performed as described below.  
ii. Protein expression and purification. 
The wild type and mutant pa-HO proteins were purified as described below.  
A single colony of freshly transformed E. Coli BL21 Gold (DE3) pigA or its mutant 
cell was grown overnight in 10 ml of LB-media containing 100 µg/ml of ampicillin at 
37 °C with a 225-240 rpm shaking speed.  Then a 10 ml culture was transferred into 
LB-Ampicillin media (1 liter).  After reaching mid-log phase, expression was induced 
by the addition of a final 1 mM concentration of IPTG (isopropyl-1-thiol-(D)-
galactopyranoside).  The cells were grown further for 4-5 hours at 30 °C and 
harvested by centrifugation (4500 rpm for 10-15 min).  After stored overnight at -20 
°C, cells were thawed at 4 °C and lysed in lysis buffer, lysozyme, 
phenylmethysulfonyl fluoride (PMSF), deoxycolic acid and DNase.  After incubated 
for 20 minutes at 37 °C and stirred for one hour at room temperature, the cells were 
defragmented by sonication for 10 cycles of 1.5 mins each on ice.  The cell 
suspension was then ultracentrifuged at 23,500g for 2 hrs.  The clear supernatant was 
loaded onto a Sepharose-Q Fast Flow column (1.5 cm x 15 cm) previously 
equilibrated with 20 mM Tris-HCl (pH 7.6).  After loading the sample, the column 
was equilibrated with one volume of 20 mM Tris-HCl (pH 7.6).  The column was 
applied with NaCl linear gradient from 50 -500 mM.  Protein eluted at about 200-250 
mM.  After run on SDS-PAGE and UV-vis, the pa-HO protein fractions were 
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collected and dialyzed against potassium phosphate (pH 7.0, u=0.1) (2 x 4 L) at 4 °C.  
The protein was either reconstituted with heme as described below or stored at -80 °C 
for later usage.  
The 15N labeled protein was expressed in a 1 liter minimal medium containing 
nutrients at natural isotopic abundance using the same protein expression procedures 
described above.  After reaching mid-log phase, the cells were spun down and 
transferred to the same volume of the fresh minimal medium containing labeled 
material, for example, 1g 15NH4Cl.  The cells were grown further to O.D. = 0.6 ~ 0.7, 
then the temperature was lowered to 30 °C.  Inducted with 1mM IPTG, the cells were 
harvested 5 hours later. 
The 19F-Phe protein was expressed as described in the study of Benjamin 
Schuler et al. [21].  Again, using a similar expression system as above, to a 1 liter 
minimal medium with all nutrients was added 1g of glyphosate (N-
(phosphonomethyl)-glycine) and 50 mg of all amino acids except L-Phe; 5mg of this 
amino acid were added.  The cell growth was monitored closely by measuring O.D.  
When O.D. reached ~1.1 at 550 nm, the cell growth went into lag phase due to the 
depletion of Phe.  Then 200 mg (~1 mM) of ortho-, meta- or para-19F-Phe (D-, L-) 
(purchased from MP Biomedicals Inc.) was added for labeling, at which point the 
temperature was lowered to 30 °C.  IPTG was added 30 mins later.  The cells were 
harvested after 5 h of growth following induction.  The expressed protein contained in 
excess of 95% 19F-Phe, as determined from mass spectrometer analysis.  
The 15N and ortho-19F-Phe double labeled protein was expressed using a 
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similar method as for labeling protein with 15N except that the second batch of 
minimal medium contains both 1 g 15NH4Cl and 600 mg (~3 mM) ortho-19F-Phe (D-, 
L-). 
iii. Reconstitution of the WT and mutant pa-HO proteins with heme 
Hemin (aliquot of 5~50 µl of heme DMSO solution: 10 mg heme dissolved 
into 3 ml DMSO) was titrated into the purified HO protein solution (20~80ml 2~6 
µmol protein in 20mM pH 7.6 Tris buffer) with moderate stirring.  The titration is 
monitored by UV-vis spectrum until the absorbance ratio A280/A405 reaches a 
maximum (0.4~0.5).  Then the holo-form HO protein was concentrated into 1~3 ml 
volume and purified by size exclusion chromatography using a sephadex Gel-50 fine 
or superfine (for labeled protein) column (3.0 cm x 100 cm) pre-equilibrated with 
sodium phosphate (pH 7.0, u=0.1) (pH 7.0).  The protein was then concentrated by 
Centricon tubes and stored at -80 °C. 
iv. Extinction coefficient of pa-HO mutants 
The millimolar extinction coefficient (e405nm) of the heme-HO complex was 
determined via the pyridine hemochrome method [22-24].  The experiment was 
conducted with 900ul protein (concentration is adjusted to have UV-vis absorbance 
1.089 at 405nm) in 50mM pH 7.0 sodium phosphate buffer inside a 1cm path length 
black quartz curvette.  Then 100ul pyridine was added to coordinate the heme by 
displacing the heme out of heme protein pocket.  Then heme was converted to the 
reduced ferrous pyridine hemochrome by reduction with excess sodium dithionite 
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(about several grains added).  After mixing the solution with parafilm covering on top 
of the curvette, final UV-vis spectrum is taken.  Then the concentration of the heme 
was calculated by Beer-Lambert Law using millimolar extinction coefficient values 
of 170, 17.5 and 34.4 at 418.5, 526, and 555 nm, respectively, for reduced ferrous 
pyridine-hemechrome [18].  The extinction coefficient for heme-HO complex 
(e405nm) is then calculated based on the calculated heme concentration and previously 
measured absorbance.  Three trials were taken for each sample. 
v. Circular Dichroism Spectrophotometry of WT and mutant pa-HO  
CD spectra were measured on a JASCO J-710 spectropolarimeter equipped 
with a Jasco PTC-4235 Peltier thermostated cell holder.  Spectra were recorded in the 
far UV (190-250 nm) in a 2 mm flat cell at 25 °C in pH 7.0 KH2PO4 buffer (µ=0.1) 
with 4 sec response time, 50 nm/min scan rate and 5 times average.  Three trials were 
taken for each sample.  Baseline correction was carried out by subtracting averaged 
sample spectra from averaged buffer spectra recorded at the same conditions.  The 
reading of molar ellipticity (degree cm2 dmol-1) was calculated by dividing the 
subtracted (protein – blank) spectra with protein concentration (about 3 µM).  
vi. Thermal denaturation study of WT and mutant pa-HO  
Thermal denaturation was measured on a Varian Carey 100 Bio UV/visible 
spectrophotometer equipped with a Peltier-thermostated cell holder.  Sample 
concentration was about 3 µM in pH7 phosphate buffer (µ=0.1).  Temperature 
increment is 2 °C; it was monitored by using a temperature probe (±0.1 °C).  The 
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thermal denaturation temperature was averaged from the calculated first derivative 
values based on the three trial plots of soret absorbance (405 nm or so) vs. 
temperature. 
vii. Hydrogen Peroxide Assay Study of the wild-type and pa-HO 
mutants 
Reconstituted heme-paHO complex (5 µM in 2 ml of phosphate buffer, µ=0.1, 
pH7) was placed in a 1.0 cm cell with moderate stirring at 25 °C.  The soret 
absorbance was adjusted to 1.0 with Soret peak at ~405 nm.  Reaction was initiated 
by titrating 1.0 equivalent of H2O2, and the spectra were monitored with respect to 
changes in time.  Verdoheme formation, followed by increase in absorbance at 600 
nm was plotted as a function of time, as a means to indicate heme oxygenase 
reactivity [25, 26]. 
Guaiacol assay was carried out under the same conditions as the above 
procedure with the following exceptions: 1.0 mM guaiacol was initially present and 
100 equivalents of peroxide were added.  The 470 nm peak formation of guaiacol 
oligomer with time was plotted as an indication of ferryl formation, which suggests 
peroxidase reactivity [26, 27].  
viii. NMR Spectroscopy 
NMR samples of pa-HO, pa-HO-N3 and pa-HO-CN complexes contained 
1.0~2.0 mM protein in 50 mM sodium phosphate, pH 7.0 and 5-10% D2O [19, 20].  
One-dimensional 1H NMR spectra were acquired on a 600 MHz Varian Unity Inova 
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spectrometer equipped with a triple resonance triple-axis gradient probe.  Spectra 
were referenced to the residual water peak at 4.8 ppm.  One-dimensional 19F NMR 
data were acquired with a 400 MHz Bruker Avance spectrometer equipped with a 5 
mm inverse broad-band probe with the proton channel tuned to fluorine.  Spectra 
were referenced to the CF3COOH peak at -75.3 ppm at 37 °C, -75.6 ppm at 25 °C and 
-75.9 ppm at 5 °C.  
 Two- and three-dimensional NMR experiments (1H-15N-HSQC 
(Heteronuclear Single Quantum Coherence) and 1H-15N-NOESY-HSQC (Nuclear 
Overhauser Enhancement spectroscopy – HSQC) [20]) were acquired using a Bruker 
Avance 800 spectrometer equipped with a 5 mm TXI 1H-13C/15/D xyz gradient probe.  
1H chemical shift was referenced to the proton resonance of DSS at 0 ppm, and 15N 
and 13C shifts were referenced indirectly to DSS using the ratios 0.101329118 and 
0.251449530, respectively [28]. 
ix. NMR resonance assignments of F45L pa-HO-CN 
The resonance assignments (Table S-2-1) for the F45L pa-HO-CN complex 
were obtained by comparing the HSQC spectrum of F45L pa-HO-CN with the 
HSQC spectrum WT pa-HO-CN and by identifying sequential amide HN to HN 
NOEs in a 1H-15N NOESY-HSQC spectrum, using the assignments of the wild type 
pa-HO-CN previously published [20].  If the peak in F45L pa-HO-CN has identical 
or very similar chemical shift as in WT pa-HO-CN HSQC spectra, a direct 
assignment transfer can be made.  Most peaks in the spectrum of the single mutant 
 43 
F45L pa-HO-CN have chemical shifts that are very similar to their counterparts in 
the spectrum of WT pa-HO-CN.  Consequently, the sequential NOE connectivities 
obtained from 3D NOESY-HSQC experiment could be used to confirm the directly 
transferred assignments and assign the peaks that can not be assigned previously by 
comparing the HSQC spectra of F45L and WT pa-HO-CN complexes.    
The 3D 15N-edited NOESY experiment is composed of 2D 1H-1H NOESY 
and 2D 1H-15N HSQC.  One can imagine the 3D 1H-1H-15N NOESY experiment as 
the 1H-1H 2D NOESY with an extra extended dimension along the nitrogen 
frequency.  The 3D 1H-15N NOESY-HSQC detects 1H-1H NOE correlations between 
amide hydrogen atoms located nearby in space.  The NOE (Nuclear Overhauser 
Enhancement) correlation reveals the location and the specific interaction of amide 
hydrogen within its spatial environment, as shown below (modified and adapted 
from http://rmn.iqfr.csic.es/guide/man/3d/chap4-1.html).    
 
Figure 2-4.  NOE correlation between amide protons in protein sequence. 
 
NOE is a spatial phenomenon for two nuclei close in space.  Transfer of spin 
polarization from one spin population to another is via dipolar cross-relaxation; the 
interaction is through space, not bonds [29].  The intensity of the NOE is related to 
the nuclear distance (e.g. usually for 1H-1H, distance ≤ 5 Å) and molecular motion:  
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INOE  ∝ f(τC)*1/r6        (2-1) 
τC: rotational correlation time of a protein [29]. 
 By measuring the intermolecular 1H (amide hydrogen) -1H (amide hydrogen) 
NOE, one can obtain the sequential connectivity for protein sequence.  The NOE 
effect is distance dependent.  The closer a hydrogen atom is to another hydrogen 
atom, the larger the enhancement for that hydrogen atom signal is.  
Pa-HO polypeptide is highly helical.  Therefore, in the NOESY-HSQC 3D 
experiments, the most intense signals are from the directly neighboring amide protons, 
e.g. 1H- 1H inter-residual NOE between amide hydrogen atoms from residue i and 
residue i+1 or i-1 (off diagonal cross peaks) and 1H- 1H intra-residual NOE between 
two amide hydrogen atoms from the same residue (diagonal cross peaks).  The 
assignment of R47 in F45L pa-HO-CN is shown below as an example to demonstrate 
the assignment procedure.  
 
Figure 2-5. R47 amide peak comparison between WT pa-HO-CN (A) and F45L pa-HO-CN 
(B) HSQC spectra.  Some peaks shifted, for example as shown above, R47 in WT (left) and 
F45L (right) NMR spectra.  The black bar connects the side chain peaks which are not the 
(A) (B) 
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focus of our study.  The K34 moved out of the selected spectrum window as shown in the 
case of the mutant F45L. 
 
As shown in the above comparison for small areas of HSQCs from WT pa-
HO (Figure 2-5 (A)) and F45L pa-HO (Figure 2-5 (B)), I164 does not move much.  
The other peaks are more difficult to assign by comparison.  The black line connects 
the side chain peaks which are not the focus of this study.  Although the side chain 
peak moved a little away from its position in WT for 0.2 ppm in the 15N dimension, it 
superimposed even more severely with R47 in F45L than in WT.  Also, there are 
other neighboring peaks that moved, for example, L138 and K34.  The K34 moved 
out of the selected spectrum window as shown in the F45L spectrum.  Due to all these 
complications, there is no simple way to assign R47 for 100% certainty by simply 
comparing the two HSQC spectra because the neighboring peaks of R47 also moved 
and one peak is partially superimposed with R47.  Therefore, it is necessary to assign 
the R47 in the NOESY-HSQC spectra.  
Shown in Figure 2-6 below, the left side shows the 2D 1H-1H plane of 3D 
NOESY-HSQC experiment with the specific nitrogen frequency of each target 
residue, and the right side shows the target residue in the 2D 1H-15N HSQC 
experiment.  In Figure 2-6(A), residue A46 is the residue i-1 in reference to R47, the 
yellow cross lines locate the position of A46 in two 2D spectra, the yellow and white 
cross lines locate the position of A46 to R47 off-diagonal NOE peak. In Figure 2-6(B) 
showing residue R47, the white cross lines locate the position of A46, the white and 
yellow cross lines locate the position of R47 to A46 NOE peak and the white and red 
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cross lines locate the position of R47 to F48 NOE peak.  In Figure 2-6(C), residue 
F48 is the residue i+1 to R47, the red cross lines locate the position of F48, and the 
red and white cross lines locate the position of F48 to R47 NOE peak. 
 
Figure 2-6. 3D NOESY-HSQC assignment using R47 as an example.  The left side shows 
the 2D 1H-1H plane of 3D NOESY-HSQC experiment with the specific nitrogen frequency 
(value is shown at the bottom of the spectrum, as the 3rd dimension of the 3D experiment) of 
each target residue, and the right side shows the target residue in the 2D 1H-15N HSQC 
experiment.  (A) Residue A46 as the i-1 residue to R47.  The yellow cross lines locate the 
position of A46 in two 2D spectra, the yellow and white cross lines locate the position of A46 
to R47 off-diagonal NOE peak; (B) Residue R47.  The white cross lines locate the position of 
A46, the white and yellow cross lines locate the position of R47 to A46 NOE peak and the 
white and red cross lines locate the position of R47 to F48 NOE peak; (C) Residue F48 as the 
i+1 residue to R47.  The red cross lines locate the position of F48, and the red and white cross 
lines locate the position of F48 to R47 NOE peak. 
 
Therefore, the assignment of R47 is achieved by identifying and matching the 
NOE cross peaks with its two neighboring residues A46 and F48 on the protein 
(B) 
(A) 
(C) 
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sequence.  Other amino acids can be assigned using the same method.  
x. H/D exchange experiments 
A series of 1H-15N-HSQC experiments were measured at 37 °C on a Bruker 
Avance 800 spectrometer equipped with a 5 mm TXI 1H-13C/15N/D xyz gradient 
probe using 15N labeled WT or F45L pa-HO-CN complex NMR sample for H-D 
exchange NMR experiment.  The 500 µl NMR samples contained 1.0-2.0 mM protein 
in 50 mM sodium phosphate, pH 7.0 and 5-10% D2O.  First, NMR samples were 
freeze-dried in a Savant® Speed Vac (Farmingdale, N.Y.) for about 6 hours to dry 
protein powder.  Immediately before the NMR experiments, the sample was 
resuspended in 500 µL of D2O together with 5~10 times pH 7 NaCN to compensate 
for the loss of CN¯  during the freeze-drying process [20].  Then the first 1H-15N 
HSQC was taken with a 10-15 min dead time between the start of amide proton to 
amide deuterium (HN-DN) exchange upon adding D2O into lyophilized protein and the 
start of data acquisition.  Subsequently, a series of HSQC spectra were monitored as a 
function of time for the exchange process.  The total acquisition time for each HSQC 
spectrum was 20 mins and the H-D exchange experiments were monitored for at least 
24 hrs until the end of exchange event, indicated by no further peak intensity decrease 
observed in the 1H-15N HSQC spectrum.  Spectra were acquired every 20 mins for the 
first 7-12 h; subsequently the time interval between spectra was increased to 1 h for 
the remaining time.  These 1H-15N-HSQC spectra were collected over a 19.2 KHz 
(1H) and 3 KHz (15N) spectral widths, with 16 scans per increment and 2560 and 256 
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complex points for the 1H- and 15N- dimension.  Spectra were processed using 
NMRPipe and analyzed using Sparky.  Each spectrum was processed with a 90° 
shifted sine bell squared window function in each dimension and zero filled to twice 
the number of points.  The per residue H/D exchange rate constant (kex) measured 
experimentally was calculated by fitting the time-dependent decay of peak intensities 
to a single-exponential decay of three parameters (Equation 2-2 and Figure 2-7) using 
Sigma Plot 2001 [30, 31].    
I(t) = I∞ + A (-kex t) (2-2) 
I∞ : the intensity at infinite time for each amide peak when reaching steady-
state or equilibrium;  
A : I0 - I∞ (the total change in intensity from “zero time” to equilibrium);  
      kex : the experimentally observable rate of N-H exchange.  
 
Figure 2-7. Proton-deuterium exchange rate constant determination for residue E194 in F45L 
pa-HO-CN complex at pD 7.03.  The red line represents the fit of equation 1 to the 
experimental data. 
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One example is given in Figure 2-7 for fitting the experimental time 
dependent intensity to calculate intensity a rate constant.  After the rate constants 
were obtained from the above fitting, the residue specific protection factors were 
calculated by following the same method reported by Englander et al. [32, 33].  First 
the values for sequence-specific intrinsic rate constants (kch) were calculated using the 
spreadsheet available from S. Englander’s Web site at http://hx2.med.upenn.edu/ 
download.html.  Then the protection factors (P) were determined by the relation: P = 
kch/kex [32, 33].  The pH value employed in the calculations was 7.03 for F45L pa-
HO-CN complex.  The pertinent data for the WT pa-HO-CN was obtained by Dr. 
Juan Carlos Rodriguez [20].  
RESULTS AND DISCUSSION 
1. Expression, Purification and Spectral Characterization of the WT, 
mutants and 19F-Phenylalanine labeled pa-HO  
The proteins were expressed and purified as described previously.  After 
protein purification, the proteins were judged > 95% pure by SDS-PAGE (data not 
shown) as well as a UV-vis 280 nm/405 nm absorbance ratio (WT < 0.3, others < 
0.35).  Other than F128L pa-HO, all mutants show more yellowish and lighter 
greenish color than WT, which suggests that biliverdin is not as tightly bound to the 
expressed apo protein as in WT.  While F128L shows strong greenish color, its UV 
spectrum suggests that it binds more biliverdin than WT apo protein during protein 
expression and purification.  The changes in protein color and UV-vis spectra could 
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be due to the unique position of residue 128. F128 is located in between two heme 
propionate groups.  Therefore, a F128L mutation possibly facilitates protein folding 
to bind biliverdin or heme (later incorporated after purification) more tightly.  While 
the other pa-HO mutations likely weaken the cofactor-binding to differing extents. 
The Soret maxima of the resting state (FeIII) heme-pa-HO wild type and 
mutant proteins are very similar, ranging from 402 nm to 406 nm (Table 2-1).  The 
extinction coefficients were measured using the pyridine hemochrome method [34].  
The values vary from 113 mM-1·cm-1 to 141 mM-1·cm-1 for single mutation or ortho-
19F-phenylalanine labeling, and those of double mutations are between 76 mM-1·cm-1 
and 134 mM-1·cm-1. 
 
Figure 2-8. Illustration of pa-HO 19F-phenylalanine labeling, the top is unlabeled, ortho-19F 
labeled, meta-19F labeled and para-19F labeled phenylalanine, the bottom is the WT pa-HO 
with phenylalanines in yellow stick, heme in red stick and H26 in magenta stick. 
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Similar Soret bands show that the heme is still contained in the heme pocket, 
and it also suggests that the overall protein-heme structure is maintained.  As for the 
change of extinction coefficient in double mutation or mutation with 19F Phe labeling, 
it suggests that protein structure is slightly disrupted; it could be more manifested in 
the heme distal pocket.  Protein structure characterization and enzyme properties are 
further tested by the following experiments. 
Table 2-1. The soret maxima and extinction coefficients of the resting state (FeIII) heme-pa-
HO WT, mutant and 19F-Phe labeled proteins. 
 
407406403405405402403UV Abs Peak(nm)
99768013412496108
Extinction 
Coefficient
(ε,mM-1cm-1)
o-F45LF45/189LF39/189LF45/128LF39/128LF39/48LF39/45L
405403405404404404405UV Abs Peak(nm)
141113140117101129129
Extinction 
Coefficient
(ε,mM-1cm-1)
o-19F PheF189LF128LF48LF45LF39LWT paHO
 
 
2. Protein secondary structure study by circular dichroism  
Circular dichroism (CD) is a physical property of the absorption difference 
between left and right circularly polarized light.  Because amino acids are 
enantiomers, different elements of secondary structures (like the alpha-helix, beta-
sheet, beta-turn or random coil) have distinctive CD spectra.  So CD spectroscopy is 
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commonly used to determine the secondary structure conformation changes in 
proteins [25].  The CD-spectra of the pa-HO wild type, F39L, F45L, F128L mutants 
and ortho-, meta-, para-19F-phenylalanine labeled WT and ortho-F45L mutant are 
shown in Figure 2-9.  As indicated by the crystal structure, pa-HO is mainly α-helical.  
These CD spectra show very similar α-helix content.  This implies no major 
secondary structural perturbation occurred.  It seems that the overall helical protein 
structure is still well maintained.  In addition, the difference, as judged by the change 
of intensity at 194 nm, 208 nm and 224 nm, may suggest a slight change in α-helical 
content.  F128L and ortho-WT have larger ellipticities, while F45L has the least 
between 200-240 nm (characteristic region for α-helix).  This could mean that F128L 
and ortho-WT have more helical content than F45L.  Further studies supporting this 
idea are discussed below. 
 
Figure 2-9. The superpositioned CD spectra of WT, mutant, 19F-Phe labeled pa-HO proteins. 
The unit of CD spectrum is θ MRW (mean residue weight) (x10-3degree cm2 dmole-1). 
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3. 1D proton NMR study of the heme distal pocket  
Due to the paramagnetic influence from heme iron, the heme inside protein 
pocket is commonly studied by 1D proton NMR.  The mutant and 19F-Phe labeled pa-
HO proteins have been studied by 1H NMR spectroscopy and compared with WT pa-
HO in the resting form, cyanide (CN-) or azide (N3-) ligand bound forms.   1D 1H 
NMR spectra of these proteins in their resting state are shown in Figure 2-10 (A), 
they are compared with the spectra of the same proteins in their CN- bound forms in 
Figure 2-10(B).  In the 1H NMR spectra of Figure 2-10 (A), the broad resonances 
between 60 and 80 ppm from heme-methyl, indicate high-spin FeIII-H2O where the 
ferric ion is axially coordinated by a His and H2O molecule [25].  While the sharp 
heme-methyl peaks near 20 ppm suggest the low-spin FeIII-OH complex (OH is 
coordinated instead of H2O) [25].  The WT resting state protein has mixtures of both 
high (above 40 ppm) and low spin (below 30 ppm) peaks in exchange [25].  The 
mutant proteins all have those low-spin and high-spin peaks as shown in WT spectra.  
But, the peaks in mutations are somewhat different in intensity, line width and peak 
area from those in WT.  The difference between mutant and WT NMR spectra 
suggests that mutation costs a change in the heme distal pocket leading to different 
heme seating suggested by different isomer ratio and different proportion of high and 
low spins.  F128L and F39L seem to possess more high spin features, and F45L has 
more low spin features; furthermore, the double mutants F39/128L and F45/128L pa-
HO are showing the features in combination of both two single mutations.   
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(A) (B)
 
Figure 2-10. The 1D proton NMR spectra of (A) ligand free and (B) CN- bound pa-HO 
proteins at 25 °C, pH7 phosphate buffer.  The bottom axis shows 1H chemical shift in ppm. 
 
As for the spectra of the ligand bound form shown in Figure 2-10 (B) and 
Figure 2-11, again the spectra from mutant proteins show major similarities to the 
spectra from the WT protein, except for the presence of several isomer peaks.  Shown 
in Figure 2-10 (B), bound with CN- ligand, F128L seems to be more similar to WT 
than F39L and F45L.  As in the F39L and F45L mutants, the extra new peaks are 
likely suggestive of heme in-plane disorder [35].  Interestingly, the effect of F128L 
stabilizing the protein seems to be dominant in double mutants, F39/128L and 
F45/128L, as the two double mutants show a more similar pattern to WT than either 
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F39L or F45L.  It may suggest that the F128L mutation indeed makes the protein 
folding of F39/128L and F45/128L similar to WT in the distal heme pocket 
environment.  Also ortho-19F labeled proteins show similar 1D NMR spectra as WT 
in both azide and CN- inhibited (ligand bound) forms, as shown in Figure 2-11. 
  
Figure 2-11. The 1D proton NMR spectra of (A) CN- bound and (B) N3- bound pa-HO 
proteins at 25 °C, pH7 phosphate buffer.  
 
4. Protein conformational stability probed by thermal denaturation 
experiments 
 
Assuming protein is experiencing two states: folded and unfolded in 
equilibrium, thermal unfolding of proteins is used to determine protein 
conformational stability.  Study comparing WT and mutant proteins could give 
insights in the extent of protein structural disruption upon mutation.  Thermal 
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denaturation curves comparing WT, mutant and 19F-Phe labeled proteins are shown in 
Figure 2-12.  The data in the Figure 2-12 (A) and (B) suggests that 19F-Phe labeling 
does not change protein thermal stability much.  During unfolding, all proteins 
experience overall similar temperature dependent conformational changes.  In 
contrast, as shown in Figure 2-12 (C), mutant proteins not only have different Tm as 
reported in Table 2-2, but also unfold differently from low to high temperatures.  
These observations suggest that even at relatively low temperatures, the mutant 
proteins are exploring globally unfolding conformations, as compared to WT.  It is 
interesting but not surprising that F128L has even higher Tm than WT, which again 
suggests that the F128L mutation makes the heme pocket more compact. 
From the above observations, it is reasonable to assume that overall protein 
structure is well maintained with a single mutation or 19F-labeling.  The studies 
described below will reveal how these alterations to the protein affect the dynamics 
and function of pa-HO.  
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Figure 2-12. The comparison of the thermal denaturation curves in (A) WT vs 19F-Phe 
labeling, (B) F45L vs 19F-Phe labeling, and (C) WT vs Mutants. UV-vis absorbance 
normalized to 1.0. 
 
Table 2-2. Thermal denaturation temperatures (Tm, ºC) derived from the above thermal 
denaturation curves.  Left: WT vs 19F-Phe labeling; middle: F45L vs 19F-Phe labeling; right: 
WT vs Mutants. The largest Tm difference in each group is shown by maximum delta. 
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5. Heme Oxygenase Reactivity Assay with Hydrogen Peroxide 
The peroxide shunt reaction (Scheme 2-1) is commonly used to test heme 
oxygenase reactivity [26].  
As shown earlier in Figure 2-1, once the hydroperoxyl group binds to heme 
iron, the ferric hydroperoxyl heme is obligated to two pathways: one goes to form 
ferryl as seen in cytochrome P450, peroxidase, etc; the other in the heme metabolism 
pathway forms verdoheme.  It has been reported by Paul Ortiz De Montellano’s 
human HO-1 study, that Asp-140 mutations can disrupt the hydrogen bond in heme 
distal pocket so that the human heme oxygenase-1 is converted into a peroxidase; in 
other words, the ferryl formation pathway is preferred [26].  Here we implement the 
peroxide shunt reaction to test the heme oxygenase reactivity change.  The reaction is 
implemented with WT as control.  Formation of verdoheme is indicative of the heme 
oxygenase reaction.  
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Figure 2-13. Heme oxygenase reactivity monitored by the peroxide shunt reaction.  The 
reaction of pa-HO proteins with addition of one equivalent of peroxide is illustrated by the 
inset of UV-vis spectra changing with time at 25 ºC.  The left plot shows the accumulation of 
verdoheme with time in pa-HO proteins.  The right figure shows the heme hydroxylation 
pathway.  Blue color highlights the heme oxygenase pathway. 
 
As shown in above Figure 2-13, WT pa-HO produces the largest amount of 
verdoheme; formation of the latter is also faster relative to the mutant proteins, 
suggested by the slope of the plot.  It is interesting that although F128L may facilitate 
a more stable pa-HO folding, the alteration increased stability of the distal pocket 
costs loss of heme oxygenase reactivity.  Also it is clear that double mutants produce 
even less verdoheme.  The plateau of each curve suggests the total amount of 
verdoheme formation.  The difference between mutant and WT could be due to the 
ferric hydroperoxide accessing the alternative path in the right side of Figure 2-13.  
The formation of guaiacol is a very common assay to detect peroxidase reactivity [4]. 
 60 
verdoheme
ferryl
Ferric hydroxy
heme
paHO Ferryl Reacted with 4mM Guaiacol
        300sec after adding 100eq H2O2
Wavelength(nm)
420 440 460 480 500 520 540 560 580 600
∆
=
∆
=
∆
=
∆
=
(R
x
n
 
W
/ G
u
ai
ac
o
l -
 
R
ef
 
W
/O
 
G
u
ai
ac
o
l)
-0.02
0.00
0.02
0.04
0.06
0.08
0.10
WT
F39L
F45L
F128L
F39F128L
F45F128L
(A) (B)
(C)
∆
=
∆
=
∆
=
∆
=
(R
x
n
 
W
/ G
u
ai
ac
o
l -
 
R
ef
 
W
/O
 
G
u
ai
ac
o
l)
∆
=
∆
=
∆
=
∆
=
(R
x
n
 
W
/ G
u
ai
ac
o
l -
 
R
ef
 
W
/O
 
G
u
ai
ac
o
l)
 
Figure 2-14. Peroxidase reactivity monitored by guaiacol formation assay.  (A) The 
subtracted spectra of the peroxide protein guaiacol reaction after 300 sec from the peroxide 
protein control at 25 ºC.  (B) The protein guaiacol peroxide assay for peroxidase reactivity 
test.  The changing spectra after guaiacol reacting with ferryl heme to form guaiacol oligomer 
are adopted from [4].  (C) The heme hydroxylation pathway.  The blue color highlights the 
taken pathway in this study. 
 
Shown in Figure 2-14, the black dotted line for WT is located lowest in the 
plot.  This pattern suggests WT forming the least amount of guaiacol which indicates 
that WT has the least ferryl formation, whereas the double mutant has the largest.  
Although the order is not exactly the same as what we would expect from the 
implication of Figure 2-13, this is likely due to the unpredictable protein intermediate 
degradation.  The two assays show that the mutation has decreased heme oxygenase 
reactivity and correspondingly increased peroxidase reactivity.  The ortho-19F 
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labeling also had similar impact toward heme oxygenase reactivity, as shown in 
Figure 2-15. 
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Figure 2-15. Heme oxygenase reactivity monitored by peroxide shunt reaction.  The reaction 
of pa-HO proteins is initiated by addition of one equivalent of peroxide at 25 ºC.  (A) 
Comparison between WT and 19F-Phe labeling.  (B) Comparison between WT and mutants. 
 
The heme oxygenase reactivity is related to the protein structure and 
dynamics. NMR is a powerful tool to study both protein structure and dynamics as 
shown in the discussion below.  
6. Study of Protein Structure and Dynamics by 1D 19F NMR Spectroscopy 
19F NMR is a powerful tool for protein structure and dynamics study.  It has 
several advantages:  First, it is generally believed that 19F-Phe labeling does little 
impact to overall protein stability, structure and function because it has similar atomic 
radius as H.  Second, it is a very sensitive probe for NMR studies, comparable to 1H.  
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Third, it can be used to probe the interior of proteins because the 19F chemical shifts 
are very sensitive to chemical environment.  
There are thirteen phenylalanines in pa-HO, as shown in the 3D protein 
crystal structure shown in Figure 2-16.  Most of them are concentrated around the 
heme distal pocket.  F128, as mentioned earlier, is pointing to the heme propionate 
groups.  F39, F45 and F48 are very close to each other.  Together, they form a well 
packed phenylalanine ring cluster.  F39, F45 and F48L are so closely packed that 
rotation of the F45 side chain could affect the side chains of F39 and F48.  Also, F161 
is in proximity to F72 and F117.  F117 could be connected to F189 and F55 by F186 
in space.  And F189 is close to F48, F128 is close to F130 which is also close to F39.   
F142 seems to be far from the other Phes, but it is located on top of the strand which 
is the most exposed to solvent.  A hydrophobic channel (in a shape of long cylinder) 
seems to be crossing the protein at the back of the heme pocket. 
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Figure 2-16. Target 13 phenyalanines in pa-HO (PDB: 1SK7) in the left figure.  The top 
right figure shows the cluster of phenyalanines around heme in the heme pocket, the bottom 
right figure shows the compact cooperative packing of three phenyalanines: 39, 45 and 48. 
 
After successful incorporation of 19F-Phe into our target proteins, 1D 19F 
NMR spectra were obtained in a 400 MHz Bruker NMR spectrometer.  Chemical 
shift variation and temperature dependencies of 19F-Phe peaks have been studied to 
compare WT with mutants in the absence and presence of protein ligand.  The ligands 
are cyanide (CN-) and azide (N3-).  
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Figure 2-17. 1D 19F NMR of WT and F45L pa-HOs in resting state, CN- or Azide bound 
complex forms at 37 °C. 
 
Figure 2-17 shows the comparison between WT and F45L mutant proteins in 
3 states: resting state, azide bound and CN- bound forms.  It is obvious that ligand 
binding “cools down” protein motions, as suggested by the sharper line widths and 
resolved peaks.  In the resting state, o-19F Phe labeled F45L compared to o-19F Phe 
labeled WT has 14 peaks detected.  This suggests that at least one Phe has been 
detected to have more than one conformation, since there are 13 Phe residues in total.  
In comparison to the WT spectrum, the peaks in the F45L spectrum have much 
broader line widths.  This suggests that the mutation disrupted the heme pocket and 
created conformational disorder.  These observations match previous findings that the 
mutation disrupts the distal heme pocket. 
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In the spectra of F45L complexed with CN- or N3-, there are two peaks 
missing.  The disruption introduced by the side chain of 19F-Phe is not only seen in 
the heme pocket environment but is also transferred to other Phe residues.  Finally, 
when we compare the N3- set and the CN- set, the F45L-N3 complex looks more 
similar to the WT-N3 complex than the F45L-CN complex to the WT-CN complex.  
It seems that binding of N3- does a better job in stabilizing the mutant protein than 
binding of CN-. 
The temperature dependence of the 19F NMR spectra was tested with WT in 
resting state as well as with N3- or CN- ligand bound forms; the spectra are shown in 
Figure 2-18, 2-19 and 2-20.  Most of the resolved peaks exhibit a trend of line width 
broadening as the temperature decreases.  Also there are fewer peaks at lower 
temperatures; which suggests that the system approaches from fast towards 
intermediate exchange as the temperature decreases. 
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Figure 2-18. 1D 19F NMR of o-19F-Phe labeled pa-HO at resting state. 
 
Figure 2-19. 1D 19F NMR of o-19F-Phe labeled pa-HO in complex with N3-. 
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Figure 2-20. 1D 19F NMR of o-19F-Phe labeled pa-HO in complex with CN-. 
 
7. Protein Dynamics Probed by Amide H/D Exchange NMR Study 
Using the sequential backbone NMR assignments of the WT protein obtained 
by Dr. Juan Carlos Rodriguez [20, 36], the assignments for F45L were achieved by 
comparing HSQC from F45L with HSQC from WT as well as finding NOEs between 
the sequential amide protons (HN) in a 1H-15N NOESY-HSQC spectrum of F45L.  
With the available assignment of F45L, the H-D exchange experiments were carried 
out as described in Experimental Section.  The 2D 1H-15N HSQC results are shown in 
Figure 2-21.  
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Figure 2-21. Superimposed H/D exchange 2D 1H-15N HSQC spectra of WT pa-HO-CN (red 
at bottom) and F45L pa-HO-CN (green on top).  (a) 0 time in H/D exchange; (b) 1st H/D 
exchange HSQCs; (c) last H/D exchange HSQCs, after 24 hrs. 
 
As shown in Figure 2-21 (a), overall, the HSQC spectrum of F45L pa-HO-CN 
is similar to the HSQC spectrum of WT, except that some peaks are shifted as 
indicated by the red peaks.  These chemical shift changes indicate some structural 
changes in the protein.  Figure 2-22 shows the mapped chemical shift changes 
between F45L and WT pa-HO-CN complexes.  
 
Residue
10 20 30 40 60 70 80 90 110 120 130 140 160 170 180 1900 50 100 150 200
∆
δ
 
∆
δ
 
∆
δ
 
∆
δ
 (
Ν
Η
)
(Ν
Η
)
(Ν
Η
)
(Ν
Η
) a
v
e     
    (p
pm
)
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
 (A) 
 69 
Δ > 0.8
Δ > 0.7
Δ > 0.6
Δ > 0.5
Δ > 0.4
Δ > 0.3
Δ > 0.2
Δ > 0.1 ppm
(B)
 
Figure 2-22. Chemical shift perturbation caused by the F45L mutation in the CN- complex.  
(A) Chemical shift perturbation per residue plot.  The weighted chemicals shift change ∆δ is 
obtained by subtracting the 1H and 15N chemical shift of a residue in F45L pa-HO-CN from 
the corresponding shifts in WT pa-HO-CN, then the weighted average chemical shift change 
is calculated using the equation 
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δ
δ
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∆ =
.  The average difference of all residues 
(0.11) is indicated by a horizontal line.  The dots above the residue axis indicate the location 
of phenylalanine residues.  The secondary structure of pa-HO at the bottom of the plot was 
obtained from its 3D crystal structure (PDB: 1SK7) in DSSP view: Helix I (14-21), II(23-36), 
III(42-63), IV(66-71), V(75-78), VI(81-91), VII(109-121), VIII(126-133), IX(134-136), 
X(145-147), XI(154-167), XII(172-197).  (B) Weighted average amide chemical shift 
differences mapped onto the crystal structure of resting state pa-HO. The F45L mutation is 
highlighted by ball and stick.  The color coding follows the plotted ∆δ using the colors 
demonstrated in the color gradient on the right side.  The heme is shown in red.  Both the 
heme and His26 are shown in sticks. 
 
Herein, this chemical shift perturbation analysis is used to identify residues 
experiencing altered chemical properties as a result of the F45L mutation.  The per 
residue change indicated by weighted average chemical shift difference of amide 1H 
and 15N nuclei is plotted in Figure 2-22 (A), and further mapped onto the 3D crystal 
structure of the pa-HO in the resting state (ligand free) in Figure 2-22 (B).  The data 
show clear differences in amide chemical shifts between the mutant and WT in 
complex with CN-.  The overall chemical shift difference is relatively small.  The 
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average chemical shift change is 0.11.  It suggests that the overall protein structure is 
maintained.  While some local regions are changed to a greater extent, as shown in 
Figure 2-22 (A), the largest change is located around the residues 135-145, 88-92 and 
the mutation site 45-50.  Mapped onto 3D crystal structure in Figure 2-22 (B), the 
color gradient indicates that those regions experience the largest perturbation by the 
warmer color (red compared with blue).  The weakly affected residues are located 
both on the bottom and on the top of the heme pocket.  Largely affected residues are 
located on the helix III (42-63), VI (81-91) and IX (134-136).  All Phe residues, as 
represented by dots underneath the x axis, have various chemical shift perturbations.  
F39, F45 and F55 are not included in the analysis because their resonances were not 
assigned.  F48, F117 and F142 have larger than average chemical shift perturbation.  
And F72, F128, F130, F161, F186 and F189 and F197 are below average.  As 
discussed in the introduction, F55, F189, F197, F48, F45, F39, F130 and F128 can 
possibly form a hydrophobic channel located around the heme pocket, especially 
because the F39, F45 and F48 are positioned so closely to each other (shown earlier 
in Figure 1-5 in Chapter I).  Here the evidence from chemical shift perturbation 
suggests that the F45L mutation does change its local ring cluster so that F48 
experiences large chemical shift perturbation.  The influence of F45L mutation does 
not affect all the Phe residues in the hydrophobic channel, but it influences the 
residues nearby that make the heme distal pocket.  
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The local structural disruptions together with the small overall conformational 
difference suggest that the protein likely has a different dynamic behavior.  This idea 
is confirmed by the results from H/D exchange studies discussed below.  
There are three kinds of hydrogens in proteins: the hydrogen on the amino 
acid side chain that exchanges very rapidly and mostly can not be detected; the 
hydrogen covalently bonded to carbon does not exchange at all; and the hydrogen on 
the amino acid backbone amide is exchangeable and measurable.  The protein 
backbone amide hydrogen-deuterium (H/D) exchange is a chemical reaction in which 
a covalently bonded hydrogen atom is exposed to the deuterated solvent and 
exchanging for a deuteron.  Taking advantage of the magnetic property of proton and 
deuterium (deuterium is “invisible” for NMR detection), NMR amide H/D exchange 
studies monitored by 2D HSQC spectra give information regarding solvent 
accessibility to different parts of the protein.  The largest advantage is that it produces 
specific information of each individual amino acid about whether the residue or 
region comprised of a group of residues is buried and therefore protected or exposed 
and prone to exchange.  H/D exchange experiments were used to test the difference in 
protein conformational dynamics among the CN- complexes of WT, F45L, ortho-19F 
Phe labeled WT and ortho-19F Phe labeled F45L pa-HO.  Apparent rates of exchange 
were calculated from the time-dependent intensity changing plot of the HSQC amide 
cross peaks, as demonstrated in the Experimental Section.  From the HSQC spectra 
obtained at different times of the H/D exchange experiment shown in Figure 2-21, it 
can be seen that the intensities of amide cross peaks decay with time.  It is obvious 
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that at the end of the exchange, more green peaks (F45L) have disappeared than red 
peaks (WT).  The faster intensity drop of F45L suggests the faster H/D exchange for 
F45L than WT.  Detailed analysis of time-dependent intensity changes were used to 
calculate the protection factors, as demonstrated in Experimental Section [32, 33].  
The calculated protection factors for F45L pa-HO-CN are compared with the 
corresponding values from WT pa-HO-CN in Figure 2-23 (a) and (c), and a per 
residue plot of protection factors (P), expressed as log P, is shown in Figure 2-23 (c) 
and (d) and mapped onto the 3D crystal structure in Figure 2-24.  To compare F45L 
pa-HO-CN and WT pa-HO-CN, data from both complexes are included in the same 
plot, with red triangles representing values obtained from F45L pa-HO-CN and blue 
circles representing values obtained from WT pa-HO-CN.  The values corresponding 
to WT pa-HO-CN was kindly provided by Dr. Juan Carlos Rodriguez in our lab [20].  
The missing symbol in the plot indicates that the corresponding residues are either a 
proline or not assigned due to broad line width and low intensity of their cross-peaks 
in HSQC spectra [20].  The symbols with log P > 2.0 are for the residues exchanging 
at rates with practical measurement of kex [20].  The blue circles (WT pa-HO-CN) are 
all above the red triangles (F45L).  This suggests that WT pa-HO-CN is less prone to 
H/D exchange than F45L mutant; thus WT is more protected than F45L.  This 
difference, indicated by the H/D exchange study, is related to the altered dynamic 
behavior.  In the context of relatively small changes in protein structure, the mutation 
makes the protein more dynamic in the time scales probed by H/D exchange 
experiments.  The subtracted protection factors are plotted in Figure 2-23 (b) and (d), 
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and the corresponding residues are mapped onto the crystal structure in Figure 2-24. 
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Figure 2-23.  (a and c) Protection factors per residue plot obtained from amide H/D exchange 
experiments with F45L pa-HO-CN (red triangles) and WT pa-HO-CN (blue circles).   
logP=2: exchange rates too fast to be measured (TFTM);  
logP=1: Unassigned or superimposed or disappeared peaks.  
logP=1.5: Exchange rates too slow to be measured (TSTM);  
          (b and d) Residue differences in protection factors (∆ logP =llogP =logPWT-CN – 
logPF45L-CN);  
∆ logP = logP = -3: residue has TFTM in WT while measurable rate in F45L;∆logP = +3: 
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residue has TFTM in F45L while measurable rate in WT; 
Phes are indicated by the empty circle in between two plots. 
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Figure 2-24. ∆logP(logPWT-CN – logPF45L-CN) plot mapped on to 3D crystal structure of pa-HO 
to highlight the regions in which WT pa-HO-CN exhibits enhanced protection to exchange 
relative to F45L pa-HO-CN.  The color gradient is shown on the right side.  The most 
pronounced differences in exchange behavior are shown by red color (0< Δ =< 3; 3 is TFTM 
in F45L but measurable in WT; gray is the amino acid that has no or smaller than 0.33 
deltaLogP). 
 
 
In Figure 2-24 the residues most protected in WT pa-HO-CN relative to F45L 
pa-HO-CN are colored red, and some of them are located closely to the mutation site.  
Residue 27, 29, 34 and 37 are located on helix II, close to the heme distal ligand H26.  
Residue 85 and 88 are located on helix VI.  And residues 133, 139, 142, 144, 147 and 
148 are located on helices VIII, IX and X.  They are distant from the heme and the 
distal ligand.  As suggested by the previous studies of the pa-HO-CN and pa-HO-N3 
by Juan Carlos Rodriguez and coworkers [20, 36] and the Human HO-1 by La Mar 
and coworkers [5, 37], most of the residues with distinct protection factors are likely 
to be involved in the hydrogen bonding network of the structural water molecules.  
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The single F45L mutation produces large protein dynamic change not only around its 
mutation site but also on the heme pocket as well as at the peripheral region on top of 
the heme pocket.  This observation again supports that F45L mutation in the 
hydrophobic cluster composed of F39, F45 and F48 not only perturbs protein 
structure in different regions but also alters the overall protein dynamics, especially 
the regions that are structurally perturbed.  Therefore, the phenylalanine rings not 
only function as an important structural component but also restrict the enzyme’s 
plasticity for the specific catalytic requirement of heme oxygenase reactivity.   
Next, we used the ortho-19F-Phe labeling to study the Phe clusters.  It is 
generally accepted that 19F-Phe labeling is a good atomic level probe because it does 
not change protein stability, structure or dynamics.  In order to evaluate the impact of 
ortho-19F-Phe labeling in WT pa-HO, the chemical shift difference is acquired by 
comparing the same amino acid’s HSQC peak in ortho-19F-Phe labeled to WT paHO 
CN- complexes.  The result is shown in Figure 2-25.  Inspecting the whole plot of 
Figure 2-25 (A), again the overall chemical shift difference is small which suggests 
that the protein structure is maintained.  Similarly, some local regions exhibit larger 
changes, for example, in regions of helix II (bottom of heme pocket) and III (one side 
of heme pocket), and in regions of helix XIII (126-133) and IX (134-136), and the 
strand in-between and X (145-147) (these helices and neighboring loops are 
accessible to solvent).  The regions perturbed by ortho-19F-Phe labeling are different 
from those perturbed by the F45L mutation in the first two helix groups, and 
somewhat similar in the last three groups mentioned above.  The 45 mutation site (45-
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50) and the 88-92 regions are not much affected by the ortho-19F-Phe labeling.  All 
ortho-19F labeled Phe residues, as represented by dots underneath the residue axis, 
have various degrees of chemical shift perturbations, for example, F48, F55, F130, 
F142 and F189 have chemical shift perturbation larger than the average.  In the 
protein 3D crystal structure of resting state pa-HO, one can see that all these Phe 
residues seem to be randomly placed in the protein.  By observing them closely, they 
fall into the proposed hydrophobic channel (F55, F189, F197, F48, F45, F39, F130 
and F128 in the shape of a long cylinder that crosses the back of the heme pocket).  
The flexibility of the loop would possibly explain the large chemical shift 
perturbation.  Again, the influence of ortho-19F-Phe labeling does not channel through 
all the Phe candidates in the hydrophobic channel, and it affects the heme distal 
pocket to a larger extent than the F45L mutation.  
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Figure 2-25. Chemical shift perturbations caused by ortho-19F Phe labeling in the WT pa-
HO-CN complex.  (A) Chemical shift perturbation per residue plot, similarly presented as in 
Figure 2-22. The average 0.136 is shown by the horizontal line.  (B) Weighted average amide 
chemical shift differences mapped onto the crystal structure of resting state pa-HO.  The 
color coating follows the plotted ∆δ using the colors demonstrated in the color gradient on the 
right side.  The heme is shown in red.  The heme, phenylalanines and His26 are shown in 
sticks.  
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Figure 2-25 (B) illustrates the chemical shift perturbations mapped onto the 
3D crystal structure of pa-HO, with the warmer color representing larger chemical 
shift perturbations.  Again, the distribution of the several warm colored Phes shows a 
clear pattern that the heme pocket and the loop on the right top of the structure have 
larger chemical shift perturbations.  H26 and Q27 show the largest change, which 
suggests that there are possibly some disruptions to heme coordination in the heme 
pocket.  
The H/D experiment was carried out with ortho-19F-Phe pa-HO-CN as 
mentioned above.  The calculated protection factors are compared with the 
corresponding values from WT pa-HO-CN in Figure 2-26 (a) and (c).  The blue 
circles (WT for WT pa-HO-CN, CN- here is the default binding ligand in this H/D 
exchange study) are all above the red triangles (o-WT for ortho-19F-Phe labeled WT 
pa-HO-CN).  It suggests that WT pa-HO-CN is less prone to H/D exchange than o-
WT.  This observation is similar that made in the comparison between WT and F45L.  
Here, ortho-19F-Phe labeling also makes the protein more dynamic and more prone to 
the exchange compared with WT.  The subtracted protection factors are plotted in 
Figure 2-26 (b) and (d), and the corresponding residues are mapped onto the 3D 
crystal structure in Figure 2-27.  It is very surprising that a large influence on the 
flexibility of the protein occurs upon ortho-19F-Phe labeling not only in the regions of 
the close proximity to the heme but also in the portions of the proteins that are far 
removed from the heme iron and distal ligand.  Interestingly, the most affected 
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regions are similar like in the previous comparison between F45L mutant and WT pa-
HO.  The difference is that the previously affected residue 85 and 88 in the F45L 
mutant are not distinguishable between ortho-19F-Phe labeling and WT.  Yet the 
residue 20 and 21, as well as residues 110-120 seem to be more different here than in 
the comparison between mutation and WT.  Overall, there are more residues prone to 
exchange found in the comparison between WT and ortho-19F-Phe labeled pa-HO-CN 
than found in the comparison between WT and F45L mutation.  Therefore it is not 
surprising that there are more Phe residues (indicated by a black circle in Figure 2-23 
and 2-26) that are affected by ortho-19F-Phe labeling than F45L mutation.  This is 
because the ortho-19F-Phe labeling that produces small but direct change in all total 
13 Phe residues, but the F45L mutation only directly changes one Phe residue.  All 
these differences suggest that the F45L mutation does not impact the protein 
dynamics as much as ortho-19F-Phe labeling.  Due to the limited data, protection 
factors for only a few Phe residues were calculated to compare with WT; F39, F128 
and F161 seem to exhibit the most dramatic influence in protection factor.  Although 
not all Phes in ortho-19F-Phe labeled protein have dramatic change in protection 
factors, still most of them become more prone to exchange.  Mapping log P on the 
structure of resting state pa-HO also reveals that sections of the protein remote from 
the heme-iron and distal ligand, where there is significantly less flexibility in ortho-
19F-Phe labeled pa-HO-CN relative to WT pa-HO-CN, appear to be in some kind of 
communication with the distal ligand via this hydrophobic channel formed by Phe 
residues.  This observation in turn suggests that the hydrophobic cluster in the 
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structure plays an important role in maintaining protein tertiary structure and fine-
tuning protein dynamics in heme oxygenase.  Therefore, it again supports previous 
hypothesis that Phes not only function as an important structural component but also 
maintain the enzyme’s plasticity for the specific catalytic requirement of unique heme 
oxygenase reactivity.  By analyzing the residues showing the large change in both 
chemical shifts and protection factor in context of protein 3D crystal structure, the 
observation strongly suggests the possibility that hydrophobic channel (here proposed 
to be represented by a series of Phes forming a horizontal cylinder in this protein) 
inside the protein may function more importantly than is appreciated.  It is easy to 
understand that the H-bonding network formed with structural water molecules plays 
a key role in protein structure and function.  On the other hand, the hydrophobic 
channel (a hydrophobic core) may be as important to the integrity of the H-bonding 
network.  Further detailed study is necessary to test this hypothesis.  
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Figure 2-26.  (a and c) Protection factors per residue plot obtained from amide H/D exchange 
experiments with o-19F-Phe labeled pa-HO-CN (red triangles) and WT pa-HO-CN (blue 
circles).   
logP=2: exchange rates too fast to be measured (TFTM);  
logP=1: Unassigned or superimposed or disappeared peaks.  
logP=1.5: Exchange rates too slow to be measured (TSTM);  
 (b and d) Residue differences in protection factors (∆logP =logPWT-CN – logPo-19F-
PheWT-CN);  
∆logP = -3: residue has TFTM in WT while measurable rate in o-19F-Phe-WT; 
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∆logP = +3: residue has TFTM in o-19F-Phe-WT while measurable rate in WT; 
Phes are indicated by the empty circle in between two plots 
 
 
Figure 2-27. Mapping of ∆logP(logPWT-CN – logPo-WT-CN) plot on to 3D crystal structure of 
pa-HO to highlight the regions in which WT pa-HO-CN exhibits enhanced protection to 
exchange relative to o-WT pa-HO-CN.  The color gradient is shown on the right side.  The 
most pronounced differences in exchange behavior are shown by red color (0< Δ =< 3; 3 is 
TFTM in o-WT but measurable in WT; gray is the amino acid that has no or smaller than 
0.33 deltaLogP). 
 
A similar study was conducted by combining ortho-19F-Phe labeling and the 
F45L mutation.  The results are shown in Figure 2-28 and 2-29.  Because of the 
aggravated change brought by mutation together with ortho-19F-Phe labeling, many 
more residues were not assignable due to missing signals in the HSQC spectrum, due 
to broad line width and weak signal intensity caused by dynamic properties at 37 °C.  
Some of the signals reappear when the temperature is lowered.  Thus, their 
assignments were achieved at lower temperatures.  Those peaks with fast dynamics 
Δ > 2.67
Δ > 2.33
Δ > 2
Δ > 1.67
Δ > 1.33
Δ > 1
Δ > 0.67
Δ > 0.33
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are very prone to H/D exchange.  Therefore, they are still included in the H/D 
exchange study as the least protected residues.  From the chemical shift perturbation 
plot in Figure 2-28, it is clear that it has larger perturbation than either ortho-19F-Phe 
labeling or F45L mutation, and the perturbed regions are the combination of both.  
Also, the average shift 0.14 is larger than either ortho-19F-Phe labeling or F45L 
mutation.  As shown in Figure 2-28 (B), the mapping suggests that the chemical shift 
change is spread around the whole protein.  
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Figure 2-28. Chemical shift perturbation caused by both ortho-19F Phe labeling and F45L 
mutation in WT pa-HO-CN complex. (A) Chemical shift perturbation per residue plot, 
similarly presented as in Figure 2-22.  The average 0.14 is shown by the horizontal line.  (B) 
Weighted average amide chemical shift differences mapped onto the crystal structure of 
resting state pa-HO.  The color coating follows the plotted ∆δ using the colors demonstrated 
in the color gradient on the right side.  The heme is shown in red.  The heme, phenylalanines 
and His26 are shown in sticks.  
 
H/D experiments were also conducted with o-19F-Phe F45L.  The calculated 
protection factors again are compared with the corresponding values from WT pa-
HO-CN in Figure 2-29.  The blue circles (WT) are all above the red triangles (o-WT).  
Once again, these data suggest that WT pa-HO-CN is less prone to H/D exchange 
than o-F45L (o-F45L for ortho-19F-Phe labeled F45L pa-HO-CN).  Green diamond 
represents the new assignments achieved only at lower temperatures for the fast 
exchange residues.  It is apparent that these green diamond symbolized residues are 
located in the regions that are more prone to H/D exchange in either ortho-19F-Phe 
labeling or the F45L mutation compared with WT.  Therefore, in the case of 
combining both ortho-19F-Phe labeling and the F45L mutation, these residues are 
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even more dynamic than before.  From temperature dependent experiments, these 
green diamond labeled residues were only detectable at lower temperatures.  These 
observations confirm that the previous findings in ortho-19F-Phe labeling or the F45L 
mutation were no coincidence.  Again, log P plot was mapped onto the 3D crystal 
structure in Figure 2-30.  The regions with warmer color resemble the above 
mappings for F45L and ortho-19F-Phe labeling H/D exchange studies.  
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Figure 2-29.  (a and c) Protection factors per residue plot obtained from amide H/D exchange 
experiments with o-19F-Phe labeled F45L pa-HO-CN (red triangles) and WT pa-HO-CN 
(blue circles).   
logP=2: exchange rates too fast to be measured (TFTM);  
logP=1: Unassigned or superimposed or disappeared peaks.  
logP=1.5: Exchange rates too slow to be measured (TSTM);  
logP=0.5: Assigned at 15oC with assignment peak appearing or increasing intensity, shown 
by green diamond: sure assignments: 0.5, guessed assignments: 0.0. 
 (b and d) Residue differences in protection factors (∆logP =logPWT-CN – logPo-F45L-CN);  
∆logP = -3: residue has TFTM in WT while measurable rate in o-19F-Phe-F45L; 
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∆logP = +3: residue has TFTM in o-19F-Phe-F45L while measurable rate in WT; 
Phes are indicated by the empty circle in between two plots 
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Figure 2-30. ∆logP(logPWT-CN – logPo-F45L-CN) plot mapped on to 3D crystal structure of pa-
HO to highlight the regions in which WT pa-HO-CN exhibits enhanced protection to 
exchange relative to o-F45L pa-HO-CN.  The color gradient is shown on the right side.  The 
most pronounced differences in exchange behavior are shown by red color (0< Δ =< 3; 3 is 
TFTM in o-F45L but measurable in WT; gray is the amino acid that has no or smaller than 
0.33 deltaLogP).  
 
CONCLUSION 
Phe is a hydrophobic residue; its ring rotation displaces about 80 cubic 
angstroms volume.  The cluster of Phe rings can possibly form a hydrophobic cluster 
and exclude water molecule.  In a way it works like the “bank sides to river” to 
facilitate the internal structural water to form an H-bonding network with the protein 
side chain.  Also the hydrophobic cluster is especially important in the protein folding 
and conformational changes in the protein dynamics [38].  
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By using mutagenesis and fluorine labeling to the Phe residues using pa-HO 
as a model, we investigated the observed Phe hydrophobic cluster inside heme 
oxygenase.  Using ortho-19F-Phe labeling and F45L etc mutations studied by NMR, 
UV-vis and CD, it is discovered that this Phe ring cluster not only functions to 
maintain protein structure but also fine-tunes the protein dynamic motion for this 
specific heme oxygenation catalysis.  
Phe45 is the key residue in the hydrophobic Phe ring cluster inside pa-HO.  
F45L mutation causes certain disruptions in heme distal pocket and the loss of heme 
oxygenase reactivity while maintaining overall protein structure.  It increases protein 
dynamic motion in the large (hrs-days) time scales detected by H/D exchange 
experiment.  
Ortho-19F-phenylalanine labeling in pa-HO decreases reactivity while 
maintaining the intact protein structure.  Surprisingly contrary to general 
understanding that 19F-Phe labeling will provide very little influence in protein 
structure and function.  Again protein dynamic motion is altered.  And with the 
combination of ortho-19F-phenylalanine labeling and F45L mutation, the impact is 
enhanced on both reactivity and protein dynamics.  
As shown in the studies of human HO-1[5, 37] and pa-HO [20, 36], a 
propagated water channel and H-bonding network exist for assisting protein catalysis.  
From this study of Phe ring cluster in pa-HO, we predicted that the H-bonding 
network in the heme binding pocket is likely altered during the protein mutation 
or/and the ortho-19F-Phe labeling.  
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  The understanding of how pa-HO possesses and carries out its unique 
catalysis gives us a solid foundation in searching and testing its redox partner proteins 
where pa-HO gets the seven electrons for heme degradation.  The study of a novel 
pa-HO redox partner protein, ferredoxin NADPH reductase protein from 
Pseudomoonas aeruginosa will be discussed in next two chapters.  
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 APPENDIX 
 
Figure S-2-1. 2D 1H-15N HSQC spectrum of ortho-19F labeled pa-HO-CN. 
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Figure S-2-2. 2D 1H-15N HSQC spectrum of ortho-19F labeled F45L WT pa-HO-CN. 
 
Table S-2-1. F45L pa-HO-CN 2D 1H-15N HSQC NMR assignments, chemical shifts are 
given in ppm. 
 
 
Residue No.  15N  1H 
MET 1   
ASP 2   
THR 3   
LEU 4   
ALA 5   
PRO 6   
GLU 7   
SER 8   
THR 9   
ARG 10   
GLN 11   
ASN 12   
LEU 13 121.23  7.89  
ARG 14 128.15  8.81  
 96 
SER 15 117.50  11.49  
GLN 16 121.88  6.65  
ARG 17 121.73  8.16  
LEU 18 118.84  8.85  
ASN 19 120.83  7.98  
LEU 20 119.79  8.02  
LEU 21 119.39  8.36  
THR 22 106.02  8.12  
ASN 23 124.20  8.18  
GLU 24 120.04  9.84  
PRO 25   
HIS 26 120.64  10.46  
GLN 27 123.37  10.73  
ARG 28 120.59  8.93  
LEU 29   
GLU 30   
SER 31 112.97  7.21  
LEU 32 124.21  7.43  
VAL 33 118.87  7.69  
LYS 34 116.43  7.11  
SER 35 114.98  7.48  
LYS 36 119.17  6.85  
GLU 37 111.17  7.28  
PRO 38   
PHE 39   
ALA 40 120.90  7.70  
SER 41 105.07  7.35  
ARG 42   
ASP 43   
ASN 44   
PHE 45   
ALA 46 121.08  8.59  
ARG 47 116.02  6.94  
PHE 48 123.14  7.59  
VAL 49 121.42  9.21  
ALA 50 122.51  8.56  
ALA 51 121.06  7.04  
GLN 52 116.43  7.83  
TYR 53 119.45  9.33  
LEU 54 120.31  8.35  
PHE 55   
GLN 56   
HIS 57   
ASP 58 122.21  7.92  
LEU 59 113.45  6.77  
GLU 60 124.53  7.43  
PRO 61   
 97 
LEU 62 116.27  7.66  
TYR 63 114.95  7.70  
ARG 64 112.03  7.30  
ASN 65 122.81  7.22  
GLU 66 128.38  9.09  
ALA 67 122.30  7.90  
LEU 68 119.39  8.36  
ALA 69 122.29  8.37  
ARG 70 114.75  7.26  
LEU 71 118.50  7.07  
PHE 72 115.62  7.93  
PRO 73   
GLY 74 115.61  8.96  
LEU 75 123.24  7.96  
ALA 76 117.81  8.76  
SER 77 111.83  7.91  
ARG 78   
ALA 79 122.86  6.79  
LEU 80 117.77  7.80  
ASP 81   
ASP 82 119.90  8.29  
ALA 83 123.59  8.16  
ALA 84 117.50  8.08  
ARG 85 118.16  8.36  
ALA 86 123.24  7.96  
ASP 87 122.29  8.37  
LEU 88 119.21  7.90  
ALA 89 120.46  7.40  
ASP 90 120.84  8.23  
LEU 91 116.52  7.59  
GLY 92 108.88  7.96  
HIS 93 122.68  8.17  
PRO 94   
VAL 95 123.93  8.84  
PRO 96   
GLU 97 119.91  8.41  
GLY 98 111.04  8.43  
ASP 99 119.99  8.62  
GLN 100 118.03  8.73  
SER 101 117.03  8.77  
VAL 102 122.86  8.26  
ARG 103 121.82  8.29  
GLU 104 114.80  7.79  
ALA 105 122.81  7.22  
ASP 106 120.89  8.36  
LEU 107 121.75  7.73  
SER 108 119.00  8.45  
 98 
LEU 109 123.30  8.53  
ALA 110 116.98  8.29  
GLU 111 115.46  7.40  
ALA 112 121.03  8.62  
LEU 113 115.91  8.08  
GLY 114 104.32  7.63  
TRP 115 121.67  7.54  
LEU 116 117.91  8.50  
PHE 117 119.58  8.47  
VAL 118 118.13  7.15  
SER 119   
GLU 120 117.74  8.99  
GLY 121 111.69  7.66  
SER 122 113.94  6.37  
LYS 123   
LEU 124   
GLY 125   
ALA 126   
ALA 127   
PHE 128 117.60  8.20  
LEU 129 120.49  8.59  
PHE 130 120.33  9.98  
LYS 131 116.91  7.38  
LYS 132 119.27  7.32  
ALA 133 122.09  8.22  
ALA 134 120.46  7.40  
ALA 135 120.40  7.52  
LEU 136 117.74  7.56  
GLU 137 114.48  8.11  
LEU 138 116.91  6.94  
ASP 139 120.10  9.31  
GLU 140 116.69  10.42  
ASN 141 116.38  8.84  
PHE 142 122.99  7.91  
GLY 143 118.29  9.58  
ALA 144 119.27  7.32  
ARG 145   
HIS 146 116.29  11.28  
LEU 147 120.56  7.64  
ALA 148 122.98  7.50  
GLU 149 122.62  8.38  
PRO 150   
GLU 151   
GLY 152 113.56  9.09  
GLY 153 108.04  8.14  
ARG 154 125.19  9.46  
ALA 155 122.68  8.68  
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GLN 156   
GLY 157 107.61  7.72  
TRP 158 125.04  7.62  
LYS 159 118.09  8.28  
SER 160 112.80  8.12  
PHE 161 123.84  7.22  
VAL 162 117.31  8.35  
ALA 163 119.82  7.51  
ILE 164 117.05  6.77  
LEU 165 121.23  7.89  
ASP 166 116.51  8.63  
GLY 167 106.53  7.46  
ILE 168 121.12  6.80  
GLU 169 129.51  8.69  
LEU 170 124.86  7.90  
ASN 171 121.39  9.47  
GLU 172 116.94  8.45  
GLU 173 121.07  8.08  
GLU 174 120.49  8.59  
GLU 175 119.67  8.66  
ARG 176 119.05  7.46  
LEU 177 122.62  8.05  
ALA 178 124.06  8.25  
ALA 179 118.59  7.27  
LYS 180 121.73  8.16  
GLY 181 106.77  8.86  
ALA 182 121.31  7.64  
SER 183 112.86  7.92  
ASP 184 122.75  9.32  
ALA 185 125.79  7.78  
PHE 186 115.46  7.40  
ASN 187 117.77  7.80  
ARG 188 121.59  8.57  
PHE 189 119.42  8.08  
GLY 190 102.94  7.60  
ASP 191 121.83  7.69  
LEU 192 120.91  8.16  
LEU 193 119.23  8.05  
GLU 194 115.50  7.56  
ARG 195 117.99  7.60  
THR 196 110.95  8.70  
PHE 197 120.06  7.70  
ALA 198 129.33  6.99  
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Table S-2-2. ortho-19F labeled pa-HO-CN 2D 1H-15N HSQC NMR assignments, chemical 
shifts are given in ppm. 
 
Residue No.  15N  1H 
MET 1   
ASP 2   
THR 3   
LEU 4   
ALA 5   
PRO 6   
GLU 7   
SER 8   
THR 9   
ARG 10   
GLN 11 8.17  120.98  
ASN 12 8.31  118.95  
LEU 13 7.91  121.25  
ARG 14 8.81  128.26  
SER 15 11.54  117.72  
GLN 16 6.67  121.82  
ARG 17 8.19  121.88  
LEU 18 8.86  118.74  
ASN 19 8.04  120.98  
LEU 20 8.05  120.13  
LEU 21 8.32  119.31  
THR 22 8.13  107.11  
ASN 23 8.19  124.17  
GLU 24 9.80  119.75  
PRO 25   
HIS 26 10.31  119.51  
GLN 27 10.51  121.99  
ARG 28 8.73  120.91  
LEU 29 8.58  122.99  
GLU 30   
SER 31 7.03  112.70  
LEU 32 7.45  124.50  
VAL 33 7.74  118.92  
LYS 34 7.04  116.47  
SER 35 7.50  114.97  
LYS 36 6.92  119.30  
GLU 37 7.35  110.88  
PRO 38   
PHE 39 7.80  108.43  
ALA 40 7.72  120.75  
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SER 41 7.41  104.81  
ARG 42   
ASP 43 8.22  118.07  
ASN 44 7.95  120.68  
PHE 45 8.63  123.93  
ALA 46 8.92  121.57  
ARG 47 6.99  116.69  
PHE 48 7.40  122.94  
VAL 49 8.84  121.55  
ALA 50 8.40  122.07  
ALA 51 6.97  120.99  
GLN 52 7.83  116.58  
TYR 53 9.43  118.95  
LEU 54 8.30  120.28  
PHE 55 8.46  121.79  
GLN 56 8.52  115.46  
HIS 57 9.21  122.14  
ASP 58 7.81  122.34  
LEU 59 6.75  113.79  
GLU 60 7.45  124.50  
PRO 61   
LEU 62 7.58  116.31  
TYR 63 7.76  115.01  
ARG 64 7.30  111.84  
ASN 65 7.22  122.89  
GLU 66 9.10  128.37  
ALA 67 7.91  122.41  
LEU 68 8.39  119.14  
ALA 69 8.36  122.10  
ARG 70 7.29  115.04  
LEU 71 7.03  118.05  
PHE 72 7.93  115.62  
PRO 73   
GLY 74 8.97  115.70  
LEU 75 7.98  123.12  
ALA 76 8.84  117.70  
SER 77 7.91  111.65  
ARG 78 8.18  120.01  
ALA 79 6.75  123.08  
LEU 80 7.81  117.53  
ASP 81 8.92  120.75  
ASP 82 8.21  119.83  
ALA 83 8.16  123.79  
ALA 84 8.18  117.22  
ARG 85 8.42  118.41  
ALA 86 8.02  123.37  
ASP 87 8.36  122.10  
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LEU 88 7.78  118.72  
ALA 89 7.57  120.99  
ASP 90 8.55  121.99  
LEU 91 7.58  116.12  
GLY 92 8.05  109.35  
HIS 93 8.27  122.97  
PRO 94   
VAL 95 8.86  124.13  
PRO 96   
GLU 97 8.43  120.01  
GLY 98 8.44  110.99  
ASP 99 8.68  119.92  
GLN 100 8.75  118.07  
SER 101 8.82  117.12  
VAL 102 8.27  122.97  
ARG 103 8.36  122.10  
GLU 104 7.77  114.66  
ALA 105 7.19  122.85  
ASP 106 8.37  120.79  
LEU 107 7.73  121.61  
SER 108 8.45  118.99  
LEU 109 8.54  123.32  
ALA 110 8.31  117.06  
GLU 111 7.44  115.59  
ALA 112 8.64  121.08  
LEU 113 8.11  115.86  
GLY 114 7.65  104.57  
TRP 115 7.57  121.83  
LEU 116 8.52  117.48  
PHE 117 8.54  119.58  
VAL 118 7.13  118.07  
SER 119 8.01  112.09  
GLU 120 9.02  117.25  
GLY 121 7.59  111.93  
SER 122 6.37  114.23  
LYS 123   
LEU 124   
GLY 125   
ALA 126   
ALA 127   
PHE 128 8.19  117.74  
LEU 129 8.82  120.51  
PHE 130 10.03  119.84  
LYS 131 7.40  116.77  
LYS 132 7.43  119.40  
ALA 133 7.95  121.87  
ALA 134 7.35  120.69  
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ALA 135 7.50  121.12  
LEU 136 7.42  117.63  
GLU 137 8.15  115.25  
LEU 138 6.83  116.53  
ASP 139 9.26  121.12  
GLU 140 10.54  116.92  
ASN 141 8.85  116.84  
PHE 142 7.85  121.87  
GLY 143 10.03  119.84  
ALA 144 7.46  119.09  
ARG 145 11.58  126.14  
HIS 146 11.38  116.90  
LEU 147 7.66  120.45  
ALA 148 7.55  123.05  
GLU 149 8.41  122.66  
PRO 150   
GLU 151   
GLY 152 9.14  113.99  
GLY 153 8.13  107.95  
ARG 154 9.45  125.05  
ALA 155 8.66  122.54  
GLN 156 8.98  118.97  
GLY 157 7.72  107.01  
TRP 158 7.63  125.33  
LYS 159 8.31  118.17  
SER 160 8.11  112.70  
PHE 161 7.17  123.79  
VAL 162 8.33  117.53  
ALA 163 7.63  120.28  
ILE 164 6.77  116.71  
LEU 165 7.95  121.35  
ASP 166 8.68  116.75  
GLY 167 7.44  106.31  
ILE 168 6.85  121.21  
GLU 169 8.71  129.63  
LEU 170 7.91  124.83  
ASN 171 9.48  121.34  
GLU 172 8.45  116.95  
GLU 173 8.09  121.07  
GLU 174 8.60  120.50  
GLU 175 8.66  119.63  
ARG 176 7.46  119.09  
LEU 177 8.07  122.61  
ALA 178 8.25  123.98  
ALA 179 7.25  118.57  
LYS 180 8.16  121.63  
GLY 181 8.85  106.63  
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ALA 182 7.57  121.14  
SER 183 7.86  112.54  
ASP 184 9.29  122.40  
ALA 185 7.67  125.46  
PHE 186 7.44  115.59  
ASN 187 7.79  117.06  
ARG 188 8.58  121.70  
PHE 189 7.94  118.74  
GLY 190 7.48  102.37  
ASP 191 7.57  121.83  
LEU 192 8.12  120.85  
LEU 193 7.94  118.74  
GLU 194 7.51  115.21  
ARG 195 7.53  117.79  
THR 196 8.62  110.60  
PHE 197 7.70  120.17  
ALA 198 7.03  129.36  
 
 
 
Table S-2-3. ortho-19F labeled F45L pa-HO-CN 2D 1H-15N HSQC NMR assignments, 
chemical shifts are given in ppm. 
 
Residue No.  15N  1H 
MET 1   
ASP 2   
THR 3   
LEU 4   
ALA 5   
PRO 6    
GLU 7   
SER 8   
THR 9   
ARG 10   
GLN 11   
ASN 12   
LEU 13 121.24  7.90  
ARG 14 128.20  8.81  
SER 15 117.70  11.53  
GLN 16 121.76  6.65  
ARG 17 121.68  8.16  
LEU 18 118.70  8.85  
ASN 19   
LEU 20 120.06  8.03  
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LEU 21   
THR 22 107.06  8.11  
ASN 23 124.13  8.18  
GLU 24 119.77  9.80  
PRO 25   
HIS 26 119.85  10.37  
GLN 27 122.39  10.64  
ARG 28 121.02  8.86  
LEU 29   
GLU 30   
SER 31   
LEU 32   
VAL 33   
LYS 34 116.81  7.17  
SER 35 114.69  7.48  
LYS 36 119.38  6.94  
GLU 37 111.21  7.32  
PRO 38   
PHE 39   
ALA 40 120.92  7.83  
SER 41 105.31  7.36  
ARG 42 118.09  8.23  
ASP 43   
ASN 44   
PHE 45   
ALA 46 121.20  8.59  
ARG 47   
PHE 48 122.96  7.54  
VAL 49   
ALA 50 121.90  8.47  
ALA 51 120.83  6.94  
GLN 52 116.52  7.82  
TYR 53 119.17  9.35  
LEU 54 120.65  8.33  
PHE 55 122.85  8.55  
GLN 56   
HIS 57   
ASP 58 122.09  7.83  
LEU 59 114.00  6.78  
GLU 60 124.24  7.42  
PRO 61   
LEU 62 116.34  7.60  
TYR 63 114.88  7.73  
ARG 64 112.08  7.27  
ASN 65 122.81  7.22  
GLU 66 128.44  9.10  
ALA 67 122.32  7.91  
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LEU 68 118.99  8.42  
ALA 69 122.27  8.36  
ARG 70 115.05  7.30  
LEU 71 118.08  7.04  
PHE 72 115.51  7.92  
PRO 73   
GLY 74 115.28  8.95  
LEU 75 123.17  7.99  
ALA 76 117.80  8.81  
SER 77 111.85  7.92  
ARG 78 119.89  8.18  
ALA 79 122.79  6.79  
LEU 80 117.88  7.84  
ASP 81   
ASP 82 119.89  8.34  
ALA 83 123.67  8.19  
ALA 84 117.57  8.12  
ARG 85   
ALA 86 123.17  7.99  
ASP 87 122.54  8.39  
LEU 88 119.12  7.88  
ALA 89 120.42  7.45  
ASP 90   
LEU 91 116.34  7.60  
GLY 92 108.89  7.99  
HIS 93 122.67  8.23  
PRO 94   
VAL 95 123.81  8.86  
PRO 96   
GLU 97 119.91  8.42  
GLY 98 110.92  8.43  
ASP 99 119.99  8.64  
GLN 100   
SER 101 117.08  8.78  
VAL 102 122.85  8.27  
ARG 103 121.71  8.29  
GLU 104 114.98  7.79  
ALA 105 122.81  7.22  
ASP 106 120.79  8.36  
LEU 107 121.82  7.73  
SER 108 118.99  8.42  
LEU 109 123.41  8.55  
ALA 110 117.13  8.33  
GLU 111 115.49  7.46  
ALA 112 121.21  8.64  
LEU 113 116.03  8.11  
GLY 114 104.65  7.65  
 107
TRP 115 121.80  7.63  
LEU 116 117.73  8.56  
PHE 117 119.60  8.50  
VAL 118 118.03  7.14  
SER 119   
GLU 120 117.45  9.02  
GLY 121   
SER 122   
LYS 123   
LEU 124   
GLY 125   
ALA 126   
ALA 127   
PHE 128   
LEU 129 120.47  8.60  
PHE 130   
LYS 131   
LYS 132   
ALA 133   
ALA 134   
ALA 135   
LEU 136   
GLU 137   
LEU 138   
ASP 139   
GLU 140   
ASN 141 116.51  8.85  
PHE 142 123.07  7.94  
GLY 143   
ALA 144   
ARG 145   
HIS 146   
LEU 147   
ALA 148   
GLU 149   
PRO 150   
GLU 151   
GLY 152 113.81  9.11  
GLY 153 108.07  8.16  
ARG 154 125.32  9.47  
ALA 155 122.74  8.70  
GLN 156   
GLY 157 107.75  7.75  
TRP 158   
LYS 159 118.09  8.30  
SER 160 112.90  8.14  
PHE 161 123.94  7.22  
 108
VAL 162 117.54  8.31  
ALA 163 120.23  7.59  
ILE 164 116.90  6.82  
LEU 165 121.39  7.96  
ASP 166 116.82  8.67  
GLY 167 106.37  7.45  
ILE 168 121.18  6.85  
GLU 169 129.55  8.70  
LEU 170 124.81  7.91  
ASN 171 121.33  9.47  
GLU 172 116.98  8.46  
GLU 173 121.09  8.09  
GLU 174 120.47  8.60  
GLU 175 119.63  8.66  
ARG 176 119.09  7.47  
LEU 177 122.64  8.07  
ALA 178 124.01  8.27  
ALA 179 118.68  7.28  
LYS 180 121.68  8.16  
GLY 181 106.70  8.86  
ALA 182 121.29  7.62  
SER 183 112.80  7.91  
ASP 184 122.56  9.31  
ALA 185 125.54  7.71  
PHE 186 115.49  7.46  
ASN 187 117.88  7.84  
ARG 188 121.72  8.58  
PHE 189 118.92  7.98  
GLY 190 102.62  7.57  
ASP 191 121.80  7.63  
LEU 192 120.95  8.15  
LEU 193   
GLU 194   
ARG 195 117.61  7.60  
THR 196 110.64  8.61  
PHE 197   
ALA 198 129.40  7.12  
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CHAPTER III: CHARACTERIZATION OF PSEUDOMONAS 
AERUGIONSA FPR: FERREDOXIN NADP+ REDUCTASE: A KEY PROTEIN 
INVOLVED IN HEME-IRON ACQUISITION 
 
INTRODUCTION 
As discussed in previous chapters, the identification and characterization of 
redox partners that deliver electrons to HO, as well as the characterization of protein-
protein interactions that facilitate the electron flow from NAD(P)H to HO are 
important steps toward a molecular-level understanding of heme metabolism.  
Thorough study of the novel protein ferredoxin-NADPH redutase from Pseudomonas 
aeruginosa (pa-FPR) in the proposed iron acquisition pathway (Figure 1-2 in Chapter 
I) is very important and has been carried out in our lab.  The interesting findings will 
be shown both in this and the next chapters. 
Pa-FPR belongs to the flavoprotein family, one of the most abundant protein 
families.  In human there are 361 flavoproteins; in E. Coli there are 205 flavoproteins 
[1].  In Pseudomonas aeruginosa genome PA01 (http://www.pseudomonas.com), 
there are 79 hits of flavoproteins.  It is well known that flavoprotein has enormous 
metabolic versatility, and most of flavoproteins function as electron transfer redox 
proteins in mammal, bacteria, plant, etc many organisms [1-4].  One unique example 
of flavoprotein’s versatility in nature is shown by a novel kind of cytochrome P450 
reductase found in Ralstonia, Burkholderia and Rhodococcus bacteria.  This 
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flavoprotein has three components: 2Fe-2S ferredoxin domain, FMN-dependent 
NADP(H) reductase domain and cytochrome P450 domain[1].  Nature fused the three 
different proteins into one to conduct the same catalysis function done by the three 
individual proteins all together. 
Ferredoxin(flavodoxin)–NAD(P)H reductase (FNR) is one of the most 
important and well-studied flavoproteins [2, 3, 5].  In plastids, mitochondira, bacteria 
and parasite, it transfers electrons either from NAD(P)H  to its redox partner protein 
ferredoxin/flavodoxin or from redox partner protein to NAD(P)+ [5-17].  When FNR 
receives electron from reduced partner protein and transfers hydride to NADP+, this 
reaction is so called the photosynthetic path, a reversible process shown below in 
Equation 3-1 [2, 3].  And in the nonphotosynthetic path, it receives two electrons and 
a proton or a hydride (H:) from NADPH and delivers electrons to the oxidized partner 
protein, shown in Equation 3-2 [2, 3].  As will be mentioned in this study, the Maize, 
Pea, Spinach leaves and Anabaena FNRs are following the photosynthetic pathway, 
while E. coli and Azotobacter vinelandii FNR, same as our pa-FPR are following the 
nonphotosynthetic pathway.  
 
2Fd(FeII)/2Fld(FMNH·) + NADP+ + H+ ↔ 2Fd(FeIII)/2Fld(FMN) + NADPH       (3-1) 
NADPH + H+ + FNRox ↔ NADP+ + FNRH2, 
FNRH2 + n Proteinox → FNRox + n Proteinred  n =1 or 2            (3-
2) 
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These reactions are by no means limited to protein redox partner, and FNR 
can readily react with many molecules, e.g. ferredoxin, flavodoxin, ferricynaide, 
heme, phenol for different purposes in vivo [5].  Interestingly enough, there is very 
high similarity between NAD(P)H and NAD(P)+ binding domains in many examples 
[5, 14, 18-22].  And from the phylogenetic study done by E. Ceccarelli and 
coworkers, they found that the photosynthetic and nonphotosynthetic FNR groups 
share the same ancestor; the functional difference is most likely the evolution result 
of different metabolic pressure [2].    
Structural characterization of FNR proteins is done mainly by crystallography.  
FNR structure is highly conserved.  The protein is composed of two binding domains, 
the N-terminal beta barrel which binds FAD, connected by one alpha helix with C-
terminal alpha-beta sandwich adopting altered Rossmann fold (composed of six 
parallel β-strands intervened with α-helices, one half β1α1β2α2β3 binds cofactor as 
the N-terminal domain, the other half β4α4β5α5β6 binds the NADH as the C-terminal 
domain, connected by α3 in dehydrogenase [23])  to bind NAD(P)H[24].  And the 
FAD and NAD(P)H are placed in close proximity to each other in space, the common 
protein binding site is the concave region of FAD binding domain.  The FAD cofactor 
adopts bend (in Azotobacter vinelandii FNR, pdb:1A8P [25] ) or extended form (in 
Spinach FNR, pdb: 1FDR [6] and NADPH-P450 reductase, pdb: 1AMO [26]).  Either 
in bend or extended form, the isoalloxazine ring of FAD is inserted into the protein, 
while the NAD(P)+ binding site varies  in different proteins [24].  FNR proteins have 
characteristic conserved sequence motifs which are different from other flavoproteins, 
 112 
like, glutathione reductase (GR), pyruvate oxidase (PO) etc; the sequence motifs are 
RxYS(T) (the Arg binds FAD’s negative pyrophosphate oxygen atom: Op1 or Op2, 
and the Tyr H-bonds to ribityl 4’ hydroxyl O4 and forms extensive van der Waals 
interaction with FAD), GxxS(T)xxL(x)5G(x)7PxG (well known phosphate binding 
motif,  Ser or Thr is able to H-bond to Op2 or Op1 in FAD), and MxxxGT(S)G(A)IxP 
(the βαβ motif binds NAD(P)+) [24].  
The spinach FNR is the first crystallized FNR protein by Shin et al. in 1963 
[27].  Its high resolution crystal structure was solved by Karplus and coworkers in 
1991 [18].  Nowadays spinach FNR is commercially available from Sigma-Aldrich.  
In its structure, FAD’s isoalloxazine ring is stacked in between Tyr96 on si- face and 
Tyr314 on re- face.  Tyr314 is close to the NADPH binding site.  This Tyr at C-
terminal as a key structural feature is conserved in many FNRs.  Its unique location 
has been studied intensively and will be described later in this and the next chapter.  
Since 1991, many other FNR protein structures have been solved under different 
conditions, e.g. containing oxidized FAD, containing reduced FADH2, NAD(P)H or 
NAD(P)+ bound, NAD(P)H analog bound forms [6, 18, 28-31].  Also, the detailed 
studies of NAD(P)H binding, structure-catalysis relationship and electron transfer 
have been carried out with the aid of site-directed mutagenesis, X-ray diffraction, 
NMR protein titration and protein-protein interaction techniques.  
By searching Pseuodomonas areuginosa genome PA01,  it is found that there 
are two plant-type FNRs (bacterial subclass I and II) and a mitochondrial-type FNR 
which is very unique comparing to most organism only having one FNR form [2].  
 113 
Unfortunately, there is no study to differentiate the functions of these three FNRs yet.  
Our interested protein pa-FPR(PA3397, gene fpr) is the bacterial subclass I FNR[2].  
It has two most similar (>30%) homolog proteins: Av-FPR(98%) and Ec-FldR(35%) 
with crystal structure available.  The other FNRs with crystal structure available have 
less than 20% similarity, e.g. Anabaena FNR (17%) and spinach FNR (11%).  
Under the context of the redox partner proteins study in search for iron 
acquisition pathway of pathogenic bacterium Pseudomonas aeruginosa under iron-
starvation condition, the key protein pa-FPR is crucial in mediating electron transfer 
in the process of heme degradation and iron release.  The structural and biochemical 
studies of pa-FPR described below have proved the previous finding about FPR being 
a 98% sequence identical homolog protein as Av-FPR.  From the crystal structure of 
pa-FPR, indeed it is highly similar to Av-FPR in which both have the unique Ala 
instead of the “common” Tyr at the end of C-terminus.  In general, ferredoxin (Fd) 
or/and flavodoxin (Fld) is considered to be the physiological redox partner(s) of the 
FNR , like in the case of Anabaena, Pea, Spinach FNR and Av-FPR proteins.   
Therefore, our initial proposed electron transfer path from NADPH to 
ferredoxin to ferrdoxin reductase and at last to heme oxygenase is a conventional 
opinion.  Interestingly, pa-FPR is able to transfer electrons to not only its proposed 
physiological partner protein: pa-Bfd (ferredoxin protein in Pseudomonas 
aerguniosa) but also proteins like pa-HO and pa-Bfr (bacteria ferritin in 
Pseudomonas aerguniosa).  Surprisingly, studies done by Yuhong Zeng and Saroja 
Weerutunga reveal that in the NADPH initiated protein reduction assays, pa-FPR as 
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the redox partner can donate all seven electrons to pa-HO and reduce it in a much 
faster rate than pa-Bfd.  This novel redox partnership between pa-Fpr and pa-HO has 
never been found before. Also, the versatile redox partnership between pa-FPR and 
other proteins in the heme-iron acquisition pathway in Pseudomonas aerguniosa 
indicates that pa-FPR is a key protein with profound physiological functions.  
.  
EXPERIMENTAL SECTION 
i. Cloning and expression of pa-FPR   
The genes encoding for pa-FPR (PA3397) was synthesized and subcloned into 
the pET11a vector, GeneScript Corporation (Piscataway, NJ).  The genes were 
engineered with silent mutations introducing codons favored by E. coli [32] and with 
Nde I and a BamH I restriction enzyme sites at 5’ and 3’ ends, respectively, for 
subcloning into the pET11a vector.  The above work is accomplished by previous lab 
member Bailey Morgan (Figures S1/S2).  The pET11a vector harboring the fpr gene 
was transformed into E. coli ArcticExpressTM RIL Competent Cells (Stratagene), in 
order to overcome protein misfolding and insolubility issues observed with BL21 
Gold (DE3) cells.  To express pa-FPR a single colony of ArcticExpressTM RIL cells 
was introduced into 10 mL of an LB medium containing ampicillin as above and 
cultured at 37 °C and 220 rpm overnight.  The cell suspension was transferred into a 1 
L LB-ampicillin medium and further cultured at 37 °C (4-5 hrs) to an OD of 
approximately 0.7.  At this point the cells were transferred to another shaker 
incubator (Barnstead) pre-equilibrated at 10 °C and cultured for an additional 30 min.  
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Protein expression was then induced by addition of IPTG to a final concentration of 
0.3 mM and the cells were subsequently cultured for approximately 14 hrs before 
they were harvested by centrifugation (4000 rpm for 10 min) and stored at – 20 °C. 
ii. Purification of pa-FPR   
 Cells were resuspended in 3 mL lysis buffer, stirred for 20 min at 4 °C, 
incubated at 37 °C for 20 min, stirred at ambient temperature for one hour and then 
sonicated at 4 °C.  The lysed cells were centrifuged at 35,000 rpm for 2 hrs to 
sediment cell debris and the supernatant dialyzed against 4 L of 20 mM Tris-HCl (pH 
7.5, 4 °C) with at least three buffer changes over a period of approximately 16 hrs.  
The resultant solution was applied to a Q-Sepharose Fast Flow column (10 cm × 2.5 
cm i.d.) previously equilibrated with 20 mM Tris-HCl (pH 7.5, 4 °C).  The column 
was washed with 3 volumes of 20 mM Tris-HCl (pH 7.5) containing 50 mM NaCl 
and the protein eluted in the same buffer with a linear gradient (50 mM to 500 mM) 
of NaCl.  Fractions containing FPR (yellow) were pooled, concentrated and then 
loaded onto a Sephadex-G50 column (3.0 cm x 100 cm) pre-equilibrated and eluted 
with phosphate buffer (µ = 0.1, pH 7.0) at 4 °C.  Fractions with absorbance ratio 
A280/A450 less than 8 were pooled and pa-FPR was determined to be homogeneous by 
SDS-PAGE and mass spectrometry.  To improve stability during storage (-80 °C) the 
solutions were made either 0.3 M in NaCl or 10% in glycerol before they were frozen 
and stored. 
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iii. Protein Extinction Coefficient Measurement  
The extinction coefficient of the flavin in pa-FPR was determined spectro-
photometrically using a previously established protocol [33].  Flavin in the protein 
was first released and quantified by the trichloroacetic acid method.  Then the 
extinction coefficient of the flavoprotein is calculated to be 11.5±0.1 mM-1·cm-1 by 
using the following relationship: 
εunknown =  εFAD * (Abs450nmFlavoprotein / Abs450nmFreeFAD) ,  
and  εFAD = 11.3 mM-1·cm-1. [33] 
iv. Characterization of pa-FPR FAD/FMN cofactor 
 The flavin cofactor was released from pa-FPR by addition of trichloroacetic 
acid, as has been described earlier [34].  Denatured protein was removed by 
centrifugation and the yellow supernatant was analyzed by mass spectrometry 
(MS/MS), which was performed using a Q-Tof-2 hybrid mass spectrometer 
(Micromass, Manchester, UK) housed in the Protein Mass Spectrometry Laboratory 
at the University of Kansas.  The instrument was operated for maximum sensitivity 
with all lenses optimized while infusing a sample of lysozyme.  The cone voltage was 
45eV and Ar was admitted to the collision cell.  Spectra were acquired at 11,364 Hz 
pusher frequency, covering a mass range 800 to 3000 amu and accumulating data for 
5 seconds per cycle.  Time to mass calibration was made with CsI cluster ions 
analyzed under the same conditions.  Samples (500 µg) were desalted on a short 
column (3 cm x 1 mm ID) of polymeric HPLC resin (Hamilton PRP1, Reno Nevada) 
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by loading the protein dissolved in a solution of 1% HOAc and eluting the column 
directly into the source at 25 µL/min with 95% MeOH, 0.08% formic acid.   
v. Protein Substrate NADPH/NADH Determination  
Pa-FPR is a ferredoxin-NAD(P)+ reductase protein.  The protein binds either 
NADP+ or NAD+ specifically.  Parallel Fpr-NADH and NADPH reduction 
experiments were taken place under the same conditions in aerobic and anaerobic 
environments.  The experiments were conducted in 800ul 50mM Na2Pi (pH 7.0) 
containing 70 µM pa-FPR (UV-vis absorbance is 0.8 at 450nm).  The reactions were 
initiated by the addition of 2 equivalents amount of NADPH or NADH.  The NADH 
and NADPH concentrations were determined by UV-vis using the same extinction 
coefficient of 6.22mM-1·cm-1 [35] at 340nm after making fresh solutions in 50 mM 
Na2Pi (pH 7.0) either inside glove box (coy) or at aerobic condition.  The reactions 
were monitored using UV-Vis S2000 spectrophotometer (Ocean Optics, Dunedin, 
FL).  
vi. X-ray crystallography   
Crystal growing conditions were identified in the High Throughput Screening 
Laboratory of the Hauptman Woodward Medical Research Institute, Buffalo, New 
York [36].  X-ray-quality single crystals of pa-FPR were grown using the hanging 
drop vapor diffusion method by mixing 2 µL of pa-FPR (18 mg/mL) dissolved in 20 
mM Tris, pH 7.6 with 2 µL of a solution consisting of 125 mM sodium cacodylate, 
200 mM ammonium sulfate and 20% (w/v) PEG- 8000 acetate, pH 6.5.  Diffraction 
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data were recorded at –180 °C using the rotation method on a single flash-frozen 
crystal [Detector: R-axis IV++ image plate; X-rays: CuKα, focused by mirror optics; 
Generator: Rigaku RU300 (MSC, The Woodlands, TX, USA)].  The cryoprotectant 
was 20 % ethylene glycol.  X-ray data were reduced with XDS [37]; the program 
package CNS [38] was employed for phasing and refinement; model building was 
performed with O [39].  The structure was solved by molecular replacement using the 
coordinates of ferredoxin oxidoreductase from Azotobacter vinelandii (PDB entry 
1A8P) as search model, stripped of solvent molecules and ligands.  Refinement was 
performed using data to the highest resolution with no sigma cut-off applied.  Several 
rounds of minimization, simulated annealing (2500 K starting temperature) and 
restrained individual B-factor refinement were implemented.  Data collection and 
refinement statistics are summarized in Table 3-1. 
Table 3-1. Summary of data collection and structure refinementa. 
 
Data set FPr liganded with FAD 
Space group P21212 
Unit cell dimensions (Å) a=68.7 b=74.9 c=52.8 
α=β=γ=90º 
Protein atoms 2071 
[average B-factor = 11.6 Å2] 
Ligand  FAD (53 atoms) 
[average B-factor = 8.1 Å2] 
Solvent molecules 385 
[average B-factor = 25.2 Å2] 
rmsdb bonds (Å) 0.01 
rmsdb angles (°) 1.54 
Resolution range 15-1.55 (1.6-1.55) 
Unique reflections 40,269 (3,620) 
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Completeness (%) 98.9 (95.6) 
I/σI 26.4 (9.9) 
Rmerge (%) 3.6 (9.9) 
Rcryst
c
 (%) 15.8 
Rfree
d
 (%) 19.0 
a
 Values in parentheses refer to the highest-resolution shell.  
b
 Rootmean-square deviation from ideal values.  
c
 Rcryst ) 100 * ∑|Fobs - Fmodel|/∑Fobs, where Fobs and Fmodel are observed and 
calculated structure factor amplitudes, respectively.  
d
 Rfree is the Rcryst calculated for randomly chosen unique reflections, which were excluded 
from the refinement (1234 for FPR liganded with FAD). 
 
vii. Electronic absorption spectrophotometry  
NADPH-cytochrome C reduction activity is commonly used to study the 
activity of the ferredoxin reductase in complex with ferredoxin [40-44].  In order to 
study the electron transfer from pa-FPR to ferredoxin, a modified activity assay [43] 
was used for pa-FPR in complex with spinach ferredoxin (Sigma-Aldrich, St. Louis, 
MO) in the presence of cytochrome C (Sigma-Aldrich, St. Louis, MO).  The reactions 
were performed in the anaerobic condition inside a glove box (Coy) and monitored by 
Ocean Optics 2000 spectrophotometers (Dunedin, FLA) equipped with fiber optics. 
The 1 cm cuvette was filled with 2 mL (final volume) of 20 mM Tris-HCl Buffer 
(pH7.5), followed by the addition of 3.5 µM pa-FPR (100µl pa-FPR stock solution 
giving 0.04 absorbance at 450nm), 12.5 µM cytochrome c (50 ul 0.5mM stock, 
protein purified by Gel-50 size exclusion chromatography column), 2.5 µM spinach 
ferredoxin (5ul of 1mM stock solution); then the reaction is initiated by the addition 
of 200 µM NADPH and the increase in absorbance at 550 nm was monitored. 
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Catalase (0.1 mg/mL final concentration) was used as a H2O2 scavenger.  The 
reaction is under constant stirring condition with speed 4 using CorningTM stirring 
plate.  The similar reaction of pa-FPR complex with spinach ferredoxin was repeated 
in air under the following conditions: 7.5 µM cytochrome c, 3.5 µM pa-Fpr, 2.5 µM 
spinach ferredoxin, then add 0.2 mM NADPH to initial reaction in 2 mL 20mM Tris-
HCl Buffer (  pH 7.6).  
The following electron transfer reactions done by electron transfer reactions 
from NADPH to pa-HO using different redox protein mediators were carried out with 
pa-Bfd, pa-FPR, spinach ferredoxin and spinach ferredoxin reductase (Sigma-
Aldrich, St. Louis, MO), using a previously reported method with modifications [45].  
The reactions are done by Yuhong Zeng and Saroja Weerutunga in our lab.  The 
reactions were taken place either in a glove box (Coy) under O2-free conditions or in 
air, in a 1 cm path-length cuvette, and monitored by electronic absorption 
spectroscopy using diode array Ocean Optics 2000 spectrophotometers (Dunedin, 
FLA) equipped with fiber optics.  For each reaction the cuvette was filled with 2 mL 
of 25 mM HEPES-KOH (pH7.5), followed by the addition of a few µL of stock 
solutions of the enzymes and proteins to be tested.  In typical experiments the final 
concentration of resting state pa-HO was 10 µM and the concentrations of pa-Bfd, 
pa-FPR, spinach ferredoxin and spinach ferredoxin reductase were 10 µM, 8 µM, 5 
µM and 0.05 U/mL, respectively.  Catalase (0.1 mg/mL final concentration) was used 
as a H2O2 scavenger.  The electron transfer reactions were initiated by the addition of 
a stock solution of NADPH to give a final concentration of 200 µM.  The expression 
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system for pa-HO [46] was a gift from Dr. Angela Wilks (the University of 
Maryland) and the protocols for expression and purification of this enzyme have been 
reported previously [47].  
RESULTS AND DISCUSSION 
 
1. Expression and purification of pa-FPR   
Protein is expressed from DNA listed below, initially by previous lab member 
Bailey Morgan in an LB medium [48]. 
 
5’    Nde I 
GGGCATATG AGC AAC CTG TAT ACC GAA CGT GTG CTG AGC GTG CAT CAT TGG AAC GAT ACC  
          M   S   N    L    Y   T    E   R    V   L   S    V   H    H   W   N   D   T 
CTG TTT AGC TTT AAA ACC ACC CGT AAC CCG GGC CTG CGT TTT AAA ACC GGC CAG TTT GTG 
L  F    S    F   K    T   T    R   N   P    G    L   R    F   K    T   G   Q    F   V 
ATG ATT GGC CTG GAA GTG GAT GGC CGT CCG CTG ATG CGT GCG TAT AGC ATT GCG AGC CCG  
 M    I   G    L    E   V    D   G    R   P   L   M   R    A   Y    S    I    A    S   P 
AAC TAT GAA GAA CAT CTG GAA TTT TTT AGC ATT AAA GTG CCG GAT GGC CCG CTG ACC TCT 
 N    Y    E    E   H   L    E   F    F   S    I   K    V   P   D    G   P    L    T   S 
CGT CTG CAG CAT CTG AAA GAA GGC GAT GAA CTG ATG GTG AGC CGT AAA CCG ACC GGC ACC  
 R    L    Q   H    L   K   E   G    D   E    L   M   V    S   R   K    P    T   G   T   
CTG GTG CAT GAT GAT CTG CTG CCG GGC AAA CAT CTG TAT CTG CTG AGC ACC GGC ACC GGC  
 L   V    H   D    D   L    L   P   G    K   H    L   Y    L   L    S   T    G    T   G   
ATG GCG CCG TTT CTG AGC GTG ATT CAG GAC CCG GAA ACC TAT GAA CGT TAT GAA AAA GTG  
 M   A    P   F    L   S    V   I    Q   D    P    E    T   Y    E   R    Y   E    K   V 
ATT CTG GTG CAT GGC GTG CGT TGG GTG AGC GAA CTG GCG TAT GCG GAT TTT ATT ACC AAA 
I    L   V    H   G   V    R   W   V   S    E    L    A   Y   A    D   F    I   T   K 
GTG CTG CCG GAA CAT GAA TAT TTT GGC GAT CAG GTG AAA GAA AAA CTG ATT TAT TAT CCG  
 V    L   P   E    H   E   Y    F   G    D   Q   V    K    E   K    L    I   Y   Y    P   
CTG GTG ACC CGT GAA CCG TTT CGT AAC CAG GGC CGT CAG ACC GAT CTG ATG CGT AGC GGC   
L   V    T   R   E    P   F    R   N   Q    G   R    Q   T   D    L   M    R   S    G  
AAA CTG TTT GAA GAT ATT GGC CTG CCG CCG ATG AAC CCG CAG GAT GAT CGT GCG ATG ATT 
 K    L   F   E    D    I   G    L   P    P   M    N   P    Q   D    D   R    A   M   I 
TGC GGC AGC CCG AGC ATG CTG GAA GAA ACC AGC GCG GTG CTG GAT AGC TTT GGC CTG AAA  
 C    G   S    P    S   M    L   E   E    T    S    A   V    L    D    S   F   G    L   K 
ATT AGC CCG CGT ATG GGC GAA CCG GGC GAT TAT CTG ATT GAA CGT GCG TTT GTG GAA AAA  
  I    S   P   R    M   G    E   P    G   D    Y   L    I   E    R   A    F   V   E    K    
      BamH I     3’    
TAA GGATCCGGG 
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Figure 3-1. DNA sequence of fpr (PA3997) from P. aeruginosa (PA01 genome) and 
the corresponding amino acid sequence.  A  Nde I and a BamH I restriction 
endonuclease sites were constructed at the 5' and 3' ends for subcloning. 
 
The pa-FPR enzyme was purified to homogeneity, as judged by the presence 
of a single band in SDS-PAGE gels (Figure 3-2).  
 
Figure 3-2. SDS PAGE obtained from homogeneous solutions of pa-FPR. 
 
Pa-FPR’s theoretical pI is 5.65 (calculated via pI tool from 
http://ca.expasy.org/tools/pi_tool.html), and protein is purified and stable around 
neutral pH.  The protein is prone to precipitate under high protein concentration (> 
1.5 mM).  As for short term storage (less than a week), low temperature (0~4 °C) and 
high ionic strength (50 mM Na2Pi pH7) will help preventing it from denaturation, 
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aggregation and precipitation.  As for long-term storage, the protein coming out of  -
20 °C or -80 °C freezer will form large percent (30~50%) of precipitation during 
thawing on ice.  Shaking and thawing under higher temperature (37 °C) will slightly 
decrease the amount of precipitated protein.  From SDS-PAGE and UV-vis 
absorption studies, pa-FPR loses activity and partially dimerizes during precipitation 
process.  It is critical to search for the optimal storage conditions for FPR.  The 
similar phenomenon is discovered for Av-FNR by Burgess group [49].  They use 0.3 
M NaCl to stabilize Av-FNR at low temperatures for the long-term storage [49].  It is 
proved to work for our low temperature storage as well.  Also, some additives like 
10-15% glycerol or 50 mM L-Arg [50] also stabilize the protein as 0.3 M NaCl.   
2. Identification of co-expressed substrate FAD/FMN  in pa-FPR 
The molecular weight of pa-FPR measured by ESI-MS is 29,386 Da, a value 
that is in good agreement with the molecular weight of the enzyme calculated from 
the sequence, not including the initiator methionine (29,387).  Solutions containing 
pa-FPR are yellow, which is consistent with the presence of a flavoprotein.  Indeed, 
the electronic absorption spectrum of oxidized pa-FPR (Figure 3-3(A)) is typical of 
flavin containing proteins, with bands at 370 nm, 450 nm and 475 nm; these bands 
lose their intensity and almost disappear when a solution of NADPH is added to a 
solution of pa-FPR under anerobic conditions, a spectroscopic property typically 
observed upon reduction of flavin containing proteins [33].    
The nature of the cofactor in pa-FPR (FAD or FMN) was determined to be 
FAD using mass spectrometry by previous lab member Bailey Morgan [51], 
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following its extraction from the enzyme into an aqueous solution.  The mass 
spectrum of the pa-FPR cofactor (Figure 3-3(B)) exhibits a parent ion peak (X0) at 
m/z = 788.41 Da, which corresponds to the calculated mass of FAD + 3H+.  
Fragmentation of this peak in an MS/MS experiment renders peaks at m/z 439.12, 
348.10 and 136.07.  The peak at m/z = 439.12 (X1) corresponds to the FMN + 2H+ 
fragment, the peak at m/z = 348.10 (X2) corresponds to the AMP + H+ fragment and 
the peak at 136.07 m/z (X3) corresponds to the adenine fragment + 2 H+.  This 
fragmentation pattern together with the fact that the mass spectrum of an FAD 
standard is identical to that of Figure 3-4(B) indicates that the cofactor in pa-FPR is 
FAD.  The nature of the electron donor to FAD, NADH, or NADPH, was addressed 
next. 
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Figure 3-3. (A) Electronic absorption spectra of pa-FPR in oxidized and reduced form.  (B) 
MS/MS spectrum of the cofactor extracted from pa-FPR.  The fragmentation pattern 
unequivocally identifies the cofactor as FAD. 
 
3. Protein Substrate NADPH/NADH Determination 
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By adding the same equivalent of NADPH or NADH into the same amount of 
FPR proteins under either aerobic or anaerobic conditions, the reduction of protein is 
monitored by UV-vis with respect to time.  After adding the colorless NADPH into 
the yellowish protein solution, the mixture solution color changes from yellow into 
pale green quickly.  It is known that oxidized FAD is yellowish, while FAD 
semiquinone (FADH: one electron reduction of FAD) is blue, and fully reduced FAD 
is colorless.  The light green color suggests that the reduction is not 100% fully 
toward reduced FAD; the small amount of residual yellow oxidized FAD and blue 
semiquinone together might contribute to the light green color.  As for the reaction 
with NADH which has no absorbance above 400 nm, the yellow color of the protein 
and NADH mixture does not change even with more access of NADH or at longer 
incubation time.  
The results show that NADPH reduces FPR in a much faster and more 
efficient way than NADH.  It suggests that NADPH indeed is the physiological 
coenzyme for FPR.   The same reactions under both aerobic and anaerobic conditions 
show the same results.  The anaerobic reactions are shown below in Figure 3-4.  Also, 
FPR-NADP+ crystal has been successfully achieved, the detailed discussion about pa-
FPR-NADP+ complex and the reason for this coenzyme specificity are explained in 
next chapter.  
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Figure 3-4. pa-FPR physiological substrate determination: (A) reduction test by 
titrating 2 units (1 equivalent) of NADPH into 1unit pa-FPR; (B) reduction test by 
titrating 2 units (1 equivalent) of NADH into 1unit pa-FPR.  
 
4. The structure of pa-FPR  
The polypeptide in pa-FPR folds into the classical two-domain structure of 
ferredoxin NAD(P)H reductases (Figure 3-5(A)), which includes spinach FNR.  The 
N-terminal domain, residues 1-87, comprise an anti-parallel β-barrel (β1-β6) capped 
by helix α1, where FAD binds near the N-terminal end of α1 and the carboxy ends of 
β4 and β5.  The C-terminal domain, residues 104-258 fold into the typical nucleotide 
binding fold comprised of a five-stranded parallel β-sheet (order β9, β8, β7, β10, β11) 
that is surrounded by nine α-helices (α2 – α10).  The NADP+ domain in ferredoxin 
reductases of known structures is across the carboxy-terminal domain of the β-sheet 
encompassing β7, β10, the loop connecting β7 to α3 and the N-terminal residues of 
α3.  The NADP+ and FAD binding domains are joined mainly by α3, α6 and to a 
certain extent by α5 and by the loops preceding and succeeding it.  This interface 
produces a deep cleft where the FAD and NADP+ cofactors reside in close proximity 
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to one another.  Finally, the two domains are linked by residues 88 to 103, which 
comprise elements of secondary structure β6-loop-α2. 
 
 
Figure 3-5. (A) View of pa-FPR depicting the two domains and the bound FAD.  (B) Amino 
acid sequence alignment of pa-FPR and Av-FPR using ClustalW (http://www.ebi.ac.uk). 
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Residues distinct among the two enzymes are shown in blue.  The conserved sites for binding 
the isoalloxazine ring of FAD, as well as phosphates P1 of FAD and the feature phosphate 
group of NADP are highlighted by cyan, magenta and green, respectively.  (C) Left: 
superposition of Av-FPR (blue) and pa-FPR (red) obtained using the Protein3Dfit server 
shows a Cα RMSD of 0.416 Å.  The view is as shown in (A). 
 
 The structure of pa-FPR is very similar to the characteristic of the superfamily 
of NAD(P)H reductases and most similar to the structure of NADPH ferredoxin 
reductase from Azotobacter vinelandii (Av-FPR) [52].  The latter is perhaps not 
surprising, given the 85% amino acid identity and 91% similarity between the two 
enzymes (see Figure 3-5(B)).  The high degree of structural identity can be seen in the 
superposition (RMSD Cα = 0.42 Å) of pa-FPR (red) and Av-FPR (blue) shown in 
Figure 3-5(C), in a view identical to that of Figure 3-5(A).  Only a few amino acids 
differ in the position of their Cα carbons; these are Ser2, Gly74, Arg186 and Glu257.  
The position of Ser2 in the amino terminal sequence is expected to impart it with a 
large B factor, which is likely the reason for the discrepancy in the Cα position of this 
residue in the two structures.  R186 is located in the middle of the loop connecting β9 
with α8, thus it would also be expected to experience conformational flexibility.  This 
leaves Gly74 and Glu257, which are located in the FAD binding domain, where the 
largest differences in structure are observed between pa- and Av-FPR.  In both crystal 
structures the B-factors exhibited by these residues are very close to the average B-
factor for each structure, which suggests that Gly74 and Glu257 have low 
conformational flexibility.  Consequently, the differences in the crystal structures 
likely represent subtle differences in the way in which each of the enzymes interacts 
with their FAD cofactors. 
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The FAD cofactor binds to pa-FPR using contacts that are typical of the 
superfamily of NAD(P)H reductases; these conserved sequences have been 
highlighted in Figure 3-5(B).  Among residues in the R51xYS/T motif in strand β4, 
the side chain of R51 hydrogen bonds the phosphate in the FMN moiety, the carbonyl 
oxygen of A52 accepts a hydrogen bond from the ribityl C2’ hydroxyl, the hydroxyl 
group in Y53 hydrogen bonds with the ribityl C4’ hydroxyl and the aromatic side 
chain in the same residue π-stacks against the isoalloxazine ring (see Figure 3-6).   
 
Figure 3-6. Stereo view of the FAD binding site in pa-FPR. 
 
The phosphate in the FMN portion of the cofactor is stabilized by hydrogen 
bonding interactions to the amides of L76 and T77, which are part of the G74xxT/S 
motif near the amino terminal section of helix α1.  The FAD cofactor in pa-FPR 
adopts a conformation that places the isoalloxazine and adenine rings in close 
proximity.  This conformation is similar to that adopted by the FAD cofactor in Av-
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FPR [49, 52] and E. coli flavodoxin reductase (EcFldR) [53] but distinct from that 
seen in spinach FNR [54] and other members of the reductase family [55], where an 
extended cofactor places the adenine ring distant from the isoalloxazine moiety.  As is 
the case in the structures of Av-FPR and EcFldR, the adenine ring in the cofactor of 
pa-FPR π-stacks with the aromatic side chain of F255; this residue is F255 in Av-FPR 
and W255 in EcFldR.  Hence, the observations made in the crystal structure of pa-
FPR support the idea that the conformation of FAD in Av-FPR, EcFldR and now pa-
FPR, is driven by stabilizing π-stacking interactions [52].  In comparison the adenine 
ring in spinach FNR is extended into the surface of the protein, where it π-stacks with 
the side chain of Y120.  It is also worth noting that similar to the structure of Av-FPR, 
the structure of pa-FPR lacks an aromatic side chain on the face of the isoalloxazine 
ring, opposite to the side that interacts with Y53 of the R51xYS/T motif on β4.  
Instead, the fold of Av-FPR and pa-FPR place A254 at the equivalent position, where 
the side chain of A254 is directed away from the isoalloxazine ring.  It has been 
pointed out in the context of the structure of Av-FPR that the carbonyl oxygen of 
A254 and its negatively charged dipole may alter the electronic structure of the 
isoalloxazine ring, which may account for the absence of a stable semiquinone state 
in this enzyme [52].  It is therefore interesting that a stable semiquinone state is also 
not observed in pa-FPR because it suggests that the electronic structure of the 
isoalloxazine ring in this enzyme is similar to that of Av-FPR and distinct from other 
reductases.  An additional difference pointed out between Av-FPR and other 
reductases in the superfamily [52] is the three amino acid carboxy terminal extension, 
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which includes K258 as the terminal residue.  The side chain of this residue together 
with the side chain of R51 in the R51xYS/T motif interacts electrostatically with the 
two phosphate groups of FAD.  A similar electrostatic interaction between K258 and 
one of the phosphate groups in the FAD cofactor is also present in the structure of pa-
FPR (Figure 3-6), which also has the three amino acid carboxy-terminal extensions in 
its sequence.  Hence, it appears that the microenvironment of FAD in pa-FPR is very 
similar to that of FAD in Av-FPR but distinct from that observed in other enzymes 
from the ferredoxin reductase family.  How these subtle differences affect reactivity 
and perhaps redox complementarity with physiologic partners remains to be 
investigated. 
5. NADPH cytochrome c reduction assay for Ferredoxin Reductase 
reactivity 
The NADPH cytochrome c reduction assay is commonly used to measure the 
ferredoxin dependent cytochrome c reduction activity by monitoring the reduction of 
cytochrome c [43, 56].  In this assay, cytochrome c is reduced by the mediated 
electron transferred from NADPH to ferredoxin reductase to ferredoxin then to 
cytochrome c, as illustrated below. 
 
Figure 3-7. Electron transfer pathway in cytochrome c reduction assay. 
 
NADPH 
NADP+ 
Ferredoxin Reducatase (oxidized)
 
Ferredoxin Reducatase (reduced) 
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The UV-vis absorption spectrum of cytochrome c has distinguished soret band 
and charge transfer band in its oxidized and reduced forms, as exhibited in Figure 3-8. 
Upon reduction, a sharp absorption peak is observed at 550 nm.  Thus, the reduction 
of cytochrome c is monitored by the increase of 550 nm absorbance with time. 
 
Figure 3-8. Cytochrome c reduction assay in aerobic condition. 
 
Figure 3-9. Cytochrome c reduction assay in anaerobic condition. 
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The above two similar experiments are done at either an anaerobic or aerobic 
condition.  The results are similar except that the reaction is slower in the aerobic 
condition.  It is likely due to the oxygen in air that oxidation of the reduced proteins is 
toward the opposite direction of cytochrome c direction.  These experiments suggest 
no surprise but pa-FPR indeed is a typical ferredoxin reductase that can reduce 
common ferredoxin protein like Spinach ferreodoxin.  However, a surprising result is 
revealed by further redox reactions tested with Pseudomonas aeruginosa ferredoxin 
(pa-Bfd), the predicted physiological partner protein executed by Dr. Yuhong Zeng 
initially and Saroja Weeratunga later from our lab.  
6. Pa-FPR is a ferredoxin reductase NADP+ protein 
The crystal structure of pa-FPR revealed a fold typical of the ferredoxin 
reductase superfamily and provided unequivocal corroboration to biochemical 
observations described herein, indicating that the flavin cofactor is FAD.  Structural 
comparisons indicate that the structure of pa-FPR is almost identical to that of Av-
FPR and very similar to that of E. coli flavodoxin reductase.  The function of the 
latter two enzymes has been proposed to be their participation in a putative redox 
pathway leading to protection against oxidative stress, which is carried out by 
performing the reductive repair of O2¯ -damaged hydroxylases, such as the [Fe-S] 
containing aconitase [57, 58].  Additional studies suggest that a function of Av-FPR 
and EcFldR is to maintain tolerable levels of NADPH during oxidative stress, thereby 
preventing reduction or iron and other transition metals that catalyze the formation of 
highly toxic hydroxyl radicals via Fenton-type chemistry [58].  It is therefore 
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remarkable that although the structures of Av-FPR and EcFldR are nearly identical, 
each utilizes a different type of redox partner; Av-FPR interacts specifically with FdI, 
a protein containing a [3Fe-4S]+/0 and a [4Fe-4S]2+/+ clusters [59], whereas EcFldR 
interacts with a flavodoxin [60].  Our findings extend the range of possible redox 
partners for the same fold (pa-FPR) to include a bacterial heme oxygenase (pa-HO) 
which metabolizes heme in the cytosol of P. aeruginosa.  This notion is supported by 
the fact that some bacteria and algae possess flavodoxins capable of efficiently 
replacing ferredoxins as electron transfer proteins and that the expression of these 
proteins is induced under conditions of iron starvation, which limits the biosynthesis 
of [Fe-S] clusters and thus the assembly of electron transfer ferredoxins [55, 61]. 
7. Pa-FPR and not pa-Bfd is the electron donor to pa-HO   
The proposed physiological redox partner protein pa-Bfd was synthesized and 
over-expressed by Yuhong Zeng in our lab [31].  Pa-FPR was given to her first and 
later to Weeratunga, Saroja for the electron transfer assay study using pa-FPR, pa-
Bfd and pa-HO in a similar procedure as the above cytochrome c assay in the 
anaerobic condition inside glove box [31].  A surprising result was observed by them, 
as shown in Figure 3-10.  
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Figure 3-10. Spectral changes taking place upon the addition of reduced pa-FPR (8 µM) to 
resting state pa-HO (8 µM) under the anaerobic conditions.  The appearance and growth of a 
band at 430 nm is diagnostic of the formation and accumulation of deoxyferrous pa-HO.  
Inset: time dependent plot of the formation of deoxyferrous pa-HO (430 nm) upon the 
addition of reduced pa-FPR (●) and upon the addition of reduced pa-Bfd (○) to resting state 
pa-HO.  All experiments were carried out at 25 °C in the presence of catalase.  
Concentrations in parenthesis correspond to solutions in the cuvette (final concentration) [31].  
(Courtesy of Yuhong Zeng and Saroja Weeratunga) 
 
In the above reaction, the reduced pa-FPR or pa-Bfd was initially made by 
one equivalent NADPH reduction under the anaerobic condition inside glove box. 
Then direct pa-HO one electron reduction initiated by adding equivalent amount of 
reduced pa-FPR or reduced pa-Bfd was carried out under the same conditions.  The 
change of pa-HO UV-vis absorbance spectrum was monitored with time.  It was 
surprising that electron transfer from pa-Bfd to pa-HO is a slow process compared 
with the electron transfer from pa-FPR to pa-HO, as revealed in the inset in the above 
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figure.  Together with other experiments, it is found that pa-Bfd is not required to 
support the catalytic activity of pa-HO and pa-FPR by itself can donate all the seven 
electrons needed for heme degradation in pa-HO [31].  
8. Pa-FPR supports the efficient degradation of heme by pa-HO 
Previous reports suggested that HOs in cyanobacteria and eubacteria are 
ferredoxin-dependent and thus are thought to receive electrons from NAD(P)H via 
ferredoxin reductase and ferredoxin.  It is interesting; however, that the rates of heme 
degradation observed in the presence of ferredoxin are typically slow, unless a second 
reducing agent such as ascorbate, iso-ascorbate or trolox is added to the system [62-
65].  In this context, it should be pointed out that ascorbate or other similar reducing 
agents causes heme degradation by two chemically distinct processes, heme 
oxygenation (as seen in the normal catalytic cycle of HO) and coupled oxidation [66-
68].  The process of heme oxygenation occurs as outlined in Heme Oxygenase 
Metabolism Scheme 1, where O2 coordinated to iron is reduced to HOO¯ , in order to 
form the ferric hydroperoxide (FeIII-OOH) intermediate within the active site of heme 
oxygenase; and FeIII-OOH adds an OH group to the macrocycle to form meso-
hydroxyheme.  In contrast, in the coupled oxidation process non-coordinated O2 is 
reduced to H2O2 by the reducing agent (i.e., ascorbate) outside the enzyme [68].  
Once formed, H2O2 can diffuse into the active site and react with ferrous heme to 
form meso hydroxyheme, which is then channeled to iron biliverdin using additional 
electrons from ascorbate.  Thus the processes of heme oxygenation and coupled 
oxidation differ fundamentally in the form in which O2 is reduced to H2O2 [68].  In 
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addition, it is also important to consider that resting state (ferric) HO can bind 
exogenous H2O2 to form the FeIII-OOH intermediate, which decays into meso-
hydroxyheme [69, 70].  Because exogenous H2O2 is readily formed when dissolved 
O2 reacts with electron donors such as NADPH, ascorbate, hydrazine, etc., it is 
important that assays of HO activity include catalase to destroy exogenous H2O2, thus 
preventing the oxidation of heme by paths other than the catalytic cycle of heme 
oxygenase.  In this context, it is important to note that with only one exception, assays 
to determine the activity of “ferredoxin-dependent” HOs do not include catalase [62-
65].  Interestingly, the study that reports on the inclusion of catalase in the heme 
degradation assays  found that the oxyferrous complex is formed readily; decay of 
this complex into iron-biliverdin, however, is a very slow process [63].  In contrast, 
when ascorbate was added as the auxiliary electron donor in addition to ferredoxin, 
the oxyferrous complex decayed rapidly to biliverdin even if catalase was present 
[63].  Consequently, it was suggested that in addition to ferredoxin, an auxiliary 
electron donor is necessary to carry out the catalytic activity of bacterial HOs.  It is 
therefore significant that findings reported herein demonstrate that when pa-FPR is 
the redox partner of pa-HO the degradation of heme to iron biliverdin occurs rapidly 
and efficiently in the absence of an auxiliary electron donor, despite the fact that all 
assays were carried out in the presence of catalase [31].   
 In order to understand the structure, catalysis and physiological meanings 
behind this novel redox partnership, further studies of pa-FPR protein in complex 
with its coenzyme NADP+ are discussed in next chapter.  The study of the pa-FPR 
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and pa-HO protein-protein interaction will be facilitated by the analysis of the 
available crystal structures for pa-HO [71] and pa-FPR-NADP+ complex, as well as 
by the availability of sequential backbone NMR assignments for pa-FPR.  This 
information will make it possible to carry out chemical shift perturbation experiments 
[72] aimed at experimentally defining the inter-protein interface once the sequential 
assignments of pa-FPR have been obtained. 
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CHAPTER IV: X-RAY CRYSTALLOGRAPHIC AND SOLUTION STATE 
NMR SPECTROSCOPIC INVESTIGATIONS OF NADP+ BINDING TO 
FERREDOXIN-NADP REDUCTASE (FPR) FROM PSEUDOMONAS 
AERUGINOSA 
  
INTRODUCTION  
 Ferredoxin NADP+ reductases (FNRs), which catalyze the reversible electron 
transfer between NADP(H) and their cognate ferredoxin or flavodoxin partners, are 
found in plastids, phototropic and heterotropic bacteria and in mitochondria [1].  One 
of the best characterized enzymes is FNR from the spinach leafs, which is typical of 
FNRs found in plastids, where the reducing power of electromagnetic radiation is 
used by these reductases to reduce NADP+, thus producing the NADPH needed for 
the subsequent photosynthetic paths [2].  In contrast, bacterial ferredoxin reductases 
displace the equilibrium toward the oxidation of the NADPH pool, in order to use this 
reducing potential in a large number of oxidoreductive processes.  For instance, E. 
coli flavodoxin reductase functions in the reduction of flavodoxin for the activation of 
anaerobic enzymes and in the oxidation of NADPH as a mechanism of protection 
against oxidative stress [3-5].  In R. capsulatus [5], A. vinelandii [4] and E coli [3] the 
gene fpr encodes a ferredoxin (flavodoxin) nicotinamide adenine dinucleotide 
phosphate reductase (FPR) that functions in the oxidation of NADPH as a 
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mechanism of defense against oxidative stress.  A similar FPR (pa-FPR) in P. 
aeruginosa has been characterized as a 258-residue long NADPH-dependent enzyme 
that uses FAD as cofactor [6].  Although it is possible that pa-FPR also functions in 
mitigating oxidative stress [4], it has been shown that under iron starvation conditions 
pa-FPR functions by shuttling electrons from NADPH to a heme oxygenase, thus 
supporting the process of releasing iron from exogenously acquired heme for 
subsequent metabolic use [6]. 
The crystal structure of pa-FPR [6] revealed a fold very similar to the 
characteristics of the FNR superfamily and is almost identical to the structure of FPR 
from A. vinelandii (Av-FPR) [7] and E. coli flavodoxin reductase [8].  The 
comparative analysis of the X-ray crystal structures of ferredoxin reductases 
uncovered some interesting differences in the context of a similar fold.  These 
differences led to the classification of these enzymes into reductases of the plastidic 
class, i.e., enzymes from chloroplasts and cyanobacteria, and enzymes of the bacterial 
class, which are further subdivided into proteobacterial subclass I enzymes (A. 
vinelandii, R. capsulatus, P. aeruginosa) and proteobacterial subclass II reductases 
(E. coli flavodoxin reductase) [9].  The structures showed that plastidic FNRs and 
bacterial FPRs differ in the conformation and chemical environment of the FAD 
cofactor.  In the plastidic enzymes the FAD is bound in an extended conformation, 
which is stabilized by specific interactions with residues in a sheet-loop-sheet motif 
(green in Figure 4-1(A)).  These encompass π-stack the adenine ring with the 
conserved aromatic side chain of Tyr120 and the hydrogen bonding interactions 
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involving the 2’-P AMP moiety.  In comparison, bacterial FPRs lack the sheet-loop-
sheet motif that stabilizes the extended FAD conformation, thus the cofactor adopts a 
bent conformation at which the adenine ring π-stacks with the conserved aromatic 
side chain of residue 255 (Figure 4-1(B)).  The FMN portion of FAD in plastidic and 
bacterial reductases exhibits very similar conformations and chemical environments.  
Additional important differences occur in the carboxyl terminal domains, which are 
typically thought to be involved in NADP(H) binding.  Whereas in plastidic FNRs the 
carboxyl terminal Tyr (Y314 in spinach FNR, Y308 in pea FNR and Y303 in 
Anabaena FNR) π-stacks against the isoalloxazine ring of FAD [10, 11] (see Figure 
4-1(A)).  In subclass I bacterial FPRs this residue is replaced by Ala254, which is 
followed by a FVEK258 terminal sequence (Figure 4-1(B)).  In the structures of pa-
FPR and Av-FPR the carbonyl oxygen of Ala254 packs against the isoalloxazine ring, 
replacing the conserved π-stacking interaction between the carboxyl terminal Tyr ring 
and the isoalloxazine ring seen in the plastidic FNRs.  In subclass II bacterial 
enzymes, a conserved terminal Trp is found immediately after the position is 
occupied by the terminal Tyr in the plastidic enzymes, thus extending the carboxy 
terminal domain by only one residue.  In these enzymes FAD also adopts a bent 
conformation. 
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Figure 4-1. (A) The fold of plastidic FNRs exhibits a conserved sheet-loop sheet motif 
(green) that contributes to stabilizing the extended FAD (yellow) conformation characteristic 
of these enzymes.  (B) The fold of bacterial FPRs, which is devoid of the sheet-loop-sheet 
motif, exhibits a characteristically bent FAD conformation. 
 
The binding of NADP+ to FNRs has been the subject of intense investigations.  
Cocrystallization of Anabaena FNR [12] with NADP+ revealed a complex in which 
the 2’P AMP portion of the cofactor is stabilized in a manner identical to that 
observed in the NADP+ complex obtained by soaking crystals of the Anabaena 
enzyme in NADP+ solution [13].  The conformation of the nicotinamide portion of 
the cofactor, however, is different in the two structures.  The structure of Anabaena 
FNR obtained from the crystals soaked in NADP+ solutions of the nicotinamide ring 
extends toward the surface of the protein and away from the isoalloxazine ring, 
whereas in the structure obtained from the co-crystallization with NADP+, the side 
chain of the carboxyl terminal Tyr (Y303) is stacked between the nicotinamide and 
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isoalloxazine rings.  The latter structure resembles more “productive” interactions 
seen in other flavoenzyme families that are structurally and functionally different 
from FNRs (i.e. glutathione reductase), at which the nicotinamide and iosalloxazine 
rings stack parallel and adjacent to one another [14, 15].  Nevertheless, the side chain 
of Tyr303 is not displaced to allow direct overlap of the cofactor rings, as would be 
expected in a “productive” complex that facilitates direct hydride transfer.  A 
“productive” complex was observed only in Y308 mutants (the C’-terminal residue) 
of pea-FNR, where the NADP+ nicotinamide ring is nearly parallel and adjacent to 
the FAD isoalloxazine ring [16]. 
 These observations have led to the conclusion that NADP+ binding to FNRs is 
a two-step process with nearly independent binding of the two halves of the cofactor 
[16].  In the first step the 2’-P-AMP moiety binds tightly and anchors the cofactor, 
whereas the niconinamide portion is disordered.  In the second step, the enzyme-
cofactor complex is expected to sample a set of “productive” conformations in which 
the side chain of the C’-terminal Tyr is displaced, thus allowing overlap of the 
nicotinamide and isoalloxazine rings to facilitate hydride transfer.  In the context of 
this mechanism, it is significant that in the structures of FPRs from A. vinelandii and 
P. aeruginosa the terminal Tyr is replaced by Ala254, which is followed by a C’-
terminal extension (AFVEK258).  This extension of the sequence, in principle, can be 
expected to slow the rate of conformational rearrangements needed to access the 
“productive” conformation of the cofactors thought to facilitate direct hydride 
transfer, assuming that the binding of NADP+ is similar in FNRs and FPRs.  
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Nevertheless, nothing is known about the structural properties of the NADP(H) 
complex of FPRs, and the functional role, if any, played by the C’-terminal extension 
characteristic of these enzymes has so far been elusive.  In this report we present the 
X-ray crystal structure of the pa-FPR-NADP complex, which shows an extensive 
network of the interactions among FAD, NADP+ and the C’-terminal extension.  The 
complementary observations made with the aid of NMR spectroscopy in the solution 
support the notion inferred from the analysis of the network of interactions in the 
crystal structure that the C’-terminal tail is not dynamically active, even upon NADP+ 
binding.  These findings, which suggest that the C’-terminal extension will likely not 
be readily displaced to allow “productive” packing of the isoalloxazine and 
nicotinamide rings for direct hydride transfer, are discussed in the context of a 
possible multi-step hydride transfer operative in the oxidation of NADPH by FPR 
enzymes. 
Based on the insights from the biochemical and structural studies of pa-FPR 
and pa-HO proteins, we further investigated the protein-protein interaction between 
pa-FPR and pa-HO using the available protein crystal structures and NMR backbone 
assignments in the solution phase.  As discussed in chapter 3, pa-HO is a novel redox 
partner protein of pa-FPR.  Pa-FPR is a ferredoxin reductase protein.  It is generally 
known that ferredoxin reductase forms electrostatic complex with its redox partner 
proteins and the interaction interface is most likely located around the active site to 
facilitate efficient electron transfer [17-21].  Also, the NMR method is a highly 
sensitive approach in detecting ultra-weak protein-protein interactions (PPIs) and 
 154 
identifying the interaction interface.  The chemical shift perturbation study using one 
[U-15N] protein titrated by the other unlabeled protein is carried out with 1H-15N 
HSQC experiment.  By following the chemical shift perturbed residues and mapping 
them onto protein 3D crystal structure, the protein interaction interface can be 
obtained for the weak PPI with Kd > 10-4 M [22].   
By using the two proteins’ crystal structure, the interaction interfaces are 
predicted to be the area around the heme binding pocket for pa-HO and the concave 
bowl-shaped surface area on top of the FAD isoallaxozine ring.  The chemical shift 
perturbation studies by titrating unlabeled pa-FPR into 15N labeled pa-HO produced 
very small but consistent chemical shift changes for the residues located around the 
heme binding pocket.  This result matches with the predicted protein interaction 
interface for pa-HO from the crystallography study.  The chemical shift perturbation 
studies by titrating unlabeled pa-HO into 15N labeled pa-FPR did not produce obvious 
chemical shift changes, likely due to the larger protein size of pa-FPR compared with 
pa-HO.  This interesting observation of trivia chemical shift perturbation from protein 
titration experiments likely suggests that the complex is indeed ultra weak and the 
PPI is transient.   
 
EXPERIMENTAL SECTION  
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i. Expression of labeled pa-FPR for NMR Studies   
Pa-FPR was expressed and purified following previously reported protocols 
[6].  For the expression of 15N labeled pa-FPR 1.0 L-cultures were incubated at 37 °C 
in a medium containing non-labeled nutrients.  Upon reaching mid-log phase the cells 
were centrifuged and transferred to the same volume of a fresh minimal medium 
containing labeled 15NH4Cl (1.0 g/L) and cultured to an optical density at 600 nm 
(OD600) of approximately 0.7.  The culture was then transferred to a shaker incubator 
pre-equilibrated at 10 °C at which the cells were cultured for 30 min to allow for the 
thermal equilibrium.  Protein expression was then induced by the addition of IPTG 
(0.3 mM final concentration), followed by culturing at 10 °C for approximately 14 hrs 
before harvesting by centrifugation.  Uniformly 13C and 15N-labeled pa-FPR, [U-13C, 
15N]-pa-FPR was expressed in a similar manner, except that the cells centrifuged after 
reaching mid-log phase were resuspended in a minimal medium containing 15NH4Cl 
(1.0 g/L) and 13C6-D-glucose (2.0 g/L).  Uniformly 2H, 13C and 15N-labeled pa-FPR, 
[2H, 13C, 15N]-pa-FPR was expressed using similar protocols, modified to meet the 
requirements for protein perdeuteration [23-25].  Prior to the expression, the 
ArcticExpressTM RIL cells harboring the recombinant plasmid containing the pa-fpr 
gene were adapted to grow in D2O using a protocol similar to that reported for the 
expression of deuterated proteins in P. pastoris [23].  In short, cells were plated on an 
LB-ampicillin plate and grown at 37 °C for 16 hrs.  An isolated colony from this plate 
was transferred to 10 mL of an LB-ampicillin medium containing 25% D2O (v/v) and 
the cells were grown at 37 °C overnight.  The resultant cell suspension was used to 
 156 
plate LB-agar containing 25% D2O and the cells were grown at 37 °C for 16 hrs.  An 
isolated colony from this plate was transferred to 10 mL of an LB-Amp medium 
(50% D2O v/v) to start a new cycle of adaptation.  Subsequent cycles were carried out 
similarly and included the adaptation at 75% and 95 % D2O.  Cells grown in 95% 
D2O were used to make a glycerol stab culture stock.  A single colony of cells grown 
in an LB-amp plate made with 95% D2O was transferred to 10 mL of LB-Amp 
(99.9% D2O) and cultured at 37 °C and 220 rpm overnight.  This culture was used to 
inoculate 100 mL (99.9% D2O) M9 medium containing 15NH4Cl (1.0 g/L) and 3C6-D-
glucose (2.0 g/L) and the cells were grown at 37 °C to an OD600 of ~ 0.7.  Fifty mL 
from this culture were used to inoculate 1.0 L of M9 medium (99.9% D2O) containing 
15NH4Cl (1.0 g/L) and 13C6-D-glucose (2.0 g/L), and the cells were grown to an OD600 
of ~ 0.7 at 37 °C.  The culture was then equilibrated at 10 °C, followed by the 
induction of protein expression by the addition of IPTG (0.2 mM final concentration) 
and cultured at 10 °C for 30 hrs.  Cell harvesting, cell lysis and enzyme purification 
were carried out as described previously [27].  Amide and side chain deuterons were 
exchanged for hydrogen as follows: pure protein was dissolved in 50 mM sodium 
phosphate buffer (pH 7.0) containing 8 M urea, 100 mM NaCl, and 0.1 mM FAD to a 
final concentration of ~ 8 µM and incubated at 37 °C for 3 hrs.  This solution was 
dialyzed extensively against 50 mM sodium phosphate (pH 7.0) containing 100 mM 
NaCl, 10% (v/v) glycerol, 0.1 mM EDTA, and 5 mM DTT at 4 °C.  The resultant 
solution was concentrated by ultrafiltration (Centricon -10, MW cutoff 10 kDa) to 1.0 
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mL and loaded onto a Sephadex G-50 column (100 cm × 1.6 cm) to remove free FAD 
and eluted with 50 mM sodium phosphate buffer (pH 7.0). 
Selective amino acid labeling [24-26] of pa-FPR was carried out following a 
protocol reported previously [27] with some modifications [28].  The minimal 
medium used to obtain uniformly labeled protein was supplemented with the 
following amino acids (g/L): L-Ala (0.5), L-Arg (0.4), L-Asp (0.4), L-Asn (0.4), L-
Cys (0.05), L-Gln (0.4), L-Glu (0.65), Gly (0.55), L-His (0.1), L-Ile (0.23), L-Leu 
(0.23), L-Lys hydrochloride (0.42), L-Met (0.25), L-Phe (0.13), L-Pro (0.1), L-Ser 
(2.10), L-Thr (0.23), L-Tyr (0.17), L-Val (0.23), and L-Trp (0.05).  All amino acids 
except L-Trp and the 15N-enriched amino acid were added in solid form to the media 
prior to autoclaving.  15N-Trp was filter sterilized and added prior to inoculation.  For 
the preparation of [15N-Leu]-pa-FPR, 10 mL of an LB medium was inoculated with a 
single colony and grown overnight at 37 °C.  The overnight culture was used to 
inoculate 1.0 L of the M9 medium supplemented as above, but not containing L-Leu.  
The cells were grown at 37 °C to an OD600 of ~ 0.7, equilibrated at 10 °C and 
supplemented with 15N-L-Leu prior to the induction of protein expression by the 
addition of IPTG (of 0.2 mM final concentration)and cultured for 12~15 hrs.  The 
same process was used to prepare pa-FPR labeled selectively with 15N-Val, 15N-Glu, 
15N-Phe and 15N-Asp.  A slight modification was needed to prepare enzyme labeled 
with 15N-Tyr, 15N-Phe and 15N-Thr.  In the preparation of [15N-Tyr]-pa-FPR and [15N-
Phe]-pa-FPR, 0.25 g of glyphosate (N-phosphonomethyl-glycine) was added together 
with the 15N-labeled amino acid to minimize isotope scrambling via aromatic amino 
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acid metabolism [24].  In the preparation of [15N-Thr]-pa-FPR, additional 0.23 g/L of 
L-Ile and 0.115 g/L of L-Val were added together with the 15N-Thr to minimize 
isotope scrambling to Ile or Val [25].  In the preparation of [15N-Gly]-pa-FPR, the 
relatively minor scrambling from 15N-Gly to 15N-Ser was intentionally preserved 
because it was useful in the identification of cross-peaks originating from Ser residues 
in pa-FPR.  Cell harvesting, cell lysis and enzyme purification were carried out as 
described previously [29]. 
ii. NMR Sample Preparation   
 Protein concentrations were determined by measuring the absorption of pa-
FPR solutions at 450 nm (ε450 = 11.5 mM-1 cm-1) [27].  NMR samples typically 
containe 0.1 - 1.2 mM pa-FPR, 5 - 10 % D2O in 50 mM sodium phosphate buffer (pH 
= 7.0).  The details of experimental conditions used for specific NMR experiments 
are shown in the appropriate figure captions. 
iii. NMR Spectroscopy and Backbone Resonance Assignments   
NMR experiments were carried out in a Bruker Avance 800 spectrometer 
equipped with a 5 mm TXI 1H-13C/15N/Dxyz gradient probe.  Two- and three-
dimensional NMR experiments (1H-15N-HSQC, 1H-15N-TROSY-HSQC, HNCA, 
HN(CO)CA, TROSY-HNCACB, TROSY-HN(CO)CACB, TROSY-HN(CA)CO, and 
TROSY-HNCO) for NMR assignment were conducted at 25 °C.  Amino acid 
selective 15N-labeled pa-FPR: [15N-Gly]-pa-FPR, [15N-Leu]-pa-FPR, [15N-Val]-pa-
FPR, [15N-Glu]-pa-FPR, [15N-Phe]-pa-FPR, [15N-Asp]-pa-FPR, [15N-Tyr]-pa-FPR 
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and [15N-Thr]-pa-FPR were used to acquire 1H-15N HSQC spectra.  Two- and three-
dimensional NMR spectra were processed using NMR Pipe [30] and analyzed with 
Sparky [31].  1H chemical shifts were referenced to the proton resonance of DSS at 0 
ppm, while 15N and 13C shifts were referenced indirectly using the ratios 0.101329118 
and 0.251449530, respectively [32]. 
a)  Protein Sequential Backbone Assignment Methodology 
NMR spectroscopy and X-ray crystallography are two well-developed 
methods capable of determining protein structure at the atomic resolution.  NMR can 
be used to obtain protein structure in the solution phase.  Because the crystal structure 
of pa-FPR has been solved (chapter III), NMR backbone assignments are capable of 
giving protein structure in the solution phase in context with its crystal structure.  If 
the target protein has no available crystal structure, there are two additional steps in 
protein structure determination by NMR: the first uses backbone chemical shift 
information to predict the secondary structure (so called chemical shift indexing, 
CSI), and the second is the 3D structure calculation. 
For each resonance signal (cross peak, or simply stated as peak) of each 
nucleus, the NMR spectroscopy detects three types of information: chemical 
environment (via chemical shift), through-bond (via scalar coupling) and through-
space (via dipolar coupling) interactions.  Therefore, a sequential assignment can be 
made from N-terminus to C-terminus for all backbone amide peaks originating from 
the amino acids in the protein.  The strategy employed for resonance assignments 
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depends on the properties of the protein, for example, size, stability, secondary 
structure, etc.  
 A 15N isotopically labeled NMR sample is used to acquire two dimensional 
(2D) 1H-15N Heteronuclear Single Quantum Coherence (HSQC) experiment for the 
purpose of evaluating the feasibility on carrying out NMR spectroscopic studies.  
When a protein is large in size (>20kDa), the spectrum will be crowded.  
Furthermore, if the protein contains a large percentage of alpha-helix secondary 
structure or it forms dimer or multimer in solution, the spectrum can be clustered as 
well. Consequently, the assignment work can be very challenging.  The three 
dimensional NMR experiments can be used to separate the clustered signals by 
adding another extra dimension.  A 13C and 15N doubly labeled protein is needed to 
acquire three dimensional (3D) 1H-15N-13C heteronuclear correlation spectra and to 
facilitate the NMR assignments.  As for the large proteins, the serious problem in the 
3D NMR spectra is that many signals are very weak and broad due to either very 
short magnetization relaxation time or fast relaxation rate caused by slower protein 
tumbling from larger protein size.  
There are two commonly used techniques to solve this problem: (i) protein 
deuteration and (ii) the transverse relaxation-optimized spectroscopy (TROSY) [33, 
34].  
The advantage of deuteration lies in the different relaxation properties of the 
proton and deuteron.  As mentioned earlier, the NMR signal sensitivity relates to the 
dipole-dipole interaction between nuclei.  And the dipole-dipole relaxation of nucleus 
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X (such as 1H or D) and nucleus Y (such as 13C) is related to their gyromagetic ratios 
(γ) and the spin quantum number (S) shown by following equation (4-1).  
Em= - γ*Iz*Bo        (4-1) 
Where γ: gyromagnetic ratio, Iz: angular momentum quantum number, Bo: 
magnetic field vector [35]. 
The gyromagnetic ratio of deuterium (γD) is 4.107 × 10 7 T-1s-1 and that for 
proton (γH) is 6.5 times larger (2.6752 × 10 8 T-1s-1).  Also, for deuterium, the spin 
quantum number is 1, and the number for proton is 1/2.  Therefore, the total reduction 
of the dipolar relaxation for a deuterated sample is much higher than that for a non-
deuterated sample.  So the deuterated sample gives stronger and more resolved 
carbon signals compared with the non-deuterated sample in the 3D experiments [36, 
37]. 
    The transverse relaxation-optimized spectroscopy (TROSY) is a method 
developed by Wüthrich for the suppression of transverse relaxation (T2) in 
multidimensional NMR experiments [33].  The rate of the transverse spin-relaxation 
is mainly related with the dipole–dipole coupling of the observed spin (nucleus) with 
other nearby spins (nuclei), and the chemical shift anisotropy (CSA).  These two 
interactions are directly affected by the protein rotational motions in solution.  Larger 
proteins rotate more slowly.  And as a result, they have higher rates of transverse 
relaxation.  To overcome this disadvantage, TROSY uses the CSA-relaxation at high 
fields to cancel the dipolar relaxation [33] and to cause longer T2 values or slower 
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relaxation rate, therefore, to get the better signal resolution for the previous weak and 
broad cross-peaks. 
 Again sometimes even with the help of above two techniques, some signals 
may still be weak for some amino acids due to their dynamic properties, which also 
enhance relaxation rates, for example, residues located on a floppy loop or on a ligand 
binding site.  Protein-selective amino acid labeling has also been found to be a very 
helpful and practical technique to advance and complement the assignment work.  
Pa-FPR has a 30 kDa molecular weight, therefore, we used above three strategies for 
our pa-FPR backbone assignment work and results are shown below. 
b) 3D NMR Experiments and Data Processing Overview 
As mentioned above, either 1H, 13C, 15N triple resonance 3D experiments for 
13C, 15N doubly labeled pa-FPR, or 2H, 13C, 15N-Trosy version triple resonance 3D 
experiments for 2H, 13C, 15N triply labeled pa-FPR are carried out under the guidance 
from Dr. Juan Carlos Rodriguez.  The 3D experiments detect the nuclei with specific 
sequential correlations between intra- or inter-residual nuclei.  
As shown in Figure 4-2, there are through-bond correlations via scalar 
coupling (in the form of magnetization transfer in the NMR experiment) from one 
backbone atom to another.  As shown by the arrows, the amide nitrogen of residue i 
can correlate to neighboring carbons or protons by transferring magnetization to 
them; and all the different correlations can be selectively and specifically detected by 
different NMR experiments.  Because these correlations are dominated by protein 
sequence, therefore they can give us sequential connectivities between amino acids 
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(from residue i-1, to i, to i+1, …) for backbone assignment, somewhat like “walking 
down” the protein sequence.   
N i-1
H i-1
NiCoi-1
O Hi H
Coi
O
CβiH H
R
Cβi-1H H
R
Cαi-1
H
Cαi
residue i-1 residue i
 
Figure 4-2. Magnetization transfer from backbone NH of residue i to residue i-1 through 
bonds. 
 
     There are many 3D NMR experiments for detecting the correlation 
information.  At least six 3D experiments are needed for accomplishing backbone 
assignment work: HNCA, HN(CO)CA, HNCACB, HN(CO)CACB (or 
CBCA(CO)NH), HNCO and HN(CA)CO.  Each experiment is designed to detect the 
correlations between the specific carbon (Cα ,Cβ and Co or CA, CB and CO as in the 
3D experiment title) and its neighboring nuclei.  The HNCA experiment can detect Cα 
of residue i and i-1, while the HN(CO)CA can detect only Cα of residue i-1.  By 
pairing information obtained from both experiments, one can tell the Cα cross-peak of 
residue i aparts from that corresponding to Cα of residue i-1.  The same idea applies to 
other paired 3D experiments.  HNCACB and HN(CO)CACB can be used to assign Cα 
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and Cβ: HNCACB can detect both residue i and i-1, while HN(CO)CACB can only 
detect residue i.  HNCO and HN(CA)CO are for Co.  HNCO can detect Co of residue i 
and i-1 and HN(CA)CO can only detect residue i.  The parenthesis in the 3D 
experiments suggests that the included carbon can not be detected.  Because all these 
3D triple resonance experiments share the same 1H,15N chemical shifts, they have the 
same 1H,15N HSQC spectra.  Therefore, they can all be connected by the same amide 
peak in 1H,15N HSQC.  As mentioned before, the amide strip plots of the residues can 
be sequentially aligned for the assignment, as shown in the illustration.  
In Figures 4-3(A) and 4-3(B), the path of magnetization transfer in 3D HNCA 
and HN(CO)CA experiments, respectively, is illustrated.  The HNCA experiment 
correlates the amide proton (H), the 15N spin (N) and the 13Cα of residues i and i-1 
(CA) into a three dimensional spectrum.  The HN(CO)CA experiment detects the 
correlation between the 1H and 15N spins of residue i with the 13Cα spin of residue (i-
1).  The HN(CO)CA spectrum shows cross-peaks with coordinates (1HNi, 15Ni, 13Cα (i-
1)).  The HNCA spectrum shows the same cross-peaks, but also the intra-residue 
(1HNi, 15Ni, 13Cα (i)) cross-peaks.  The signal containing 13Cα (i) is stronger than the 
signal containing 13Cα (i-1).  In the HN(CO)CA, the Co frequency of residue i-1 is not 
measured; instead, the Co only helps in transferring magnetization.  By aligning the 
strip plots (as shown in Scheme 4-1) of both HNCA and HN(CO)CA, we can identify 
the signals from Cα.  Examples will be given in the later discussion.  
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Figure 4-3. Magnetization transfer in (A) 3D HNCA and (B) 3D HN(CO)CA experiment.  
The gray circles show the nuclei whose chemical shifts are measured.  The arrows show the 
transfer of magnetization.  The open circle indicates that the magnetization is transferred 
through this nucleus, but the chemical shift is not measured. 
 
In Figure 4-4, the magnetization transfer in 3D HNCACB and HN(CO)CACB 
(or CBCA(CO)NH) experiments is illustrated.  The HNCACB experiment correlates 
both intra-residue Cα and Cβ of residue i, and sequentially correlates to the Cα and Cβ 
of residue i-1.  The HN(CO)CACB (or CBCA(CO)NH) experiment only detects the 
sequential Cα and Cβ correlation of residue i-1.  The sequential connection can then be 
made using both the Cα and Cβ chemical shifts.  Together with above HNCA and 
HN(CO)CA, we can assign all Cα and Cβ  from four experiments. 
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Figure 4-4. Magnetization transfer in (A) HN(CO)CACB (or CBCA(CO)NH) (B) HNCACB 
(or CBCANH) experiments.  The gray circles show the nuclei whose chemical shifts are 
measured.  The arrows show the transfer of magnetization.  The open circle indicates that the 
magnetization is transferred through this nucleus, but the chemical shift is not measured. 
 
Shown in Figure 4-5, the HNCO and HN(CA)CO experiments detect the 
signal from Co.  HNCO experiment detects Co of residue i-1, and HN(CA)CO detects 
both  Co of residue i-1 and Co of residue i.  Like the other two experiment pairs, the 
pair of HNCO and HN(CA)CO experiments can give sequential connectivity for the 
carbonyl Co and the carbonyl Co assignment can be done by aligning the amide strips 
from both experiments in sequence.   
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Figure 4-5. Magnetization transfer in (A) HNCO and (B) HN(CA)CO experiments.  The gray 
circles show the nuclei whose chemical shifts are measured.  The arrows show the transfer of 
magnetization.  The open circle indicates that the magnetization is transferred through this 
nucleus, but the chemical shift is not measured. 
 
Therefore, with all above three pairs of 3D experiments, all the backbone 
chemical shifts (H of NH, NH, C α , Cβ  and Co) can be assigned sequentially.  The 
procedure of doing backbone assignment is summarized in the following scheme.  
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3D HNCO, HN(CA)CO        
(left to right)
i-1 i i+1 ……
13Co
strip plots from 3D HN(CO)CA,  HNCA, 
HN(CO)CACB and HNCACB (left to right)
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Scheme 4-1. 3D NMR Sequential backbone assignment using C-terminal F255, V256, E257 
and K258 as a model (data is processed by NMR pipe and Sparky). 
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As shown on the 3D NMR sequential backbone assignment illustrated in 
Scheme 4-1, all the signals are contained in a cube instead of a plane.  The 3D 
experiment can be viewed as the combination of a series of 2D experiments.  Each 2D 
plane cutout along 15N dimension has much less signals compared with the 2D 1H, 
15N HSQC containing all amide peaks.  Subsequently one or a few peaks can be 
selected out and put into a strip (usually called amide strip, as a strip of the 2D 1H-
13C
o
/ 13C
α
/ 13C
β
 cutout plane along the amide nitrogen dimension in 3D experiments, 
shown in Scheme 4-1).  Each amide strip of the amino acid from each 3D experiment 
can then be aligned side by side and viewed together with other amino acids by 
following the protein sequence for sequential assignment.  The four c-terminal 
residues F255, V256, E257 and K258 are given as a model to illustrate how the 
assignment is done.  In the strip plots from 3D HN(CO)CA,  HNCA, HN(CO)CACB 
and HNCACB (from left to right) shown in Scheme 4-1, each four strips are from one 
residue, and each four strips are aligned by protein sequence: residue i-1, I, i+1, ….  
The Cα signal of the current residue i (i is the arbitrary assignment for the residue we 
are currently viewing) is only seen as one peak in the HNCA and HNCACB.  Its 
correlation to next residue i+1 is seen in all the four 3D experiments as a Cα peak with 
the same carbon frequency in each strip.  All the six Cα peaks from the same carbon 
are connected by red lines.  And so forth, i+1 can go to next residue.  Here, taking the 
example of V256, it is the current residue i if we have not got the assignment yet.  It 
has four Cα signals connected with two Cα signals at the same frequency from the 
previous residue i-1.  Because all the Cα signals are originated from the previous Cα 
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of F255, this peak is assigned as (1HNi, 15Ni, 13Cα (i-1)) in reference to V256.  This 
correlation from F255 to V256 is called intra-residual correlation.  An assignment 
note is made in white color to the peak.  There is another Cα peak in the HNCA and 
HNCACB strip plots of V256, seen at a little bit lower position.  That signal is 
originated from the Cα of V256.  This correlation is called inter-residual correlation. 
Therefore, connectivity as shown in the red line is made from F255 to V256.  By 
doing the same thing to next residue, connectivity is continued in protein sequence. 
That is why the assignment method is generally called the sequential assignment.  
The green peaks are 13C
β
 peaks.  They are only shown in HN(CO)CACB and 
HNCACB.  The connectivity is made in the same way as for Cα.  In residue i: V256, 
one green peak exists in HN(CO)CACB, as the same peak in HNCACB.  That peak is 
originated from residue i-1 or F255 in this case.  There is another green peak C
β
 in 
HNCACB strip of V256.  Using the same logic, this peak can be assigned as 1HNi, 
15Ni, 13C
β
 
(i)).  The connectivity is demonstrated by the yellow line connecting the 
same C
β
.  Therefore, the information for Cα and C
β
 for these four residues is obtained. 
As we discussed earlier, the 3D experiment can be seen as the combination of a series 
of 2D experiments.  Each peak in 3D experiment has chemical shifts in a format of 
(1H, 15N, 13C).  Therefore, each peak in 3D experiment is corresponding to a peak in 
2D experiment, as shown in Scheme 4-1 by the red circle, blue square, magenta and 
green triangles.  The chemical shift of 1H and 15N for each residue can be achieved as 
well.  The last one Co is detected in the other two 3D experiments: HNCO and 
HN(CA)CO.  In residue i: V256, the white line connects the peak (1HNi, 15Ni, 13Co (i-
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1)) (the left HNCO strip plot of V256 in the scheme 1) with the peak (1HNi, 15Ni, 13Co 
(i)) (the right HN(CA)CO strip plot of F255 in the scheme 1) in the 3D experiments. 
And in the right HN(CA)CO strip plot of V256, the same peak is seen in much 
weaker intensity.  And a new peak at a little lower position is originated from (1HNi, 
15Ni, 13Co (i)) or V256.  Its connectivity to next residue i+1(or E257) is shown by the 
white line.  Also, the same relationship between 3D and 2D experiments applies here. 
Therefore, we can achieve all the chemical shift assignments (H of NH, NH, Cα, Cβ 
and Co) for all the residues in protein sequence by using the same strategy.  In reality, 
even in 3D experiments, cross-peaks can still be overlapped due to the similar 
chemical shifts in many cases.  Also, as discussed previously, large protein size and 
extremely weak or broad signals from dynamic protein regions can complicate the 
assignment work as well.  Some examples will be given in the results and discussion 
part. 
iv. Chemical Shift Perturbation Experiments   
1H-15N HSQC spectra were recorded at 25 °C using Varian Unity Inova 600 
MHz and Bruker Avance 800 MHz spectrometers.  [15N]-pa-FPR (500 µL, 0.25 mM) 
in 50 mM sodium phosphate (pH 7.0, 10 % D2O) contained in a 5 mm diameter NMR 
tube was titrated with a stock solution of NADP+ (39 mM) dissolved in the same 
buffer.  Titrations were carried out by the addition of 0.05, 0.10, 0.20, 0.30, 0.40, 
0.50, 0.75, 1.0, 1.5, 2.0, 3.5, 5.0, 7.5, 10, 15, 20 and 25 equivalents of NADP+ relative 
to pa-FPR.  The pH of the solution after the addition of each aliquot of NADP+ was 
adjusted to 7.0 prior to recording the corresponding 1H-15N HSQC spectrum.  The 
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spectra were acquired at 25 °C using Varian Unity Inova 600 MHz.  For the protein-
protein interaction study, [15N]-pa-HO (500 µL, 0.2 mM) in 50 mM sodium phosphate 
(pH 7.0, 10 % D2O) with 2 mM NaCN contained in a 5 mm diameter NMR tube was 
titrated with a stock solution of pa-FPR protein (2 mM) dissolved in the same buffer.  
Titrations were carried out by the addition of 6, 12 equivalents of pa-FPR relative to 
pa-HO.  The data were processed using NMRpipe [30] and analyzed using Sparky 
[31].  Similar experiments were carried out with adenosine 2’5’-diphosphate (ADP), a 
competitive inhibitor of ferredoxin reductase enzymes.   
v. X-ray crystallography   
X-ray-quality single crystals of pa-FPR in complex with NADP+ were grown 
using the hanging drop vapor diffusion method by mixing 2 µL of pa-FPR (20 
mg/mL) dissolved in 20 mM Tris (pH 7.6) containing 10 mM NADP+ with 2 µL of a 
solution consisting of 200 mM ammonium acetate, 100 mM sodium citrate tribasic 
dihydrate and 25% PEG-4000 (pH 5.6).  Diffraction data were recorded at –180 °C 
using the rotation method on a single flash-frozen crystal [Detector: R-axis IV++ 
image plate; X-rays: CuKα, focused by mirror optics; Generator: Rigaku RU300 
(MSC, The Woodlands, TX, USA)].  The cryoprotectant was 20 % ethylene glycol.  
X-ray data were reduced with XDS [38]; the program package CNS [39] was 
employed for phasing and refinement; and model building was performed with O 
[40].  The structure was solved by molecular replacement using the coordinates of 
ferredoxin oxidoreductase from pa-FPR (PDB entry 2QDX) as search model, stripped 
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of solvent molecules and ligands.  Refinement was performed using data to the 
highest resolution with no sigma cut-off applied.  Several rounds of minimization 
simulated annealing (2500 K starting temperature) and restrained individual B-factor 
refinement were carried out.  Data collection and refinement statistics are summarized 
in Table 4-1. 
Table 4-1. Summary of data collection and structure refinementa. 
 
 
Data set FPR(FAD) – NADP+ complex 
Space group P21212 
Unit cell dimensions 
(Å) 
a=67.14 b=73.49 c=51.54 
α=β=γ=90º 
Protein atoms 2037 
[average B-factor = 22.5 Å2] 
Ligands  FAD and NADP+ (101 atoms) 
[average FAD B-factor = 19.4 
Å2] 
[average NADP+ B-factor = 
24.4 Å2] 
Solvent molecules 288 
[average B-factor = 33.1 Å2] 
rmsdb bonds (Å) 0.01 
rmsdb angles (°) 1.7 
Resolution range 20-1.90 (1.95-1.90) 
Unique reflections 20561 (2895) 
Completeness (%) 99.7 (99.4) 
I/σI 28.45 (8.44) 
Rmerge (%) 3.8 (15.7) 
Rcryst
c
 (%) 18.1 
Rfree
d
 (%) 21.8 
a
 Values in parentheses refer to the highest-resolution shell.  
b
 Rootmean-square deviation from ideal values.  
c
 Rcryst ) 100 * ∑|Fobs - Fmodel|/∑Fobs, where Fobs and Fmodel are observed and 
calculated structure factor amplitudes, respectively.  
d
 Rfree is the Rcryst calculated for randomly chosen unique reflections, which were 
excluded from the refinement (1234 for FPR liganded with FAD). 
RESULTS AND DISCUSSION 
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Precedents guiding current views of hydride transfer between flavin and 
nicotinamide are grounded on observations made with the structure of glutathione 
reductase, a flavoenzyme that is functionally and structurally different from FNR [14, 
15].  The structure of glutathione reductase shows the nicotinamide ring parallel and 
adjacent to the isoalloxazine ring; this relative orientation, which likely facilitates 
direct hydride ion transfer, is viewed as a “productive” complex.  In the structures of 
plastidic FNRs, however, the side chain of the C’-terminal Tyr lies parallel to the 
flavin isoalloxazine ring, thus occupying the place that would be taken by the 
nicotinamide ring in a “productive” complex.  Work aimed at explaining these 
structural observations led to the hypothesis that NADP+ binding to plastidic FNRs is 
a two step process; with the first step involving strong interactions between the 2’ 
adenosyl phosphate moiety and FNR, whereas the nicotinamide portion undergoes 
less specific interactions with the enzyme.  In the second step the side chain of the 
terminal Tyr moves and allows the nicotinamide ring to stack parallel to the 
isoalloxazine ring, thus forming a transient but “productive” complex conducive to 
the direct hydride transfer [16]. 
In comparison, previous to this report, virtually nothing was known regarding 
the binding of NADP+ to bacterial FPRs.  Amino acid sequence alignments and the 
structures of Av- and pa-FPRs had demonstrated that the position occupied by the 
terminal Tyr in FNRs is occupied by Ala in the bacterial enzymes (A254 in pa-FPR), 
where the carbonyl oxygen of this residue stacks against the isoalloxazine ring of 
FAD [6, 7].  In addition, FPR enzymes possess a characteristic C’-terminal extension 
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following A254 (AFVEK258).  The effect of NADP+ binding on the interaction 
between A254 and FAD and on the conformation of the C’-terminal extension, 
however, was difficult to predict.  The structure of the pa-FPR-NADP complex 
reported herein provides a first view of the interactions between NADP+ and pa-FPR.  
As will be shown below, analysis of the structure shows a vast network of stabilizing 
interactions between FAD, NADP+ and the C’-terminal extension, which suggests 
that the gross conformational rearrangements that would be needed for placing the 
nicotinamide and isoalloxazine rings parallel and adjacent is not likely to occur.  
These observations are discussed in the context of a putative mechanism where the 
oxidation of NADPH by FPRs may occur via a stepwise rather than direct hydride 
transfer. 
1. The Crystal Structure of pa-FPR-NADP shows a network of interactions 
encompassing FAD, NADP+ and the C’-Terminal Extension   
The recently reported crystal structure of pa-FPR [6] showed that the enzyme 
folds into a two-domain structure, typical of the ferredoxin NADP+ reductase 
superfamily.  The FAD cofactor binds in the N-terminal domain (residues 1-87), 
comprised of an antiparallel β-barrel (β1-β6) capped by helix α1.  The stabilizing 
interactions between FAD and pa-FPR have been described in detail [6]; these 
interactions remain largely unchanged in the structure of the pa-FPR-NADP complex, 
which shows that NADP+ binds in the C’-terminal domain of the β-sheet, comprised 
of β7, β10, the loop connecting β7 to α3, the N-terminal residues of α3 and the 
carboxy terminal residues AFVEK258 (Figure 4-6).   
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Figure 4-6. View of the structure of the pa-FRP bound to NADP+.  FAD is shown in blue, 
NADP+ in cyan, α-helices in red, β-sheets in yellow and loops in green. 
 
There are several stabilizing interactions between the polypeptide and the 
cofactor (Figure 4-7): starting at the adenine end of the NADP+ molecule, the NH2 
nitrogen in this ring is within hydrogen bonding distance of the hydroxyl oxygen in 
Ser223 and the carboxylate group of Glu227.  The 2’-phosphate (2’-P) is anchored to 
the enzyme via H-bonds and salt bridges to the hydroxyl oxygen of Thr181, the 
guanidinium NH and NH2+ groups in the side chain of Arg182 and the guanidinium 
NH group of Arg190.  A salt bridge between the negatively charged oxygen in the 
pyrophosphate P1 group of NADP+ and the guanidinium NH2+ group of Arg145, and 
a hydrogen bond between the NH group of the same side chain and the neutral 
oxygen in P1 stabilize this portion of the cofactor.  The 1’- and 2’-hydroxyl groups in 
the nicotinamide ribose ring of NADP+ are engaged in hydrogen bonding interactions 
with the adenine 3N atom and with the ribose 2-hydroxyl groups of FAD, 
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respectively.  It is important to point out that despite the proximity suggested by these 
interactions, the isoalloxazine and nicotinamide rings of FAD and NADP+ are 
separated by the C’-terminal residues.  This network is expanded by π-stacking 
interactions between the adenine ring in FAD and the aromatic side chain of Phe255; 
the latter is also T-stacked against the nicotinamide ring of NADP+.  The 
nicotinamide amide NH and cabonyl groups are within hydrogen bonding distance of 
the carboxylate group in Glu257 and the backbone N-H of Ser 223, respectively.  The 
carboxylate group of Glu257 expands the network by hydrogen bonding with the 1-
hydroxyl group in the AMP portion of FAD.  Lys258 complements the network with 
the electrostatic and hydrogen bonding interactions with FAD that involve the side 
chain NH3+ with the 2 pyrophosphate group and the terminal carboxylate with the 
2’ribityl hydroxyl, respectively. 
 
Figure 4-7. Stereoview of a portion of the structure of pa-FPR-NADP, highlighting the 
network of stabilizing interactions between the C’-terminal extension (AFVEK258) and the 
cofactors.  FAD is shown in yellow and NADP+ in cyan, with their N, O and P atoms in blue, 
red and orange, respectively. 
 Three important observations emerge from this analysis: (1) Residues in the 
AFVEK258 extension form an integral part of a complex network of interactions that 
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associate the FAD and NADP+ cofactors with the enzyme.  (2) The C’-terminal 
extension would have to undergo extensive conformational rearrangements to permit 
the formation of a “productive” complex with the nicotinamide and isoalloxazine 
rings stacked parallel and adjacent to one another.  (3) Parallel stacking of these rings 
would also acquire large conformational changes in FAD, which would have to 
change from its bent conformation to perhaps the extended conformation 
characteristic of plastidic FNRs.  This is unlikely because the bent conformation of 
FAD is stabilized by the network of interactions with NADP+ and the C’-terminal 
extension and because the absence of a sheet-loop-sheet motif in FPRs renders the 
enzyme incapable of stabilizing FAD in its extended conformation. 
 Consequently, in the context of current models for NADP+ binding to plastidic 
FNR enzymes, it seems unlikely that binding of the cofactor to pa-FPR would trigger 
the gross conformational rearrangement needed to allow parallel and adjacent 
placement of the nicotinamide and isoalloxazine rings in the pa-FPR-NADP complex.  
This in turn suggests that formation of a “productive” complex, in the sense of 
NADP+ binding to plastidic FNR, is not likely to occur with a frequency (µs-ms) 
conducive to catalytical competence. 
2. The Structure of pa-FPR Harbors a Pre-Formed NADP+ Binding Pocket   
The binding of NADP+ brings about relatively minor structural changes to pa-
FPR, as can be seen in the per-residue plot of ∆Cα (4-8(A)), obtained by aligning the 
structures of pa-FPR and pa-FPR-NADP.  The largest differences in Cα position, 
taken as ∆Cα > 1.5 times the average rmsd (0.47 Å) obtained from the alignment, are 
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localized in the N-terminal of helix α10 (residues 221-225), the middle of the loop 
connecting α10 to β11 (residues 242-244) and the carboxy terminal Lys 258.  Among 
the affected amino acids, residues 221-225 and 258 are located in close proximity to 
the bound NADP+, whereas residues 242-244 are distant; the differences in Cα 
position seen for the latter are likely a consequence of the higher than average B-
factors exhibited by these residues.  Figures 4-8(B) and 4-8(C) illustrate a portion of 
the surface of pa-FPR and pa-FPR-NADP, respectively.  The side-by-side 
comparison reveals that the surface of pa-FPR has a pre-formed cavity where the 
NADP+ cofactor binds to form the pa-FPR-NADP complex with minimal 
perturbation of the pa-FPR structure. 
It is well known that NADP+-dependent enzymes can’t substitute this cofactor 
for NAD+, a fact that is also evident in the negligible catalytic activity observed with 
pa-FPR when NADPH is replaced with NADH [6].  Site directed mutagenesis studies 
indicated that stabilization of the 2’-P in NADP+ contributes significantly to the 
mechanism whereby NADP(H) dependent FNR enzymes discriminate against 
NAD(H) [41, 42].  In this context, it is interesting that in the crystal structure of pa-
FPR a sulfate anion (from the crystallization solution) is nearly isostructural with the 
2’-P group of NADP+ in the crystal structure of the pa-FPR-NADP complex.  This is 
illustrated in Figure 4-8, where the sulfate in the structure of pa-FPR (Figure 4-8(D)) 
exhibits interactions nearly identical to those shown by the 2’P group in the structure 
of the pa-FPR-NADP complex (Figure 4-8(E)).  These observations are in good 
agreement with the idea that the structure of pa-FPR harbors a pre-formed binding 
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pocket, where residues involved in important contacts with the 2’P group of NADP+ 
require little or no rearrangement to accommodate the cofactor.  Among these 
residues, R182 and R190 are conserved in bacterial subclass II reductases, Thr181 is 
conserved in bacterial subclass I enzymes and substituted for Ser in plant reductases 
(Ser223 in spinach FNR) and R182 is conserved in all enzymes with known 
sequence. 
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Figure 4-8. (A) Per residue plot of the difference in the position of alpha carbons (∆Cα) 
obtained upon aligning the structures of pa-FPR and that of its NADP+ complex.  The 
average RMSD is 0.47 Å.  (B) Close-up view of the empty “NADP-binding pocket” on the 
surface of pa-FPR; the FAD is rendered in yellow sticks.  (C) Equivalent view, obtained from 
the structure of the pa-FPR-NADP complex, highlighting NADP+ (blue sticks) lodged in its 
binding pocket.  (D) The structure of pa-FPR displays a sulfate ion (red) from the 
crystallization buffer that occupies the position of the 2’-phosphate group in the pa-FPR-
NADP complex (E).  Note that the interactions exhibited by the phosphate and sulfate ions 
are nearly identical. 
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3. Assignment of Amide Backbone Resonances from pa-FPR   
NMR spectroscopy studies were carried out to obtain complementary 
information in solution regarding the binding of NADP+ to pa-FPR.  Before these 
investigations could begin, however, it was necessary to obtain sequential backbone 
resonance assignments.  The relatively large molecular weight of the enzyme (29,518 
Da) posed some challenges.  These were overcome with the strategy described below.  
The 1H-15N HSQC spectrum of pa-FPR acquired at 25 °C from a 1.2 mM solution of 
pa-FPR in 50 mM sodium phosphate buffer, pH 7.0 is shown in Figure 4-9(A).  These 
conditions were chosen for the NMR spectroscopic studies because they completely 
eliminate the slow precipitation of the enzyme when its concentration exceeds 1.5 
mM or when the samples are exposed to temperatures above 25 °C for 24 hrs or 
longer.  The spectrum exhibits relatively well dispersed cross-peaks, despite the 
relatively large molecular weight of the enzyme.  Conventional heteronuclear 2D and 
3D NMR experiments (see Experimental) carried out with a sample of pa-FPR 
uniformly labeled with 13C and 15N did not yield enough information to permit full 
sequential assignments.  This is mostly because many residues exhibited weak or 
absent beta carbon (Cβ) correlations in TROSY-HNCACB and TROSY-
CBCA(CO)NH experiments, which is attributed to efficient transverse relaxation 
brought about by the dipolar interactions between carbons and their attached protons 
[43].  This problem was circumvented by preparing a sample of [U-2H, 13C, 15N]-pa-
FPR, which was used to acquire TROSY-HNCACB and TROSY-CBCA(CO)NH 
experiments for subsequent use with the data obtained from the suite of experiments 
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obtained with [U-13C, 15N]-pa-FPR.  This approach allowed us to assign 
approximately 85% of the non-proline residues in the enzyme.  With respect to [U-
2H, 13C, 15N]-pa-FPR, it should be noted that although most of the exchangeable 
deuterons exchanged for protons during their purification, several residues are clearly 
protected from exchange because a number of cross-peaks displayed low-intensity or 
were absent when the HSQC spectrum of [U-2H, 13C, 15N]-pa-FPR was compared 
with that obtained from a sample of [U-15N, 13C]-pa-FPR.  Deuterons protected from 
exchange under native conditions were exchanged by dissolving the triply labeled 
sample in a urea containing solution, followed by dialysis in the presence of FAD.  
This unfolding/refolding procedure resulted in complete replacement of exchangeable 
deuterons for protons, as indicated by the fact that the TROSY-HSQC spectrum of the 
resultant enzyme is identical to that obtained with doubly labeled pa-FPR.  
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Figure 4-9. (A) 1H-15N HSQC of 1.5 mM [U-13C,15N]-pa-FPR in 50 mM sodium phosphate, 
pH 7.0, and 6% D2O, obtained at 25 °C using a Bruker Avance800 NMR spectrometer.  
Complex points, 256 (1H) x 2048 (15N); spectral width, 14.4 kHz (1H) and 3.3 kHz (15N); 4 
scans per increment, recycle delay 0.8s.  (B) Secondary structure in pa-FPR inferred from 
chemical shift indexing (Cα), which can be compared to secondary structure inferred from the 
X-ray crystal structure (top).  
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Additional assignments were obtained by incorporating amino acid-selective 
15N labeling into pa-FPR.  This strategy has been successfully utilized in our 
laboratories to complete the sequential backbone resonance assignments of a 
paramagnetic, highly helical heme oxygenase from P. aeruginosa [44].  In the context 
of assigning the backbone resonances from pa-FPR, selective labeling was important 
in our strategy for two main reasons.  (1) Because isotopic scrambling was virtually 
undetectable, the amino acid identity corresponding to well-resolved cross peaks in 
the HSQC spectrum of each selectively labeled protein could be readily established in 
the HSQC spectrum obtained with [U-15N]-labeled enzyme by simple comparison.  
This information was subsequently used in conjunction with the backbone 
connectivities derived from the suite of three-dimensional experiments described 
above in order to make the sequential assignment.  This approach was essential to 
assign stretches in a sequence where spin systems of key residues within a segment 
could not be identified due to poor detection of C β  resonances.  (2) The simplicity of 
HSQC spectra obtained from amino acid-selective 15N-pa-FPR allows identification 
of cross-peaks that can be easily overlooked in the spectrum of [U-15N]-labeled 
samples, because of overlap with other resonances or due to relative low intensity.  
For instance, in the HSQC spectrum of 15N-Gly-pa-FPR the cross-peak in red 
corresponds to G205 (Figure 4-10).  The same cross-peak is located in a crowded 
section of the spectrum obtained with [U-15N]-labeled enzyme and thus it had been 
overlooked.  Its definitive identification in the spectrum of the 15N-Gly-pa-FPR 
allowed its subsequent sequential assignment with the aid of the suite of three-
dimensional experiments described above.  In the end, the combined strategies 
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allowed us to make 95% of backbone assignments in pa-FPR, not counting Pro; these 
assignments are summarized in Table S4-1. 
 
 
Figure 4-10. [1H-15N]-HSQC of 15N-Gly selectively labeled pa-FPR in (A) compared with 
fully [1H-15N]-HSQC of [U-15N] -labeled pa-FPR in (B).  The labels are only for Gly. 
 
Once assigned, the backbone chemical shifts were used to identify elements of 
secondary structure in solution by chemical shift indexing (CSI) [45, 46].  Results 
obtained from this process carried out with C
α
 chemical shifts have been plotted per 
residue in Figure 4-9(B), where they are compared with elements of secondary 
structure obtained from the crystal structure of pa-FPR using the program DSSP 
(http://swift.cmbi.ru.nl/gv/dssp/) [38].  It is apparent that secondary structure 
identified with the aid of NMR spectroscopic studies in solution is consistent with 
secondary structure obtained from the enzyme in crystal form.  The most significant 
differences are in residues 191-197 (α 8) and residues 199-204 (α 9).  The backbone 
resonances of residues in α 8 were not assigned, most likely because the NH cross-
(A) (B) B 
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peaks of these residues are very weak or unobservable in HSQC spectra, due to line 
broadening brought about by segmental dynamic behavior.  Cross-peaks from 
residues 199-204, although observable, are significantly less intense than average, 
suggesting that these residues are also affected by dynamic conformational exchange.  
Hence, it is likely that this segment of the structure in solution is conformationally 
averaged between helical and disordered states; the fact that α 8 and α 9 are flanked by α
loops likely facilitates this segmental dynamic behavior.  Interestingly, the crystal 
structure of the pa-FPR-NADP complex shows that α 8 and α 9 are in close proximity α
to the NADP+ binding site, which suggests the possibility that local conformational 
plasticity prepares the enzyme to bind the NADP(H) cofactor. 
4. Probing the Binding of NADP+ to pa-FPR in Solution by NMR Chemical 
Shift Perturbations   
The binding of NADP+ to pa-FPR was studied by titrating NADP+ into a 
solution containing 15N-labeled pa-FPR, while monitoring induced chemical shift 
perturbations of amide 1H and 15N resonances with the aid of 1H-15N-HSQC spectra.  
The titration induced chemical shift perturbations larger than two times the average of 
the weighted chemical shift perturbation (0.12 ppm) in 22 cross-peaks, a 
characteristic that identifies the corresponding residues as potential sites of interaction 
with NADP+.  The NADP+-dependent gradual shift of cross-peaks indicates that 
interconversion between NADP+-bound and free forms of the enzyme is fast relative 
to the NMR timescale (i.e. fast exchange).  The titration also caused the 
disappearance of 18 cross-peaks, which is likely a consequence of exchange between 
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bound and free forms at rates approximately equal to the chemical shift timescale (i.e. 
intermediate exchange).  Cross-peaks exhibiting gradual chemical shift perturbations 
have been plotted per-residue (black in Figure 4-11(A)), together with cross-peaks 
that disappear upon the addition of NADP+ (red in Figure 4-11(A)).  The plot makes 
it evident that those residues whose chemical shifts exhibit gradual chemical shift 
perturbations (fast exchange) are clustered with residues whose chemical shifts 
disappear during the titration, which strongly suggests that line broadening of the 
latter is a consequence of binding interactions that trigger dynamic events taking 
place in the intermediate exchange regime.  The NADP+-dependent chemical shift 
perturbation of cross-peaks in fast exchange has been plotted for several 
representative amino acids (V144, W146 and V147) in Figure 4-12 and the curve 
fitted to a model where one molecule of pa-FPR binds one molecule of NADP+.  This 
analysis reveals an average dissociation constant (Kd) of 24 µM, a value similar to 
that reported for the binding of NADP+ to spinach FNR (14 µM)  at lower ionic 
strength [47]. 
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Figure 4-11. (A) Per-residue plot of weighted chemical shift perturbations (black lines) 
obtained upon titration of a solution of pa-FPR with a solution of NADP+ (A) and with a 
solution of ADP (B).  The weighted values of chemical shift perturbations were obtained 
from 2 2[( / 5) ] / 2weighted N Hδ δ δ∆ = ∆ + ∆  [48].  The red lines in the plot correspond to 
residues whose corresponding cross-peaks decreased in intensity and disappeared during the 
titration.  (C) Residues whose corresponding cross-peaks exhibited gradual chemical shift 
perturbations during the titration with NADP+ are highlighted green on the surface of the pa-
FPR-NADP complex, whereas those residues whose cross-peaks decreased in intensity and 
disappeared during the titration are highlighted in red.  FAD and NADP+ are rendered in 
yellow and in blue sticks, respectively.  (D) Residues whose cross peaks were affected during 
the titration of pa-FPR with ADP have been highlighted as in (C). 
 
Residue
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250
∆
δ
∆
δ
∆
δ
∆
δ
w
e
ig
ht
ed
 
(pp
m
)
0.0
0.1
0.2
0.3
Residue
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250
∆
δ
∆
δ
∆
δ
∆
δ
w
e
ig
ht
e
d 
(pp
m
)
0.0
0.1
0.2
0.3
A 
B 
C D 
 190 
[NADP+]/[pa-FPR](black and white) or [ADP+]/[pa-FPR](colored)
0 2 4 6 8 10
w
e
ig
ht
ed
 
∆
δ
∆
δ
∆
δ
∆
δ
 
(p
pm
) (
pa
-
FP
R
-
c
o
e
n
zy
m
e
 
-
 
pa
-
FP
R
)
0.00
0.05
0.10
0.15
0.20
0.25
0.30
 
Figure 4-12. Chemical shift perturbations observed upon titrating [15N]-pa-FPRP with 
NADP+ and with ADP.  The plots represent W146, V144 and V147, from top to bottom. 
These three are used to estimate the pa-FPR coenzyme dissociation constant.  (24±3µM for 
NADP+), (32±3µM for ADP ). 
 
Residues whose N-H cross-peaks exhibit weighted chemical shift 
perturbations larger than (0.08 ppm) upon titrating pa-FPR with NADP+ are 
highlighted in green on the X-ray crystal structure of the pa-FPR-NADP complex 
(Figure 4-11(C)), whereas residues whose N-H cross-peaks disappear are highlighted 
in red.  It is reassuring that the chemical shifts of amide cross-peaks corresponding to 
residues identified in the crystal structure as being in close proximity to NADP+ are 
perturbed by the presence of NADP+.  Amongst these, cross-peaks from residues 
interacting with the 2’-P group of NADP+, Thr181, Arg182 and Arg190 (see Figure 
4-7), are broadened and disappear due to exchange in the intermediate regime, 
whereas the cross-peak originating from Glu257, which interacts with the amide NH2 
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group of the nicotinamide ring exhibits perturbations in the fast exchange regime.  
Cross peaks for Arg145 and Ser223, which interact with the pyrophosphate group P1, 
and with both the nicotinamide amide and the 2’P groups of NADP+, respectively, 
have not been assigned.  A comparison of the X-ray crystal structures of pa-FPR and 
pa-FPR-NADP has been made in Figures 4-8(B) and 4-8(C), which shows that the 
structure of pa-FPR has a pre-formed “NADP+ binding pocket” where the cofactor 
binds with minimal perturbations on the structure of the enzyme.  In Figure 4-11(C), 
the cofactors have been rendered in sticks to illustrate the fact that residues 
comprising the “internal walls” of the “NADP+ binding pocket” are highlighted in red 
and green.  This observation indicates that the surface of interaction in the structure of 
NADP+ includes the “internal walls” of the “NADP+ binding pocket”, and 
demonstrates that the chemical shift perturbations and line broadening effects brought 
about by the binding of NADP+ in solution delineate a binding surface highly 
consistent with that observed in the crystal structure.  Hence, observations made with 
the enzyme in solution also indicate that the structure of pa-FPR harbors a pre-formed 
“NADP+ binding pocket”.   
Current models of NADP(H) binding to plastidic FNRs propose that parallel 
stacking of the nicotinamide ring onto the isoalloxazine ring to form a “productive” 
complex for direct hydride transfer requires displacement of the side chain from the 
terminal Tyr.  Equilibrium binding studies conducted with spinach FNR revealed that 
its binding affinity for NADP+ is approximately seven times lower than its affinity for 
adenonsine 2’,5’-diphosphate (ADP) [47], which lacks the nicotinamide nucleotide 
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moiety.  These observations have been interpreted in the context of the binding model 
to support the idea that NADP(H) binding to plastidic FNRs is a two-step process, 
with the first step involving strong interactions between the 2’adenosyl phosphate and 
FNR, and the second step requiring displacement of the terminal Tyr to allow the 
nicotinamide ring to stack parallel to the isoalloxazine ring of FAD.  In this model, 
the second step, which is thought to be energetically costly, has been invoked to 
explain the higher affinity of FNR for ADP relative to NADP+ [16, 49].  It was 
therefore of interest to examine the binding of ADP to pa-FPR and compare the 
results with those described above for the binding of NADP+.  Hence, ADP was 
titrated into a solution containing 15N-labeled pa-FPR, while monitoring induced 
chemical shift perturbations in 1H-15N-HSQC spectra.  Remarkably, titration with 
ADP revealed a pattern of perturbed residues (Figure 4-11(B)) nearly identical to the 
pattern obtained upon binding of NADP+ to pa-FPR (Figure 4-11(A)).  This fact is 
also evident in the corresponding color coded representation obtained by mapping 
residues whose cross-peaks exhibit chemical shift perturbations (green) and line 
broadening effects (red) on the structure of pa-FPR-NADP (Figure  4-11(D)).  
Chemical shift perturbations induced by addition of ADP to pa-FPR for several 
representative amino acids (V144, W146 and V147) have been plotted and fitted to a 
simple one site saturation ligand binding equation using software SigmaPlot 9.0.  This 
process reveals an average Kd of 32 µM, a value that is slightly larger than that 
measured for the pa-FPR-NADP complex (see above).  The similarity in the 
magnitudes of Kd obtained for the binding of NADP+ and the competitive inhibitor 
 193 
ADP indicates that stabilization of the pa-FPR-NADP complex is derived mainly 
from interactions between the polypeptide and the adenosine 2’, 5’-diphosphate 
moiety in NADP+.  In contrast to observations made with spinach FNR, however, the 
binding affinity of pa-FPR for NADP+ is slightly larger than its affinity for ADP, 
which indicates that the nicotinamide nucleotide moiety does not undergo 
destabilizing interactions with the enzyme, as is thought to be the case in the binding 
of NADP+ to plastidic FNRs.  It is therefore likely that NADP+ binding to pa-FPR 
occurs in one step, rather than two, as is thought to be the case when it binds to FNRs. 
As pointed out above, the X-ray crystal structure of pa-FRP revealed a 
network of interactions involving the C’-terminal extension and the two cofactors, 
strongly suggesting that the C’-terminal sequence of pa-FPR is not likely to be 
displaced readily in order to allow parallel stacking of the nicotinamide and 
isoalloxazine rings.  This notion was probed in solution by acquiring 1H-15N-HSQC 
spectra of pa-FPR, pa-FPR-NADP and pa-FPR-ADP at different temperatures (35 °C, 
25 °C and 15 °C).  Cross-peaks corresponding to the AFVEK258 sequence exhibit 1H 
linewidths very similar to the average 1H linewidth at each of the temperatures in all 
spectra, suggesting that the C’-terminal extension is unlikely to undergo significant 
conformational changes, in the presence or in the absence of NADP+. 
5. Potential Implications to the Mechanism of NADPH Oxidation by FPRs   
The above-described observations suggest that conformational reorganization 
of the C’-terminal peptide and of the NADP+ and FAD cofactors to allow formation 
of a “productive” complex for direct hydride transfer is unlikely to take place in the 
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pa-FPR-NADP complex.  In this context, it is important to consider that extensive 
fundamental investigations of the mechanism of NAD(P)H oxidation have 
demonstrated that hydride transfer can also occur in a stepwise manner by sequential 
electron-proton-electron transfer [50-59] (Equation 4-2).  These investigations 
documented the formation of radical cations and radicals of NAD(P)H and its 
+ + +NAD(P)H A NAD(P)H A NAD(P) AH NAD(P) HA            Equation 1• • • •+ → → → +L L (4-2)
analogues similar to the middle two species in Equation 4-1, which have been 
characterized with the aid of electronic absorption and EPR spectroscopic methods.  
The formation and detection of these reactive species indicated that the oxidation of 
NAD(P)H and its analogues can occur stepwise via electron-proton-electron transfer 
of hydride, if the acceptor is also capable of undergoing a stepwise two electron 
reduction.  This point has been recently underscored with the EPR and electronic 
absorption spectroscopic detection of a radical cation of an NADH analogue in the 
thermal two-electron reduction of a quinone [50].  Moreover, it has also been 
demonstrated that in the absence of H2O2, the oxidation of NADH by native 
horseradish peroxidase (HRP) begins with single-electron transfer from NADH to 
ferric HRP to form the NADH•+ radical cation and ferrous peroxidase [54].  A similar 
stepwise oxidation of NADPH is thought to be operative in the rescue of inactive 
catalase [60].  Hence, under appropriate circumstances the oxidation of NAD(P)H by 
sequential electron-proton-electron transfer of hydride is a viable alternative 
mechanistic path to the well-known direct mechanism involving synchronous transfer 
of a proton and two electrons. 
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It has also been established that long-range (up to 30 Å) electron transfer 
through proteins occurs via tunneling pathways, which involve dominant bonding 
and nonbonding interactions coupling donor and acceptor.  Coupling through 
covalent and hydrogen bonds is stronger than coupling through van der Waals gaps 
[61-63], and these differences in the details of specific paths involved in distinct 
systems account for the dependence of electron transfer rates on the particular 
aspects of the protein structure that mediate coupling of donor and acceptor [63].  
In this frame it is interesting that the structure of the pa-FPR-NADP complex 
places C4 of the nicotinamide ring 14.5 Å away from C5 of the isoalloxazine ring.  
Further inspection of the structure suggests a “tunneling pathway” connecting the 
nicotinamide ring in NADP(H) with the isoalloxazine ring in FAD.  This putative 
path (Figure  4-13(A)) can be thought to start with the T-stacking of the 
nicotinamide and Phe255 rings, continue along Phe255 into Ala254 across the 
peptide bond and finally communicate with the isoalloxazine ring via the Ala254 
carbonyl oxygen, which is 2.93 Å from the N10 and 3.93 Å from the N5 atom in 
the isoalloxazine ring.  In this putative mechanism, electron tunneling from the 
nicotinamide to the isoalloxazine ring would form an NADPH cation radical 
analogous that shown in Equation 4-2.  Radical cations of NADH model 
compounds are known to be significantly more acidic than their neutral precursors 
[57], thus, the NADPH cation radical formed upon tunneling of one electron would 
be expected to lose a proton thereby forming an NADPH radical similar, as shown 
in Equation 4-2.  Tunneling of a second electron from the latter would form the 
 196 
closed shell NADP+.  Accordingly, the electron acceptor, FAD, can be reduced in 
two sequential one-electron and one proton transfer reactions [64, 65].  In the 
context of a stepwise, electron-proton-electron, hydride transfer, it is also 
interesting to note a network of structural water molecules which may facilitate 
proton translocation from NADPH to FAD (Figure 4-13(B)). 
 
 
Figure 4-13.  Stereoviews of (A) possible “electron tunneling path” which starts with the 
T-stacking of the nicotinamide ring (cyan) and Phe255 aromatic side chain, continues 
across the peptide bond into Ala255 and across its carbonyl oxygen into the isoalloxazine 
ring of FAD (yellow).  (B) Several structural waters network the nicotinamide and 
isoalloxazine reactive sites, which suggest a possible path for proton translocation. 
 
F255 F255
A254A254
104 104
1818
32 32
4747
3333
169169
199199
(A) 
B 
A 
 197 
It is important to emphasize that one-electron reduction of NAD(P)+ 
analogues does not result in an overall hydride ion addition in the same manner in 
which one-electron oxidation of NAD(P)H triggers a multistep hydride ion release 
[53].  Hence, the proposed mechanism of NADPH oxidation by FPR enzymes is 
consistent with the fact that these enzymes function by exclusively oxidizing the 
cofactor, unlike their plastidic counterparts, which function in the “normal” sense 
by reducing NADP+ via hydride transfer from FADH2 or in the “inverse” sense by 
oxidizing NADPH.  It is therefore possible that the need to reduce NADP+ has 
placed evolutive pressure on the structure of plastidic FNRs to allow parallel 
placement of the nicotinamide and isoalloxazine rings for direct hydride transfer 
and reduction of NADP+.  In comparison, the function of FPR enzymes, which is 
solely the oxidation of NADPH, was acquired with minor modifications of the C’-
terminal domain, which makes the direct transfer of hydride (NADP+ reduction) 
unlikely but permits a multistep hydride transfer (NADPH oxidation) operative.  
These ideas, which stem from the X-ray crystallographic and NMR spectroscopic 
observations of the pa-FPR-NADP complex, have to be tested experimentally.  
Their discussion in this report is aimed at providing a frame of ideas consistent 
with experimental observations and to stimulate future experimentation directed at 
elucidating the mechanism of NADPH oxidation by FPR enzymes.  
6. Protein-Protein Interaction Studies via Crystallography and NMR 
 
It has been found that all FNRs interact with their redox proteins via mainly 
electrostatic interaction and its protein complex is transient for efficient electron 
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transfer purpose [66].  In 1995, the spinach FNR and ferredoxin (Fd) protein-
protein interaction study by Burns and Karplus suggested that protein interaction 
interface on FNR is the concave FAD binding domain [67].  Also, the protein 
complex of maize leaves Fd and FNR has been studied by crystallography and 
NMR [19]; it is found that the shortest distance between Fd and FNR is 6Å.  The 
study again confirms that the complex is electrostatic, and the interface is 
hydrophobic nearing the cofactors [19].  
In order to study the surprising redox partner proteins pa-HO and pa-FPR, 
we take advantage of the available crystal structure of pa-HO, pa-FPR and pa-
FPR-NADP+ complex and use Pymol together with APBS program to create the 
protein electrostatic potential surface views shown below in Figure 4-14, 4-15 and 
4-16. 
A B
 
 
Figure 4-14. Pa-FPR electrostatic potential surface views (A) and (B) from different FAD 
viewing angels.  FAD is shown in yellow sticks and NADP in green.  Red shows negative 
charged surface, and blue shows positive charged surface. 
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Figure 4-15. Pa-FPR-NADP+ electrostatic potential surface views (A) and (B) from 
different FAD viewing angels.  FAD is shown in yellow sticks and NADP+ in green.  Red 
shows negative charged surface, and blue shows positive charged surface. 
 
As shown in above Figure 4-14 and 4-15, the methyl group of FAD’s 
isoallaxozine ring is exposed to solvent.  It appears that there is a mostly intense 
positive charged bowl-shaped concave area on top of the isoallaxazine ring, and 
only small amount of negative charge besides the methyl group of isoallaxozine 
ring.  Also, the active sites on isoallaxozine ring seem to be exposed at the bottom 
of this bowl-shaped concave area.  As for the cofactors’ binding site, there seems to 
have more positive potential around the NADP+ binding site located down the 
center “red” negative charged C-terminus on the view after NADP+ binds.  While 
the negative charged c-terminus seems to be quite protruding.  In the case of Av-
FPR as our most similar homolog protein to pa-FPR, it has only one intensely 
positive potential area locates around the FAD binding site which is proposed to 
interact with Av-FdI [68].  Therefore, we compared the electrostatic potential 
surface views for both pa-FPR and pa-HO, as shown in Figure 4-16 below.  
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Figure 4-16. Pa-FPR electrostatic potential surface views: (A) and (B); pa-HO 
electrostatic potential surface views: (C) and (D).  FAD is shown in yellow sticks, NADP+ 
in green, and heme in magenta.  Red shows negative potential and blue shows positive 
potential. 
 
As for pa-HO, shown in above Figure 4-16 (C) and (D), there is largely 
negative charged area below the heme; and on top of the heme, there is largely 
positively charged area.  The rest of the protein is mostly negatively charged. 
Therefore, it is very likely that the pa-HO interacts with FPR by approaching the 
heme site toward the concave region of FPR to match up with the opposite charges 
as shown in Figure 4-17.  Again, due to the large positive charge on surface of pa-
HO, this active sites’ interaction is not the only possible electrostatic interaction. 
Therefore, the chance for protein-protein interaction through the proposed cofactor 
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binding sites is possibly lowered by the random electrostatic charge interaction 
between two proteins on other part of protein surfaces.  Further investigation by 
NMR titration is shown below.  
pa-Fpr
pa-HO
pa-Fpr-NADP+
 
Figure 4-17. Proposed electrostatic protein-protein interaction.  Pa-HO matches its top 
positive and bottom negative charges highlighted by green circle around heme with the top 
negative and bottom positive charges highlighted by yellow circle around FAD isoallaxozine 
ring in either pa-FPR or pa-FPR-NADP+.  FAD is shown in yellow sticks, NADP+ in green, 
and heme in magenta.  Red shows negative potential and blue shows positive potential. 
 
 Protein dissociation constant Kd<10-6M indicates strong protein-protein 
interaction (PPI), while weak PPI has Kd>10-4M [69].  In general, mapping 1H, 15N 
chemical shift perturbation via a 1H-15N HSQC NMR experiment is a very sensitive 
approach for studying the interface of weak protein binding complex [70].  By 
titrating unlabeled protein into [U-15N] labeled protein using different protein 
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proportions and tracking the chemical shift pertrubation, not only the binding 
interface, but also other information like binding specificity, affinity and 
protein:protein stoichiometry value can be obtained [71].  As for ultra-weak protein 
complex (Kd>10-3M), it is very difficult to detect using conventional methods like 
coimmunoprecipitation etc, often it is missed as false binding events [22].  But, the 
ultra-weak protein complex with 10 mM Kd has already been reported by this NMR 
chemical shift perturbation method  [72]. 
As for the electrostatic protein-protein complex of pa-FPR and pa-HO, NMR 
chemical shift perturbation study using one [U-15N] protein titrated by the other 
unlabeled protein is carried out with 1H-15N HSQC experiment.  This transient pa-
FPR pa-HO protein complex and ultra-weak protein interaction make the chemical 
shift perturbation extremely small.  The observed largest chemical shift change using 
[U-15N] pa-FPR (29.5kD) titrated by unlabeled pa-HO (23kD) is negligible.  In 
general, it could suggest either no protein interaction or protein interaction beyond 
detect limit.  As shown in previous chapter, the protein interaction between the two 
proteins indeed exists.  Therefore, we carried out the experiment by titrating 
unlabeled pa-FPR into [U-15N] pa-HO which is smaller in protein size.  Fortunately, 
with continuous searching for optimal interaction conditions, we obtained consistent 
chemical shift perturbation results from many trials.  The largest chemical shift 
change is less than 0.02 or 0.03 ppm, and once again this observation suggests that 
the protein complex is very weak.  By further mapping those perturbed residue onto 
pa-HO protein crystal structure, as shown in Figure 4-18, we found that the largely 
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perturbed residues due to protein-protein interaction are more or less located around 
the heme binding site.  The observation matches with the predicted protein interaction 
interface from the previous crystallography study.  Currently, this study is continued 
by Dr. Huili Yao in our lab.  Her preliminary data suggest the same result. 
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Figure 4-18. (A) Per residue plot of 15N pa-HO-N3 chemical shift perturbation upon titration 
with 12 equivalents of pa-FPR.  Red line shows the 1.5 times average.  (B) Residues above 
the 1.5 times average chemical shift change shown by the red line in above plot are mapped 
onto pa-HO crystal structure by cyan color. 
 
These findings shine the light in this ultra-weak PPI that can be commonly 
missed by many other techniques [72].  In general, these ultra-weak PPIs are 
neglected in many studies due to lack of evidence for interaction.  Recently, the ultra-
weak PPI has been emphasized in many studies for its important role in vivo [22].  
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Yet its study is very difficult, limited, and far from complete.  This study is the first 
example to probe the mysterious ultra-weak protein-protein interaction by analyzing 
very small change from NMR chemical shift perturbation. 
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APPENDIX 
Table S-4-1.  Backbone assignments for pa-FPR.  Chemical shifts are given in ppm.  
 
No. AA N NH Cα (i) Cα (i-1) Cβ (i) Cβ (i-1) Co (i) Co (i-1) 
1 Met         
2 Ser         
3 Asn         
4 Leu 119.40 7.94 53.93  43.83 38.54 173.97 177.40 
5 Tyr 122.40 9.35 57.07 53.98 39.37 43.87 175.72 174.05 
6 Thr 116.69 8.58 61.86 57.19 69.54 39.43 177.44 175.72 
7 Glu 125.16 9.13 52.96 61.77 31.04 69.56 176.67 177.43 
8 Arg 118.10 8.58 53.72 52.86 33.07 31.23 174.99 176.71 
9 Val 122.46 9.04 63.69 53.92 31.58 32.92 174.63 174.93 
10 Leu 130.79 10.01 55.68 63.69 43.76 31.66 174.74 174.69 
11 Ser 110.21 7.53 58.04 55.62 64.17 43.47 179.86 174.87 
12 Val 119.92 8.56 61.68 57.66 35.57 64.19 177.13 179.86 
13 His 126.77 9.28 56.06 61.68 33.79 35.56 178.17 177.13 
14 His 126.93 8.56 55.93 56.06 30.95 33.83 177.10 178.15 
15 Trp 126.20 8.29 58.33 55.93 29.45 30.62 174.92 177.09 
16 Asn 115.80 8.50 52.81 58.42 36.32 29.85 176.44 174.95 
17 Asp         
18 Thr 108.30 8.28 62.24 56.38 70.50 40.23 178.78 174.90 
19 Leu 120.81 7.83 54.03 62.28 47.75 70.61 174.64 178.75 
20 Phe 122.37 10.52 56.19 54.03 41.64 47.81 180.78 174.58 
21 Ser 115.99 9.58 57.69 56.42 67.42 41.75 179.33 180.74 
22 Phe 116.76 8.69 55.47 57.23 40.93 67.41 179.16 179.31 
23 Lys 117.66 8.41 53.64 55.35 36.40 40.87 174.25 179.12 
24 Thr 114.02 9.72 60.17 53.66 72.35 36.47 177.07 174.25 
25 Thr 109.60 8.73 63.02 60.13 70.95 72.46 179.52 177.06 
26 Arg 117.86 8.03 53.65 62.94 34.48 70.85 176.91 179.55 
27 Asn 133.2 9.66 53.81 53.65 38.75 34.13 176.74 176.89 
28 Pro 
  64.35  31.52  173.91  
29 Gly 105.00 9.17 44.96 64.35  31.52 177.07 173.91 
30 Leu 123.53 8.02 54.50 44.96 39.86  176.92 177.09 
31 Arg 128.92 8.42 54.65 54.65 30.74 39.76 177.01 176.91 
32 Phe 116.52 7.69 55.57 54.70 41.15 30.73 178.32 177.03 
33 Lys 120.43 8.44 54.46 55.58 33.03 41.16 176.56 178.31 
34 Thr 119.23 8.15 64.40 54.43 69.18 33.05 178.35 173.80 
35 Gly 116.24 8.71 45.50 64.37  69.18 174.78 178.36 
36 Gln 116.49 7.89 57.48 45.51 31.01  176.92 174.77 
37 Phe 115.07 9.15 55.35 57.49 41.26 31.03 178.02 176.90 
38 Val 114.98 8.83 58.97 55.54 35.60 41.28 178.02 178.02 
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39 Met 118.22 7.93 53.55 59.01 31.71 35.54 175.99 178.02 
40 Ile 115.46 8.88 58.72 53.35 41.24 31.63 176.51 175.92 
41 Gly 104.55 8.36 46.93 58.54  41.26 180.72 176.48 
42 Leu 115.36 7.34 52.01 47.02 46.02  175.92 180.73 
43 Glu 121.27 8.69 56.68 52.01 29.48 46.55 176.12 175.92 
44 Val 128.47 8.75 61.87 56.71 34.22 29.47 176.09 176.16 
45 Asp 127.76 9.36 55.47 61.67 39.33 34.48 175.19 176.03 
46 Gly 102.11 8.60 45.24 55.50  39.19 177.77 175.23 
47 Arg 122.43 7.95 52.08 45.26 30.58  177.93 177.76 
48 Pro 
  63.37  31.50  175.98  
49 Leu 133.00 9.06 55.21 63.37 41.69 31.50 178.00 175.98 
50 Met 119.55 8.01 52.04 55.21 33.96 41.53 174.10 178.00 
51 Arg 121.07 9.73 52.82 51.88 33.88 33.91 176.55 174.08 
52 Ala 124.40 7.77 52.82 52.83 18.30 33.88 175.60 176.57 
53 Tyr 122.37 9.25 57.41 52.82 43.46 18.29 176.26 175.54 
54 Ser 122.00 8.84 60.67 57.25 64.09 43.32 178.75 176.22 
55 Ile 123.91 7.83 63.01 60.63 36.47 64.07 176.34 178.66 
56 Ala 129.05 7.98 51.68 63.01 19.01 36.60 175.70 176.33 
57 Ser 108.20 7.24 53.61 51.75 61.86 19.01 178.39 175.73 
58 Pro 
  60.89  31.55  171.60  
59 Asn 122.01 9.43 55.11 60.89 35.98 31.55 175.27 171.60 
60 Tyr 114.26 6.46 55.18 55.18 37.53 36.17 175.28 175.26 
61 Glu 121.98 6.83 55.78 55.11 30.07 37.28 174.64 175.29 
62 Glu 121.95 8.90 56.02 55.34 28.21 30.00 177.33 174.63 
63 His 115.43 7.30 55.25 55.81 32.29 28.24 179.00 177.32 
64 Leu 118.57 8.77 53.40 55.77 43.92  176.08 178.99 
65 Glu 119.70 7.13 53.94 53.27 33.21 44.18 180.75 176.06 
66 Phe 121.18 8.21 56.36 53.83 41.83 32.72 179.00 180.73 
67 Phe 125.09 10.51 53.96 56.48 40.08 41.85 178.05 179.01 
68 Ser 119.50 9.90 55.81 54.05 65.91 40.04 178.52 177.93 
69 Ile 127.99 8.81 57.36 55.86 40.79 66.00 176.38 178.55 
70 Lys 121.81 7.59 56.47 57.69 32.56 40.89 176.69 176.46 
71 Val 127.48 8.18 59.46 56.42  32.85 175.33 176.77 
72 Pro 
      175.17  
73 Asp 118.23 8.54 53.17  33.80  174.92 175.17 
74 Gly 113.61 8.23 44.59    177.92 174.93 
75 Pro 
  66.36  32.50  174.38  
76 Leu 114.42 9.91 57.17 66.36 41.72 32.50 170.22 174.38 
77 Thr 114.34 10.13 67.41 57.31 70.38 41.88 173.77 170.19 
78 Ser 118.45 8.77 61.45 67.16 62.74 70.28 175.59 173.84 
79 Arg 120.93 7.13 57.52 61.72 30.66 62.79 172.28 175.58 
80 Leu 123.41 9.31 56.98 57.56 44.72 30.34 174.73 172.26 
81 Gln 108.50 7.51 56.66 56.66 26.48 44.63 176.68 174.74 
82 His 119.02 7.04 55.45 56.55 30.55 26.55 176.42 176.67 
83 Leu 121.85 7.52 56.04 55.41 43.80 30.56 176.19 176.35 
84 Lys 119.58 8.69 53.55 56.01 35.89 43.87 176.46 175.15 
85 Glu 119.20 8.64 58.25 53.53 28.70 35.89 174.55 176.46 
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86 Gly 114.10 9.22 44.87 58.29  28.67 174.54 174.54 
87 Asp 121.47 8.03 54.91 44.82 41.36  176.74 177.22 
88 Glu 117.15 8.13 55.13 54.95 31.82 41.36 176.31 176.73 
89 Leu 123.53 8.78 53.52 55.09 46.56 31.77 176.71 176.23 
90 Met 122.75 8.51 55.03 53.43 33.89 46.42 176.17 176.67 
91 Val 120.65 8.79 60.95 54.98 36.29 33.51 176.26 176.10 
92 Ser 121.89 9.19 58.82 60.96 63.36 36.48 179.85 176.42 
93 Arg 109.92 7.52 56.75 58.79 30.94 63.41 174.55 179.84 
94 Lys 118.27 7.72 52.82 57.09 33.20 30.90 178.48 174.49 
95 Pro 
  62.42  32.02  76.42  
96 Thr 115.28 8.27 59.78 62.42 69.16 32.02 180.93 176.42 
97 Gly 106.87 7.47 45.32 59.80  69.18 176.62 180.92 
98 Thr 109.81 8.31 61.71 45.33 70.38  174.90 176.61 
99 Leu 127.03 9.56 53.64 62.47 38.09 70.42 178.51 174.85 
100 Val 107.72 7.08 57.56 53.58 34.15 38.00 174.81 178.49 
101 His 119.70 8.66 59.50 57.42 31.25 34.16 172.37 174.81 
102 Asp 111.97 8.32 55.87 59.50 40.42 30.99 175.08 172.28 
103 Asp 117.20 7.31 54.70 55.89 39.85 40.42 177.80 175.11 
104 Leu 118.29 7.43 52.80 54.71 43.27 40.01 173.47 177.82 
105 Leu 125.61 8.60 53.52 52.81 40.40 43.28 176.52 173.46 
106 Pro 
  63.37  31.42  174.13  
107 Gly 110.96 8.66 45.03 63.37  31.42 181.37 174.13 
108 Lys 117.22 8.87 57.78 45.02 35.53  174.94 181.37 
109 His 118.42 8.11 52.45 57.75 30.92 35.55 179.21 174.91 
110 Leu 123.76 8.14 52.53 52.53 40.92 31.17 178.28 179.14 
111 Tyr 126.73 9.37 57.99 52.46 39.26 41.05 178.20 178.28 
112 Leu 125.16 9.46 52.52 57.90 39.82 39.06 178.18 178.22 
113 Leu 123.22 8.65 54.56 52.59 40.09 39.66 176.96 178.07 
114 Ser 116.72 8.44 56.98 54.64 70.70 40.01 175.97 176.98 
115 Thr 109.48 7.61 58.66 56.75 71.33 70.70 175.84 175.95 
116 Gly 108.74 7.79 47.08 58.78  71.53 174.76 175.77 
117 Thr 119.36 9.60 64.50 47.02 67.37  176.33 174.76 
118 Gly 109.88 8.87 46.60 64.59  67.46 180.01 176.22 
119 Met 114.04 6.80 57.55 46.52 33.03  173.82 180.03 
120 Ala 120.96 8.69 56.69 57.89 17.75 33.02 176.15 173.82 
121 Pro 
  65.62  30.11  172.30  
122 Phe 118.43 6.91 55.17 65.62 35.65 30.11 173.75 172.30 
123 Leu 123.26 7.87 57.71 54.92 40.40 35.73 172.64 173.71 
124 Ser 113.74 6.69 62.41 57.76 64.07 40.46 172.75 172.66 
125 Val 117.97 7.68 67.18 62.17 31.23 64.33 170.88 173.09 
126 Ile 111.62 8.57 64.26 67.48 36.45  176.13 170.80 
127 Gln 117.10 7.14 55.02 64.17 31.58 36.60 179.64 176.10 
128 Asp 122.17 7.29 50.36 55.12 42.46 31.79 176.19 179.56 
129 Pro 
      172.69  
130 Glu 118.28 8.57 58.79  28.88  173.28 172.69 
131 Thr 115.94 7.88 65.71 58.76 68.23 28.85 177.80 173.26 
132 Tyr 114.98 6.26 59.49 65.20 37.55 68.20 176.03 177.67 
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133 Glu 117.02 7.35 57.57 59.48 29.57 37.58 172.57 176.04 
134 Arg 115.21 7.21 57.81 57.81 32.62 29.51 176.34 172.57 
135 Tyr 113.49 6.83 57.86 57.86 41.51 32.63 177.28 176.35 
136 Glu 118.75 9.22 57.82 57.82 30.80 41.42 174.18 177.28 
137 Lys 113.09 7.67 53.77 57.88 37.39  177.65 174.25 
138 Val 124.08 8.88 60.43 53.71 34.01 37.16 179.24 177.63 
139 Ile 128.40 9.23 60.34 60.43 39.01 34.02 178.16 179.19 
140 Leu 128.53 9.22 53.44 60.34 43.48 39.01 178.12 178.15 
141 Val 129.41 9.42 60.96 43.45 32.49 39.01 176.20 178.16 
142 His 128.72 7.70  61.04  32.59 178.77 176.24 
143 Gly 112.63 8.59 45.61 53.22  33.83 178.66 178.78 
144 Val 120.23 8.85 59.02 45.55 34.42  176.29 178.49 
145 Arg 117.59 8.21 58.16 58.86 30.71 34.54 176.40 176.31 
146 Trp 114.68 7.25 54.36 58.16 32.98 30.91 175.21 176.45 
147 Val 123.78 9.79 65.88 54.43 31.45 33.04 172.42 175.21 
148 Ser 115.20 8.86 60.10 66.14 62.58 31.79 176.91 172.42 
149 Glu 117.36 7.85 55.99 59.99 28.74 62.48 174.27 176.91 
150 Leu 122.99 7.46 53.39 55.86 37.98 28.81 174.43 174.28 
151 Ala 127.84 8.19 51.91 53.26 19.03 38.02 176.57 174.51 
152 Tyr         
153 Ala 121.17 6.88 56.78  19.36  170.93 176.78 
154 Asp 118.16 8.59 57.45 57.21 39.49 19.57 173.72 170.93 
155 Phe 123.81 8.59 60.97 57.38 38.53 40.04 174.68 173.82 
156 Ile 118.33 8.71 65.45 61.42 38.47 38.42 175.45 174.60 
157 Thr 104.27 7.60 63.48 65.29 70.96 39.28 175.29 175.45 
158 Lys 118.31 8.56 56.99 63.38 33.87 70.88 174.28 175.32 
159 Val 121.46 7.32 65.27 57.01 31.79 34.03 173.58 174.26 
160 Leu 122.76 8.26 58.85 65.11 38.61 32.00 176.46 173.56 
161 Pro 
  64.79  31.03  176.74  
162 Glu 111.30 7.13 53.80 64.79 28.65 31.03 175.05 176.74 
163 His 123.35 7.70 59.95 53.68 30.50 28.83 173.47 175.05 
164 Glu 127.66 8.52 58.97 60.14 29.40 30.61 174.95 173.48 
165 Tyr 119.78 9.88 58.76 58.76  29.98 174.37 174.96 
166 Phe 113.97 7.66 56.65 58.40 37.65  175.68 174.29 
167 Gly 113.80 8.07 48.21 56.64  37.90 176.69 175.68 
168 Asp 118.81 8.59 57.29 48.16 39.25  172.50 176.68 
169 Gln 119.11 7.51 58.67 57.35 28.16 39.34 174.08 172.47 
170 Val 120.36 7.61 59.65 58.85 31.28 28.48 172.27 174.08 
171 Lys 118.03 8.48 59.94 66.12 32.70 31.45 172.54 172.21 
172 Glu 115.50 7.40 58.09 59.85 30.81 32.75 173.74 172.59 
173 Lys 114.50 8.36 58.73 57.97 36.81 30.76 175.78 173.74 
174 Leu 119.36 8.43 55.24 58.73 42.61 36.49 174.91 175.71 
175 Ile 131.49 9.78 60.60 55.39 39.45 42.36 178.44 174.87 
176 Tyr 128.47 8.62 54.55 60.53 39.97 39.59 178.34 178.47 
177 Tyr 134.04 9.67 55.55 54.53 39.27 39.94  178.15 
178 Pro 
  61.52  33.44  175.85  
179 Leu 122.53 8.61 54.69 61.52 46.00 33.44 177.79 175.85 
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180 Val 122.26 7.46 60.09 54.70 35.27 45.97 173.79 177.56 
181 Thr 112.90 8.10 63.09 60.14 70.30 35.66 ?? 173.84 
182 Arg 118.87 8.46 56.50 62.97 28.79 70.08 176.90 173.28 
183 Glu 116.32 7.09 53.54 56.41 30.84 28.84 179.68 176.87 
184 Pro 
  63.72  31.60  175.64  
185 Phe 120.64 7.81 57.65 63.72 41.59 31.60 177.35 175.64 
186 Arg         
187 Asn         
188 Gln 123.44 8.42 53.91 51.72 31.92 38.71 175.97 178.19 
189 Gly 109.26 7.45 43.61 53.93  31.73 180.70 175.96 
190 Arg 116.43 8.41 54.57 43.53 31.15  173.31 180.65 
191 Gln         
192 Thr         
193 Asp         
194 Leu         
195 Met         
196 Arg         
197 Ser 110.50 8.24 58.90 59.84 64.07 30.02 175.88 173.13 
198 Gly 110.19 7.30 45.15 58.94  64.25 177.86 175.88 
199 Lys 125.41 8.12 58.76 45.15 32.43  174.57 177.81 
200 Leu 115.85 7.45 58.73 58.84 41.49 32.33 175.26 174.57 
201 Phe 112.80 5.61 58.84 58.73 36.41  174.04 175.28 
202 Glu 117.68 7.43 52.68 58.84 29.36 36.46 171.62 174.09 
203 Asp 119.36 8.66 57.39 53.48 40.72 29.15 172.55 171.61 
204 Ile 109.78 7.39 61.59 57.29 38.00 40.66 175.67 172.61 
205 Gly 110.38 7.74 46.32 61.62  37.85 177.34 175.63 
206 Leu 121.58 7.82 51.97 46.36 41.92  178.25 177.32 
207 Pro 
        
208 Pro 
        
209 Met         
210 Asn         
211 Pro 
  64.19  31.51  173.14  
212 Gln 121.30 8.59 59.01 64.19 28.30 31.51 173.85 173.14 
213 Asp 115.29 7.74 55.87 58.98 43.86 28.35 174.83 173.86 
214 Asp 121.94 8.24 56.24 55.62 44.34 43.83 178.17 174.85 
215 Arg 121.06 9.11 51.15 56.20 32.41 44.29 175.84 178.14 
216 Ala 118.56 8.10 50.44 50.90 23.22 32.27 176.06 175.81 
217 Met 117.22 8.87 54.98 50.54 36.64 23.23 177.96 176.17 
218 Ile 121.22 8.81 59.62 54.98 39.71 36.58 177.35 177.96 
219 Cys 127.40 8.82 58.73 59.88 28.89 39.83 177.44 177.30 
220 Gly 111.22 6.82 45.42 58.43  29.05 179.35 177.58 
221 Ser 116.96 7.41 56.06 45.37 62.48   179.36 
222 Pro 
        
223 Ser  
224 Met 126.08 7.66 58.72 61.24 31.44 62.38 171.44 174.99 
225 Leu 122.94 8.82 58.88 58.88 41.80 31.50 171.28 171.43 
226 Glu 119.72 7.64 59.44 58.98 29.35 41.70 172.60 171.24 
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227 Glu 119.40 7.94 59.01 59.01 29.91 29.50 172.58 172.61 
228 Thr 116.20 8.90 67.00 58.78 72.81 29.84 175.07 172.56 
229 Ser 118.22 8.23 62.61 67.26   177.33 175.07 
230 Ala 120.98 7.09 54.97 62.72 17.33  170.37 177.25 
231 Val 119.00 7.34 65.94 54.98 30.69 17.23 173.07 170.37 
232 Leu 121.45 7.98 58.97 66.15 38.28 30.42 171.68 173.00 
233 Asp 120.71 8.84 56.55 58.97 39.64 38.21 169.77 171.66 
234 Ser 119.01 7.70 61.30 56.75 62.47 39.54 176.08 169.76 
235 Phe 121.10 7.43 55.99 61.30 38.49 62.40 175.75 176.11 
236 Gly 105.96 8.05 44.65 55.99  38.62 177.60 175.72 
237 Leu 122.26 7.46 57.36 44.72 42.45  175.18 177.55 
238 Lys 121.13 10.25 54.24 57.10 33.67 42.49 176.25 175.21 
239 Ile 127.47 8.43 60.90 54.31 38.48 33.63 175.48 176.25 
240 Ser 119.29 7.59 56.04 60.85 64.26 38.55 177.09 175.49 
241 Pro 
  64.25  32.30  175.03  
242 Arg 112.37 7.31 54.70 64.25 30.68 32.30 178.21 175.03 
243 Met 119.64 8.21 57.49 54.73 32.68 30.68 173.87 178.20 
244 Gly 116.79 10.12 45.18 57.46  32.75 177.77 173.87 
245 Glu 119.19 7.65 52.85 45.26 31.52  178.73 177.76 
246 Pro 
  62.47  32.00  174.38  
247 Gly 107.27 8.23 44.36 62.47  32.00 180.10 174.38 
248 Asp 119.73 8.81 55.70 44.35 41.42  175.90 180.08 
249 Tyr 108.71 7.19 55.64 55.64 41.24 41.24 180.05 175.76 
250 Leu 118.74 7.97 52.84 55.46 47.77 41.44 174.96 180.06 
251 Ile 111.18 8.32 58.71 52.78 41.74 47.78 176.38 175.01 
252 Glu 122.94 8.51 57.17 58.71 33.93 41.68 178.13 176.57 
253 Arg 124.62 8.24 56.27 57.09 29.12 34.04 177.22 178.12 
254 Ala 121.93 7.64 51.17 56.27 17.68 29.15 176.63 177.20 
255 Phe 102.75 6.48 55.19 51.22 37.04 17.71 179.85 176.56 
256 Val 114.91 8.60 60.87 55.15 33.77 36.91 175.36 179.85 
257 Glu 126.15 8.34 56.13 60.84 30.28 33.63 176.24 175.37 
258 Lys 129.26 8.31 57.83 56.19 33.31 30.27 170.28 176.24 
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Figure S-4-1. 2D 1H-15N HSQC spectrum of 15N-Gly labeled pa-FPR. (Partial scrambling to 
Serine seen as the weak intensity peak is used to assist assignment work. The black line 
connects the amide side chain peaks, excluded from analysis) 
 
 
Figure S-4-2. 2D 1H-15N HSQC spectrum of 15N-Leu labeled pa-FPR. (Some scrambling to 
Asp(D) and Val(V) is seen as weak intensity peak.) 
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Figure S-4-3. 2D 1H-15N HSQC spectrum of 15N-Val labeled pa-FPR. No scrambling. 
 
 
Figure S-4-4. 2D 1H-15N HSQC spectrum of 15N-Phe labeled pa-FPR. No scrambling. 
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Figure S-4-5. 2D 1H-15N HSQC spectrum of 15N-Thr labeled pa-FPR. (A little scrambling to 
Asp(D) and Gly(G) etc. is seen as very weak intensity peak. The black line connects the 
amide side chain peaks, excluded from analysis.) 
.  
Figure S-4-6. 2D 1H-15N HSQC spectrum of 15N-Tyr labeled pa-FPR. (Heavy scrambling to 
F, D, E, L, V etc. is seen as weak intensity peak. The black line connects the amide side chain 
peaks, excluded from analysis.) 
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Figure S-4-7. 2D 1H-15N HSQC spectrum of 15N-Ala labeled pa-FPR. (No scrambling. Peak 
doubling is caused by proton decoupling setting in HSQC experiment.) 
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CHAPTER V: CONCLUSION 
 
The heme oxygenase (pa-HO) and ferredoxin NADPH reductase (pa-FPR) 
are two key proteins in the notorious pathogenic bacterium Pseudomonas 
aerguinosa.  Unlike any other heme-containing proteins, heme oxygenase has a 
very unique heme metabolism path.  Heme in it is used as both substrate and 
cofactor for its own degradation to verdoheme together with iron and CO release 
[1-6].  In the process of P. aerguinosa initial infection to its host (especially 
human beings), pa-HO is required to degrade heme from host to release iron for 
its nutrient need [7-10].  Therefore, pa-HO is the center of the heme-iron 
acquisition pathway [11].  Based on previous intensive study of the protein 
active site as well as the intriguing heme hydroxylation chemistry [12-14], here 
this study of the phenomenal phenylalanine ring cluster existing in heme 
oxygenase reveals that not only the crucial heme-protein interaction contributes to 
the unique catalysis but also the hydrophobic Phenylalanine ring cluster maintains 
and regulates the protein structure and dynamics, therefore facilitates the protein 
catalysis through its hydrophobic interaction with the H-bonding network related 
between amino acids and internal structural water molecules.  With the thorough 
understanding of pa-HO protein structure-function relationship, we further 
searched and studied its potential redox partner proteins in the heme-iron 
acquisition pathway.  A surprising result is discovered that a ferredoxin reductase 
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protein instead of a ferredoxin protein donates all the electrons required for heme 
degradation to pa-HO [15].  Subsequent study is focused on this ferredoxin 
NADPH reductase protein: pa-FPR, the crystal structures and NMR backbone 
assignments in solution phase for pa-FPR protein and its NADP+ bound form 
were carried out.  As the first example of the bacterial FNR-NADP+ complex, we 
found that the general accepted direct hydride transfer mechanism [16] between 
FNR and NADP(H) is not applicable to pa-FPR.  Further studies lead us to 
propose a novel e-/H+/e- step-wise hydride transfer mechanism.  At last, with the 
available NMR assignment and crystal structures, we studied the protein complex 
between pa-FPR and pa-HO; the preliminary studies suggest that the complex is 
weak and transient.  In brief, the studies of these two proteins show some 
intriguing findings and possibly bring some new understanding in protein 
structure and catalysis relationship, hydride transfer mechanism in ferredoxin 
reductase protein family and weak protein-protein interaction in redox protein 
complex. 
A cluster of Phe rings exists in HO, and several of them are close to the 
heme distal pocket and are poised to interact with one another (as shown earlier in 
Figure 1-5 and 2-3).  It can possibly form a hydrophobic cluster and exclude 
water molecule.  The studies of mutagenesis and fluorine labeling to these Phe 
residues in pa-HO revealed decreased heme oxygenase reactivity and increased 
peroxidase reactivity.  While the NMR, UV-vis and CD studies show that protein 
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overall structure is maintained and only small local disruption mostly around 
heme binding pocket is observed.  Protein dynamics study via NMR suggests 
that either mutation or ortho-19F-Phe labeling increased protein dynamic motion in 
the large (hrs-days) time scales detected by H/D exchange experiment.  These 
results surprisingly contradict the general belief that 19F-Phe labeling will do very 
little to influence a protein’s structure and function [17-19].  With the 
combination of ortho-19F-Phenylalanine labeling and F45L mutation, the impact is 
further enhanced on both reactivity and protein dynamics.  
It is commonly known that the “active site” in a protein, generally 
composed of several residues, is directly involved in ligand binding and catalysis.  
It also has been recognized that protein motion/dynamics are closely related to 
protein catalysis.  Here the interaction between heme and protein active site is 
crucial in regulating this unique heme oxygenation catalysis.  Likely, protein 
peripheral area also contributes to catalysis through maintaining proper protein 
conformation as well as sufficient protein motion.  Recent NMR studies in 
human HO-1 done by Lar Mar et al. [20, 21] and in pa-HO done by Dr. Juan 
Carlos Rodriguez from our lab [22] revealed that the influence of a single 
mutation is propagated to the peripheral area in protein through the hydrogen 
bonding network and protein dynamics.  Here our studies of this Phe ring cluster 
in pa-HO found out that the H-bonding network in the heme binding pocket is 
likely altered during the protein mutation or/and the ortho-19F-Phe labeling.  It 
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suggests that this hydrophobic cluster not only maintains protein structure, but 
also fine-tunes protein dynamics to facilitate the channeled H-bonding network 
from heme binding site to the protein periphery for the unique heme metabolism.  
Therefore the understanding toward the protein structure and function relationship 
in pa-HO is obtained not only around the active site but also at the protein 
peripheral area like this phenomenal Phe ring cluster.  
Current understanding of the redox partner of bacterial heme oxygenase is 
lacking.  It is believed that cyanobacterial and eubacterial HOs are 
ferredoxin-dependent.  In the study of pa-HO redox partner in the heme-iron 
acquisition pathway, we found a surprising result that a ferredoxin NADPH 
reductase (pa-FPR) by itself can donate all seven electrons to pa-HO for heme 
degradation and iron release without the need of a ferredoxin protein [15].  
Ferredoxin NADP+ reductases (FNRs) catalyze the reversible electron transfer 
between NADP(H) and their cognate ferredoxin or flavodoxin partners [23].  
Spinach leaf FNR, as a typical plastidic FNR, is one of the best characterized 
enzymes.  It reduces NADP+ to produce NADPH necessary for the subsequent 
photosynthetic paths [24].  In contrast, bacterial ferredoxin reductases displace 
the equilibrium toward the oxidation of the NADPH pool, in order to use this 
reducing potential in a large number of oxidoreductive processes.  Pa-FPR is 
classified as a bacterial subclass I ferredoxin NADPH reductase (FNR) protein 
[25].  We studied pa-FPR by X-ray crystallography and spectroscopic methods.  
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The crystal structure of pa-FPR (1.6 Å resolution) revealed very similar protein 
folding to the structure of Azotobacter vinelandii FPR and E. coli flavodoxin 
reductase.  The latter two enzymes interact with distinct redox partners, a 
ferredoxin and a flavodoxin, respectively.  Thus these findings reported here 
extend the range of redox partners recognized by the fold of pa-FPR to include a 
heme oxygenase (pa-HO).   
NADPH
NADP+
Pa-FPR (oxidized)
Pa-FPR (reduced)
Pa-HO (FeII ) 
Pa-HO (FeIII )
FeII , CO, biliverdin
3O2
 
Figure 5-1. Proposed electron transfer from pa-FPR to pa-HO.  
 
In the reaction between pa-FPR and NADPH, pa-FPR binds its coenzyme 
NADPH first, then FAD inside pa-FPR is directly reduced to its fully reduced 
form FADH2, and finally electrons from FADH2 were delivered to pa-HO.  This 
NAD(P)+ coenzyme binding process is intensively studied in ferredoxin reductase 
protein family.  The study of electron transfer process of between NADPH and 
pa-FPR protein or NAD(P)+ is the most important step before any further study of 
protein-protein interaction between pa-FPR and pa-HO.  First, we obtained the 
NMR backbone assignment in solution phase for pa-FPR and co-crystallized 
pa-FPR-NADP+ complex crystal structure as the first example in bacterial 
subclass FNR group and second example in the whole FNR family. 
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By comparing bacterial subclass I pa-FPR with plastidic FNRs, NMR and 
crystallography studies revealed that pa-FPR has preformed and well-stabilized 
NADP+ binding site and the conformational change upon NADP+ binding is 
comparatively small.  Therefore, the NADP+ binding process in pa-FPR is 
probably different from the commonly accepted two-step NADP(H) binding in 
plastidic FNRs: with the first step involving strong interactions between the 
2’-adenosyl phosphate and FNR, and the second step requiring displacement of 
the terminal Tyr to allow the nicotinamide ring to stack parallel to the 
isoalloxazine ring of FAD [26].  In plastidic FNRs, the reaction between FAD 
and NADPH is generally considered as the result of direct hydride transfer which 
is facilitated by certain conformational rearrangement placing the nicotinamide 
and isoalloxazine rings parallel and adjacent to each other.  From our studies, 
there is no large conformational change and dynamic motion observed at the 
extended C-terminal tail in pa-FPR (AFVEK258 vs. C-terminal Tyrosine in 
plastidic FNRs).  Based on the most recent reported studies in the mechanism of 
NAD(P)H oxidation,  the hydride transfer can also occur in a stepwise manner by 
sequential electron-proton-electron transfer [27-36].  From the study of the 
pa-FPR-NADP+ complex crystal structure, we proposed a novel step-wise e-/H+/e- 
hydride transfer mechanism for bacterial FNR rather than adopting the 
conventional direct hydride transfer mechanism for plastidic FNR, as shown in 
 230
Equation (5-1).  Further study using fast spectroscopic technique can possibly 
detect the NADPH radicals in Equation (5-1) [27-36]. 
 
 
 
At last, we studied the protein-protein interaction (PPI) between pa-FPR 
and pa-HO using the available crystal structures and NMR backbone assignments 
for both proteins.  It has been found that all FNRs interact with their redox 
proteins via mainly electrostatic interaction and its protein complex is transient for 
efficient electron transfer purpose [66].  The preliminary data suggests that this 
PPI is transient, ultra-weak and electrostatic and the interaction interface on 
pa-HO is around the heme binding site.  The similar experiments were conducted 
by Dr. Huili Yao in our lab with possibly optimized conditions.  Her data have 
confirmed the above findings.  Further detailed study is ongoing.  
Overall, both pa-HO and pa-FPR proteins are excellent models for protein 
enzymology studies.  Especially, the initial biochemical and structural 
characterization of pa-FPR have brought up several interesting topics, like its 
redox partnership and protein-protein interaction with pa-HO and its unique 
hydride transfer mechanism as well as the NADP+ binding mode.  Still further 
(5-1) 
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studies via NMR structure and dynamic experiments (e.g. H/D exchange, CPMG) 
for understanding the electron transfer and redox chemistry facilitated by pa-FPR 
in complex with pa-HO or even other redox partner proteins will be important.  
All these studies are tremendously informative in revealing the iron acquisition 
pathway in Pseudomonas aerguinosa as well as making potential pharmaceutical 
applications. 
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